{
    "meta": {
        "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
        "terms": "https://open.fda.gov/terms/",
        "license": "https://open.fda.gov/license/",
        "last_updated": "2023-01-30",
        "results": {
            "skip": 0,
            "limit": 1000,
            "total": 945
        }
    },
    "results": [
        {
            "safetyreportversion": "3",
            "safetyreportid": "20298277",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220423",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220105",
            "receiptdateformat": "102",
            "receiptdate": "20220214",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2021US017932",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2021US017932"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2021US017932"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Cardiac sarcoidosis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Cardiac sarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20301818",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220423",
            "reporttype": "2",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220105",
            "receiptdateformat": "102",
            "receiptdate": "20220225",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2021US017975",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2021US017975"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2021US017975"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Rectal haemorrhage",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Gastrointestinal sounds abnormal",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Anorectal discomfort",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Therapeutic response shortened",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "drugenddateformat": "602",
                        "drugenddate": "2021",
                        "actiondrug": "1",
                        "drugadditional": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "HUMIRA",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "160",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "DAY 1 (160 MG), 1X/DAY",
                        "drugdosageform": "Solution for injection",
                        "drugadministrationroute": "058",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211216",
                        "drugenddateformat": "102",
                        "drugenddate": "20211216",
                        "drugtreatmentduration": "1",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ADALIMUMAB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20211201"
                }
            }
        },
        {
            "safetyreportversion": "3",
            "safetyreportid": "20303473",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220424",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "1",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220106",
            "receiptdateformat": "102",
            "receiptdate": "20220325",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2021US017899",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2021US017899"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2021US017899"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Colitis ulcerative",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Anal abscess",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Drug ineffective",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG AT 0, 2, 6 WEEKS AND 8 WEEKS THEREAFER, EVERY 2 MONTHS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Colitis ulcerative",
                        "drugstartdateformat": "610",
                        "drugstartdate": "201910",
                        "drugenddateformat": "610",
                        "drugenddate": "201912",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20191029"
                }
            }
        },
        {
            "safetyreportversion": "3",
            "safetyreportid": "20311528",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220423",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220108",
            "receiptdateformat": "102",
            "receiptdate": "20220317",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2021US015924",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Rheumatoid arthritis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Loss of therapeutic response",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FG4226",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "900",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "900MG, EVERY EIGHT WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Rheumatoid arthritis",
                        "drugenddateformat": "102",
                        "drugenddate": "20211116",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "3",
            "safetyreportid": "20311541",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220423",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "1",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20220108",
            "receiptdateformat": "102",
            "receiptdate": "20220225",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US000072",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US000072"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US000072"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Death",
                        "reactionoutcome": "5"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MILLIGRAM EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220103"
                }
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20316234",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220423",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "1",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220110",
            "receiptdateformat": "102",
            "receiptdate": "20220221",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US000093",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US000093"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US000093"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "2"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Myalgia",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Muscular weakness",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Joint swelling",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Dyspnoea",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Chest pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Chest discomfort",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Back pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "DK1284",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MG, EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ROSUVASTATIN",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ROSUVASTATIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "NASACORT ALLERGY 24HR",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "TRIAMCINOLONE ACETONIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "OMEPRAZOLE",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "OMEPRAZOLE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FISH OIL",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FISH OIL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "GINGER",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "GINGER"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PROBIOTICS [BIFIDOBACTERIUM LONGUM;LACTOBACILLUS ACIDOPHILUS;LACTOBACI",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3"
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SUPER LYSINE+",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3"
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VITAMIN C ACID [ASCORBIC ACID]",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3"
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VITAMIN D3",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CHOLECALCIFEROL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ZINC",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ZINC"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "DIPHENHYDRAMINE",
                        "drugbatchnumb": "UNKNOWN",
                        "drugdosagetext": "UNK",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DIPHENHYDRAMINE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20325028",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220423",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220111",
            "receiptdateformat": "102",
            "receiptdate": "20220210",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2021US017093",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2021US017093"
                },
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2021US017093"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Crohn^s disease",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Inflammatory bowel disease",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Hepatic steatosis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Eye disorder",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MILLIGRAM/KILOGRAM",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Inflammatory bowel disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "3",
            "safetyreportid": "20343326",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220423",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "1",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220117",
            "receiptdateformat": "102",
            "receiptdate": "20220310",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US000392",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US000392"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US000392"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Death",
                        "reactionoutcome": "5"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220112"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "20348585",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220423",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220119",
            "receiptdateformat": "102",
            "receiptdate": "20220119",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2021US016515",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Sympathetic ophthalmia",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Ankylosing spondylitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Keratitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Ankylosing spondylitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Sympathetic ophthalmia",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Keratitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "3",
            "safetyreportid": "20354311",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220423",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220120",
            "receiptdateformat": "102",
            "receiptdate": "20220303",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US000416",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US000416"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US000416"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Sarcoidosis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Sarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20364915",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220423",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220122",
            "receiptdateformat": "102",
            "receiptdate": "20220216",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US000472",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US000472"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US000472"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Crohn^s disease",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Psoriatic arthropathy",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Arthralgia",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10 MG/KG EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Crohn^s disease",
                        "drugenddateformat": "102",
                        "drugenddate": "20211126",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "20372182",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220423",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220124",
            "receiptdateformat": "102",
            "receiptdate": "20220124",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2021US016516",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2021US016516"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2021US016516"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Fistula",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Product substitution issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Drug ineffective",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNKNOWN DOSAGE",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "3",
            "safetyreportid": "20377263",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220423",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220126",
            "receiptdateformat": "102",
            "receiptdate": "20220319",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US000534",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US000534"
                },
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US000534"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Rheumatoid arthritis",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "3",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "3 MG/KG, EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Rheumatoid arthritis",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202109",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "METHOTREXATE",
                        "drugbatchnumb": "Unknown",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "10 PILLS WEEKLY",
                        "drugdosageform": "Pill (Except Tablets)",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHOTREXATE"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "FOLIC ACID",
                        "drugbatchnumb": "Uknown",
                        "drugdosagetext": "1 TABLET DAILY",
                        "drugdosageform": "Tablet",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FOLIC ACID"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20211129"
                }
            }
        },
        {
            "safetyreportversion": "3",
            "safetyreportid": "20380502",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220127",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US000545",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US000545"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US000545"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Sarcoidosis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Sarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "3",
            "safetyreportid": "20380569",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220127",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US000652",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US000652"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US000652"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "COVID-19",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Malaise",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "600MG, INFUSED EVERY FIVE WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "602",
                        "drugstartdate": "2021",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220118"
                }
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20388237",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220423",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220128",
            "receiptdateformat": "102",
            "receiptdate": "20220314",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US000669",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US000669"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US000669"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Uveitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Uveitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "20388985",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220423",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220128",
            "receiptdateformat": "102",
            "receiptdate": "20220128",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US000670",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US000670"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US000670"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Product distribution issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500MG EVERY 8 WEEKS INTRAVENOUSLY",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Psoriatic arthropathy",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202105",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20389169",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220423",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220128",
            "receiptdateformat": "102",
            "receiptdate": "20220319",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US000694",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US000694"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US000694"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Product distribution issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300MG EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Rheumatoid arthritis",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202108",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20404012",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220423",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220131",
            "receiptdateformat": "102",
            "receiptdate": "20220331",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2019US024147",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2019US024147"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2019US024147"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Polymyalgia rheumatica",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Psoriatic arthropathy",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Polymyalgia rheumatica",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20408444",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220423",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220201",
            "receiptdateformat": "102",
            "receiptdate": "20220316",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US000780",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US000780"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US000780"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Juvenile idiopathic arthritis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Juvenile idiopathic arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "5",
            "safetyreportid": "20415226",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220202",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US000804",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US000804"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US000804"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Uveitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Polyarthritis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Uveitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, (LAST INFUSION WAS ON 21 JUL 2022)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Polyarthritis",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220721",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "20428542",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220424",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220204",
            "receiptdateformat": "102",
            "receiptdate": "20220204",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2021US017179",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2021US017179"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2021US017179"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Weight decreased",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Diarrhoea",
                        "reactionoutcome": "2"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Hypersensitivity",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNKNOWN DOSE BY INFUSION",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Psoriatic arthropathy",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211207",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ARAVA",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "10MG DAILY BY MOUTH",
                        "drugindication": "Psoriatic arthropathy",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LEFLUNOMIDE"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20211207"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "20436638",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220424",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220207",
            "receiptdateformat": "102",
            "receiptdate": "20220207",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2021US017094",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Rheumatoid arthritis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Anti-cyclic citrullinated peptide antibody positive",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Drug ineffective",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20441116",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220720",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "1",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20220208",
            "receiptdateformat": "102",
            "receiptdate": "20220521",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US001346",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US001346"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US001346"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "4"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Death",
                        "reactionoutcome": "5"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Hormone replacement therapy",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20181210",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20181227",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20190124",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20190311",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20181210"
                }
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20441501",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220424",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220208",
            "receiptdateformat": "102",
            "receiptdate": "20220322",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US001097",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US001097"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US001097"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Iridocyclitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Iridocyclitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "20457532",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220424",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220210",
            "receiptdateformat": "102",
            "receiptdate": "20220210",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2021US017611",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2021US017611"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2021US017611"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Pyoderma gangrenosum",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Pyoderma gangrenosum",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "4",
            "safetyreportid": "20458361",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221027",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220211",
            "receiptdateformat": "102",
            "receiptdate": "20220916",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US001263",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US001263"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US001263"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "2"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Sarcoidosis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "1400",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "1400 MILLIGRAM, EVERY 4 WEEKS (28 DAYS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Sarcoidosis",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "14 100MG/20ML DIRECTIONS: INJECT (BLANK) MG OF INFLECTRA FREQUENCY: ONCE QUANTITY: 1 REFILLS:11",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "4",
            "safetyreportid": "20472179",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221027",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220214",
            "receiptdateformat": "102",
            "receiptdate": "20220808",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US001508",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US001508"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US001508"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Cellulitis",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Rheumatoid arthritis",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211210",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CELEBREX",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CELECOXIB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20478708",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220423",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220216",
            "receiptdateformat": "102",
            "receiptdate": "20220331",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US001457",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US001457"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US001457"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Rectal haemorrhage",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Anal haemorrhage",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Rectal haemorrhage",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Anal haemorrhage",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20482639",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220721",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220217",
            "receiptdateformat": "102",
            "receiptdate": "20220401",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US001516",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US001516"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US001516"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Uveitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Uveitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20492359",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220721",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "1",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20220218",
            "receiptdateformat": "102",
            "receiptdate": "20220404",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US001629",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US001629"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US001629"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Condition aggravated",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Therapeutic response changed",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Underdose",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "325",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "2",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "325 MG, EVERY 2 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "REMICADE",
                        "drugbatchnumb": "UNKNOWN",
                        "drugdosagetext": "EVERY 8 WEEKS",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "MESALAMINE",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "MESALAMINE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "20493462",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220423",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220220",
            "receiptdateformat": "102",
            "receiptdate": "20220220",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2021US018943",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2021US018943"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2021US018943"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Colitis ulcerative",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Drug level decreased",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Product temperature excursion issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Drug specific antibody absent",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNKNOWN",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "7.5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "7.5 MILLIGRAM/KILOGRAM, EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "5",
            "safetyreportid": "20505370",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221027",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "1",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20220223",
            "receiptdateformat": "102",
            "receiptdate": "20220810",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US001789",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US001789"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US001789"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Disability",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Inability to afford medication",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Product temperature excursion issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, USUALLY HAS THEM EVERY 28 DAYS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Psoriatic arthropathy",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "400 MG, EVERY 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10 MG/KG",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20510010",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220720",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220224",
            "receiptdateformat": "102",
            "receiptdate": "20220407",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US001896",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US001896"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US001896"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Uveitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Uveitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "3",
            "safetyreportid": "20521071",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20220225",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001958",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20534802",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220721",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220302",
            "receiptdateformat": "102",
            "receiptdate": "20220411",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US002180",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US002180"
                },
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US002180"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Sarcoidosis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Product use issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Sarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Immunosuppressant drug therapy",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20544571",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220721",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220303",
            "receiptdateformat": "102",
            "receiptdate": "20220413",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US002353",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.- 2022US002353"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT- 2022US002353"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Sjogren^s syndrome",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Sjogren^s syndrome",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "20557276",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220423",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220307",
            "receiptdateformat": "102",
            "receiptdate": "20220307",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US002516",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US002516"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US002516"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Crohn^s disease",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "COMIRNATY",
                        "drugbatchnumb": "Unknown",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "TOZINAMERAN"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "3",
            "safetyreportid": "20564189",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221027",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "1",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20220308",
            "receiptdateformat": "102",
            "receiptdate": "20220704",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US002746",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US002746"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US002746"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Death",
                        "reactionoutcome": "5"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "20575490",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220424",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "1",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20220310",
            "receiptdateformat": "102",
            "receiptdate": "20220310",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US001926",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Loss of personal independence in daily activities",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Condition aggravated",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Abdominal pain upper",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "LAST INFUSION WAS IN LATE DEC 2021, EVERY TWO MONTHS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "ON THE INFLECTRA FOR 6 MONTHS TO A YEAR",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20580314",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220721",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220311",
            "receiptdateformat": "102",
            "receiptdate": "20220421",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US002641",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US002641"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US002641"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Crohn^s disease",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Leukocytosis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Ulcer",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Weight decreased",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Fatigue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Arthralgia",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNKNOWN DOSAGE",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210215",
                        "drugenddateformat": "610",
                        "drugenddate": "202104",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20210201"
                }
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20580636",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220720",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220311",
            "receiptdateformat": "102",
            "receiptdate": "20220420",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US002603",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US002603"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US002603"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Diarrhoea haemorrhagic",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Abdominal pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Product availability issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "6",
            "safetyreportid": "20587864",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221027",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220314",
            "receiptdateformat": "102",
            "receiptdate": "20220808",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US002729",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US002729"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US002729"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Pyoderma gangrenosum",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Intentional product use issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MG (500 MG(EVERY",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Pyoderma gangrenosum",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "900",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "900 MG (900 MG (EVERY 6 WEEKS))",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20604825",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220721",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220317",
            "receiptdateformat": "102",
            "receiptdate": "20220428",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US002948",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US002948"
                },
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US002948"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Uveitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Ankylosing spondylitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Uveitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20605837",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220720",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220317",
            "receiptdateformat": "102",
            "receiptdate": "20220428",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US002954",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US002954"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US002954"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Decreased appetite",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Non-alcoholic fatty liver",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Hepatic cirrhosis",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Pallor",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Hepatic steatosis",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Swelling face",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Peripheral swelling",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Confusional state",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Insomnia",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Chest discomfort",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Tachycardia",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Contusion",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Condition aggravated",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Malaise",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Aggression",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Product substitution issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNKNOWN DOSE",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Ankylosing spondylitis",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Sarcoidosis",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20606054",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220720",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220317",
            "receiptdateformat": "102",
            "receiptdate": "20220429",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US002986",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US002986"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US002986"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Pulmonary sarcoidosis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Pulmonary sarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20609417",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220423",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220317",
            "receiptdateformat": "102",
            "receiptdate": "20220324",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US002958",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US002958"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US002958"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Pulmonary sarcoidosis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "24.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Pulmonary sarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20610362",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220720",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220318",
            "receiptdateformat": "102",
            "receiptdate": "20220517",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US003059",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US003059"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US003059"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Lung carcinoma cell type unspecified stage 0",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Lung carcinoma cell type unspecified stage 0",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "3",
            "safetyreportid": "20630427",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221027",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220324",
            "receiptdateformat": "102",
            "receiptdate": "20220810",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2021US014253",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2021US014253"
                },
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2021US014253"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Juvenile idiopathic arthritis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "450",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "EVERY 4 WEEKS/7.5 MG/KG (450 MG) Q 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Juvenile idiopathic arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20656655",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220720",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220331",
            "receiptdateformat": "102",
            "receiptdate": "20220512",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US003701",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US003701"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US003701"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Neurosarcoidosis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Neurosarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20656725",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220720",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220331",
            "receiptdateformat": "102",
            "receiptdate": "20220412",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US003513",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US003513"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US003513"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Throat tightness",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Flushing",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Pruritus",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Rash",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Oedema peripheral",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Nausea",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Underdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FM4731",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "200 MG",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "4",
                        "drugrecurreadministration": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FG9317",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "200 MG (PERIPHERAL IV)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220301",
                        "actiondrug": "4",
                        "drugrecurreadministration": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG AT WEEK 6",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "4",
                        "drugrecurreadministration": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220315"
                }
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20657223",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220721",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220331",
            "receiptdateformat": "102",
            "receiptdate": "20220604",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US003448",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US003448"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US003448"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Crohn^s disease",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Throat tightness",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Hypersensitivity",
                        "reactionoutcome": "2"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Hyperhidrosis",
                        "reactionoutcome": "2"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Dyspnoea",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Flushing",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Pruritus",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Erythema",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220223",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "2ND INFUSION, DOSE UNKNOWN",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Colitis",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220311",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220311"
                }
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20667807",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220720",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220404",
            "receiptdateformat": "102",
            "receiptdate": "20220516",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US003902",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US003902"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US003902"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Neurosarcoidosis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Neurosarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "4",
            "safetyreportid": "20676845",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220720",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220406",
            "receiptdateformat": "102",
            "receiptdate": "20220518",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2021US019185",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2021US019185"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2021US019185"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Juvenile idiopathic arthritis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Juvenile idiopathic arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "3",
            "safetyreportid": "20682028",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220721",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220407",
            "receiptdateformat": "102",
            "receiptdate": "20220527",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US004093",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US004093"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US004093"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Behcet^s syndrome",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Behcet^s syndrome",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20682146",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220721",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20220407",
            "receiptdateformat": "102",
            "receiptdate": "20220420",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US004035",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US004035"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US004035"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Product availability issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "8",
                        "drugstructuredosageunit": "007",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "8 MG/KG, EVERY 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Rheumatoid arthritis",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20191022",
                        "drugenddateformat": "102",
                        "drugenddate": "20191022",
                        "drugtreatmentduration": "1",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220323"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "20690421",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220721",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220408",
            "receiptdateformat": "102",
            "receiptdate": "20220408",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US004349",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US003811"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US003811"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Juvenile idiopathic arthritis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Juvenile idiopathic arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "20698150",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220721",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220412",
            "receiptdateformat": "102",
            "receiptdate": "20220412",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US004355",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US004355"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US004355"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "2"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Loss of consciousness",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Refusal of treatment by patient",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FP8963",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "400 (4 VIALS), EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20707852",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221026",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220414",
            "receiptdateformat": "102",
            "receiptdate": "20220707",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US004460",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US004460"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US004460"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Neurosarcoidosis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Metastases to meninges",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Neurosarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Metastases to meninges",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "4",
            "safetyreportid": "20728551",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221026",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220420",
            "receiptdateformat": "102",
            "receiptdate": "20220908",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US002626",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US002626"
                },
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US002626"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Cystitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Product availability issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Undifferentiated spondyloarthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Colitis ulcerative",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220309",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MG, EVERY 6 WEEKS (4 X 100 MG/20 ML; QUANTITY: 1; REFILLS: 7)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400MG EVERY 6 WEEKS QUANTITY: 1 REFILLS:7",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VITAMIN D3",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CHOLECALCIFEROL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CHOLECALCIFEROL",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CHOLECALCIFEROL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "BENADRYL",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DIPHENHYDRAMINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "COLACE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DOCUSATE SODIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CYMBALTA",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DULOXETINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "IBUPROFEN",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "IBUPROFEN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ARAVA",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LEFLUNOMIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CLARITIN",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LORATADINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CANNABIS SATIVA SUBSP. INDICA TOP",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CANNABIS SATIVA SUBSP. INDICA TOP"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "TOPROL XL",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METOPROLOL SUCCINATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "DETROL",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "TOLTERODINE TARTRATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "NORCO",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ACETAMINOPHEN\\HYDROCODONE BITARTRATE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "4",
            "safetyreportid": "20733722",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221026",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220421",
            "receiptdateformat": "102",
            "receiptdate": "20220810",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US004648",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US004648"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US004648"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Pulmonary sarcoidosis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Pulmonary sarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "3",
            "safetyreportid": "20749395",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220721",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220426",
            "receiptdateformat": "102",
            "receiptdate": "20220610",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US004496",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US004496"
                },
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US004496"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Rheumatoid arthritis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Therapy change",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, CYCLIC, EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FJ9909",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "700",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "700 MG, CYCLIC, EVERY 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220114",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FL1759",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "700",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "700 MG, CYCLIC, EVERY 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220114",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FF8960",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "700",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "700 MG, CYCLIC, EVERY 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220114",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FJ9910",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "700",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "700 MG, CYCLIC, EVERY 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220114",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "700",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "700 MG, Q 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20760523",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220721",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220428",
            "receiptdateformat": "102",
            "receiptdate": "20220609",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US005088",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US005088"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US005088"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "2"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Cardiac failure acute",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Intentional dose omission",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Underdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5MG/KG EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220420"
                }
            }
        },
        {
            "safetyreportversion": "3",
            "safetyreportid": "20763244",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20220428",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004766",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Abdominal discomfort",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Diarrhoea",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Nausea",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Vomiting",
                        "reactionoutcome": "1"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20767427",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221026",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220429",
            "receiptdateformat": "102",
            "receiptdate": "20220808",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US004936",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US004936"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US004936"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "2"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Chest pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Dyspnoea",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "980",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "980 MG EVERY 4 WEEKS (FIRST INFUSION)",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220311",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "980",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "980 MG EVERY 4 WEEKS (SECOND INFUSION)",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220413",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "BENADRYL",
                        "drugbatchnumb": "Unknown",
                        "drugindication": "Premedication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DIPHENHYDRAMINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SOLU-MEDROL",
                        "drugbatchnumb": "Unknown",
                        "drugindication": "Premedication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHYLPREDNISOLONE SODIUM SUCCINATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PEPCID",
                        "drugbatchnumb": "Unknown",
                        "drugindication": "Premedication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FAMOTIDINE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "3",
            "safetyreportid": "20768111",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220721",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220429",
            "receiptdateformat": "102",
            "receiptdate": "20220526",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US005359",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US005359"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US005359"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Neurosarcoidosis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "5 MG, EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Neurosarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG WEEK 0, WEEK 2, WEEK 6, THEN EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20768309",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220721",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220429",
            "receiptdateformat": "102",
            "receiptdate": "20220610",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US005385",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "CA-CELLTRION INC.-2022US005385"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "CA-CELLTRION HEALTHCARE HUNGARY KFT-2022US005385"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Anaphylactic reaction",
                        "reactionoutcome": "2"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Product use issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG 5MG/KG, WEIGHT BASED, INTRAVENOUS, WEEK 0, 2, 6, THEN EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "602",
                        "drugstartdate": "2021",
                        "drugenddateformat": "610",
                        "drugenddate": "202105",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG 5MG/KG, WEIGHT BASED, INTRAVENOUS, WEEK 0, 2, 6, THEN EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220411",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG (5 MG/KG, (WEIGHT BASED) (WEEK 0, 2, 6, THEN EVERY 8 WEEKS. THIS WAS WEEK/DOSE 2.))",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220425",
                        "drugenddateformat": "602",
                        "drugenddate": "2022",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220425"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "20785444",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220721",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220504",
            "receiptdateformat": "102",
            "receiptdate": "20220504",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US005685",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US005685"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US005685"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Follicular lymphoma",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Product substitution issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20786796",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220721",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220505",
            "receiptdateformat": "102",
            "receiptdate": "20220608",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US005694",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US005694"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US005694"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Haemorrhage",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Mucous stools",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20792290",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220721",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220505",
            "receiptdateformat": "102",
            "receiptdate": "20220617",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US000086",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US000086"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US000086"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Visual impairment",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Supplementation therapy",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20793500",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221027",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220506",
            "receiptdateformat": "102",
            "receiptdate": "20220908",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US005932",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US005932"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US005932"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Neurosarcoidosis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Neurosarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "4",
            "safetyreportid": "20817975",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221027",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220512",
            "receiptdateformat": "102",
            "receiptdate": "20220923",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US005999",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US005999"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US005999"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Defaecation urgency",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Haematochezia",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Frequent bowel movements",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "General symptom",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Abdominal pain",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Diarrhoea",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Fatigue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FM4731",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "1000",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "EVERY 6 WKS 1000MG",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210802",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220420"
                }
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20824505",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220720",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220513",
            "receiptdateformat": "102",
            "receiptdate": "20220617",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US006555",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Neurosarcoidosis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Neurosarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20832743",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220721",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220516",
            "receiptdateformat": "102",
            "receiptdate": "20220603",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US006311",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US006311"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US006311"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Crohn^s disease",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Mobility decreased",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Pain",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Drug hypersensitivity",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Intentional underdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNKNOWN DOSE, FIRST INFUSION",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202202",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNKNOWN DOSE, SECOND INFUSION",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "UNKNOWN",
                        "drugdosagetext": "FLUCTUATES 10MG TWICE A DAY/ FLUCTUATES ON BASED ON CROHNS",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220201"
                }
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20859585",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221027",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220523",
            "receiptdateformat": "102",
            "receiptdate": "20220707",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US006772",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US006772"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US006772"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Juvenile idiopathic arthritis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Juvenile idiopathic arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20881627",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221027",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220527",
            "receiptdateformat": "102",
            "receiptdate": "20220803",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US007351",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US007351"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US007351"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "COVID-19",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Emotional distress",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20882858",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220721",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220527",
            "receiptdateformat": "102",
            "receiptdate": "20220623",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US007349",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US007349"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US007349"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Graft versus host disease",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Stem cell transplant",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "500 MG, WEEKLY (FOR THE 5 DOSES THE PATIENT ALREADY HAS RECEIVED); BLANK MG OF INFLECTRA FREQUENCY:",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Stem cell transplant",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Graft versus host disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20889915",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221027",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220530",
            "receiptdateformat": "102",
            "receiptdate": "20220706",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US007629",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US007629"
                },
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US007629"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Sarcoidosis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Sarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "20913612",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220721",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220604",
            "receiptdateformat": "102",
            "receiptdate": "20220604",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US004469",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Cartilage injury",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FN9787",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220310"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "20916882",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220721",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220605",
            "receiptdateformat": "102",
            "receiptdate": "20220605",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US008302",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US008302"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US008302"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Rash",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Swelling",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "20923614",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221027",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "1",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220607",
            "receiptdateformat": "102",
            "receiptdate": "20220706",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US008596",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US008596"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US008596"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Death",
                        "reactionoutcome": "5"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220501"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "20953666",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220721",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220613",
            "receiptdateformat": "102",
            "receiptdate": "20220613",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US004307",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US004307"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US004307"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Cogan^s syndrome",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Hepatotoxicity",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Drug intolerance",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Drug ineffective for unapproved indication",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Cogan^s syndrome",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "RITUXIMAB",
                        "drugbatchnumb": "unknown",
                        "drugdosageform": "Solution for infusion",
                        "drugadministrationroute": "065",
                        "drugindication": "Cogan^s syndrome",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "RITUXIMAB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "METHOTREXATE SODIUM",
                        "drugbatchnumb": "unknown",
                        "drugadministrationroute": "065",
                        "drugindication": "Cogan^s syndrome",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHOTREXATE SODIUM"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "ADALIMUMAB",
                        "drugbatchnumb": "unknown",
                        "drugadministrationroute": "065",
                        "drugindication": "Cogan^s syndrome",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ADALIMUMAB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "CYCLOPHOSPHAMIDE",
                        "drugbatchnumb": "unknown",
                        "drugadministrationroute": "065",
                        "drugindication": "Cogan^s syndrome",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CYCLOPHOSPHAMIDE"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "MYCOPHENOLATE MOFETIL",
                        "drugbatchnumb": "unknown",
                        "drugadministrationroute": "065",
                        "drugindication": "Cogan^s syndrome",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "MYCOPHENOLATE MOFETIL"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "TOCILIZUMAB",
                        "drugbatchnumb": "unknown",
                        "drugadministrationroute": "065",
                        "drugindication": "Cogan^s syndrome",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "TOCILIZUMAB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "CERTOLIZUMAB",
                        "drugbatchnumb": "unknown",
                        "drugadministrationroute": "065",
                        "drugindication": "Cogan^s syndrome",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CERTOLIZUMAB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "ADALIMUMAB",
                        "drugbatchnumb": "Unknown",
                        "drugindication": "Cogan^s syndrome",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ADALIMUMAB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISOLONE",
                        "drugbatchnumb": "unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISOLONE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "20964758",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220721",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220615",
            "receiptdateformat": "102",
            "receiptdate": "20220615",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US009052",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US009052"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US009052"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "2"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Infusion related hypersensitivity reaction",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FL1260",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "200MG INTRAVENOUSLY INFUSED - FREQUENCY UNKNOWN",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Rheumatoid arthritis",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220606",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220607"
                }
            }
        },
        {
            "safetyreportversion": "3",
            "safetyreportid": "20986158",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221027",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220621",
            "receiptdateformat": "102",
            "receiptdate": "20220816",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US009425",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US009425"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US009425"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Sarcoidosis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Sarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "3",
            "safetyreportid": "21008839",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221026",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220627",
            "receiptdateformat": "102",
            "receiptdate": "20220706",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US009722",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US009722"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US009722"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Juvenile idiopathic arthritis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "EVERY 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Juvenile idiopathic arthritis",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220422",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "EVERY 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220509",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "EVERY 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220608",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "21024932",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221027",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220629",
            "receiptdateformat": "102",
            "receiptdate": "20220812",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US010107",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US010107"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US010107"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Diverticulitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Intentional dose omission",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "drugstartdateformat": "602",
                        "drugstartdate": "2019",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Diverticulitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21025151",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20220721",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220630",
            "receiptdateformat": "102",
            "receiptdate": "20220630",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US010072",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US010072"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US010072"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Ankylosing spondylitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Nerve compression",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Loss of personal independence in daily activities",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Intentional dose omission",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "3",
            "safetyreportid": "21042457",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "1",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220705",
            "receiptdateformat": "102",
            "receiptdate": "20221214",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US003716",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US003716"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US003716"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Death",
                        "reactionoutcome": "5"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Rectal haemorrhage",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Rheumatoid arthritis-associated interstitial lung disease",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Bladder disorder",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Haemorrhoids",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Cystitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Rheumatoid arthritis",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202203",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FG7688",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG WEEK 0,2,6 THEN EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Rheumatoid lung",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220317",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FN1125",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG WEEK 0,2,6 THEN EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Rheumatoid arthritis",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220317",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FP8962",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG WEEK 0,2,6 THEN EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Rheumatoid arthritis-associated interstitial lung disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220317",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Drug therapy",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20221104"
                }
            }
        },
        {
            "safetyreportversion": "3",
            "safetyreportid": "21055181",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221026",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220708",
            "receiptdateformat": "102",
            "receiptdate": "20220915",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US010575",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US010575"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US010575"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Rheumatoid arthritis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "21153936",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221027",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "1",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220801",
            "receiptdateformat": "102",
            "receiptdate": "20220915",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US011884",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US011884"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US011884"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Pancreatitis chronic",
                        "reactionoutcome": "2"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Weight increased",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Illness",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21154151",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221027",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220801",
            "receiptdateformat": "102",
            "receiptdate": "20220801",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US011828",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US011828"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US011828"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Metastatic renal cell carcinoma",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Metastatic renal cell carcinoma",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "21159732",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "2",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220802",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US012104",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US012104"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US012104"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Crohn^s disease",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug ineffective",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "HUMIRA",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "CITRATE FREE",
                        "drugdosageform": "Solution for injection",
                        "drugadministrationroute": "058",
                        "drugindication": "Juvenile idiopathic arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ADALIMUMAB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "HUMIRA",
                        "drugdosageform": "Solution for injection",
                        "drugindication": "Psoriasis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ADALIMUMAB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "HUMIRA",
                        "drugdosageform": "Solution for injection",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ADALIMUMAB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "4",
            "safetyreportid": "21170218",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20220804",
            "receiptdateformat": "102",
            "receiptdate": "20221023",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US012178",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US012178"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US012178"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "200MG OVER 1 HOUR EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21183447",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221027",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220808",
            "receiptdateformat": "102",
            "receiptdate": "20220808",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2021US011824",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Rheumatoid arthritis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Condition aggravated",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "C-reactive protein increased",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Osteoarthritis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Red blood cell sedimentation rate increased",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Synovitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Aspartate aminotransferase increased",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Alanine aminotransferase increased",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Blood glucose increased",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Blood urea increased",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Intentional product use issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "2",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "300 MG, Q2WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "600 MG, Q8W (REFILLS: 8)",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "3",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "3 MG/KG",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210915",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "INCREASE TO 5 MG/KG IV EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20210824"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21187666",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221026",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "1",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20220808",
            "receiptdateformat": "102",
            "receiptdate": "20220808",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US004960",
            "duplicate": "1",
            "reportduplicate": {
                "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US004960"
            },
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Hospitalisation",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21192878",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221026",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220810",
            "receiptdateformat": "102",
            "receiptdate": "20220810",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US009066",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US009066"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US009066"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "2"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Rash",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Infusion related reaction",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Product quality issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FL1260",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "450",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "DOSE 450MG INTRAVENOUSLY INFUSED -THIS WAS PATIENTS^ SECOND LOADING DOSE.",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Rheumatoid arthritis",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220505",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220606"
                }
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "21197924",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220810",
            "receiptdateformat": "102",
            "receiptdate": "20221007",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US006717",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US006717"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US006717"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pyoderma gangrenosum",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MILLIGRAM (FREQUENCY THREE INFUSIONS (0,2,6 WEEKS INDUCTION) FOLLOWED BY INFUSIONS Q 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Pyoderma gangrenosum",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "3",
            "safetyreportid": "21209320",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221027",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220813",
            "receiptdateformat": "102",
            "receiptdate": "20220917",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US012789",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US012789"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US012789"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "COVID-19",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Anal haemorrhage",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "No adverse event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Intentional dose omission",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "AMLODIPINE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10 MG",
                        "drugindication": "Blood pressure measurement",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "AMLODIPINE BESYLATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ANDRODERM",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "4",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "4 MG",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "TESTOSTERONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CLINDAMYCIN",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "150",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "150MG TWICE A DAY",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CLINDAMYCIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CLINDAMYCIN PHOSPHATE",
                        "drugbatchnumb": "Unknown",
                        "drugadministrationroute": "061",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CLINDAMYCIN PHOSPHATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LEFLUNOMIDE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "20",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "20MG DAILY IN THE EVENING, THIS WAS ONE OF THE MEDICATION HE WAS TOLD TO STOP WHILE TAKING PAXLOVID",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LEFLUNOMIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "5MG DAILY IN THE MORNING",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ROSUVASTATIN CALCIUM",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10MG IN THE EVENING, THIS IS THE GENERIC FOR CRESTOR. NOT TAKING AS HE WAS TOLD TO HOLD TILL DONE WI",
                        "drugindication": "Blood cholesterol decreased",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ROSUVASTATIN CALCIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VITAMINS",
                        "drugbatchnumb": "unknown",
                        "drugdosagetext": "SENIOR MULTIVITAMIN OVER THE COUNTER",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "VITAMINS"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VITAMIN D NOS",
                        "drugbatchnumb": "unknown",
                        "drugdosagetext": "2000 UNITS IN THE MORNING",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "VITAMIN D NOS"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220731"
                }
            }
        },
        {
            "safetyreportversion": "4",
            "safetyreportid": "21219855",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221027",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220817",
            "receiptdateformat": "102",
            "receiptdate": "20220919",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US011162",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US011162"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US011162"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Cardiac sarcoidosis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Pulmonary sarcoidosis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG OF INFLECTRA FREQUENCY: Q 2 WKS, Q 4 WKS, Q 8 WKS QUANTITY: (BLANK) REFILLS: 8",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Cardiac sarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "2",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "300 MG, EVERY 2 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Pulmonary sarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METHOTREXATE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHOTREXATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "21236353",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221027",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "1",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220822",
            "receiptdateformat": "102",
            "receiptdate": "20220926",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US012578",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US012578"
                },
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US012578"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Paraesthesia oral",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Hypoaesthesia oral",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Pharyngeal hypoaesthesia",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Anaphylactic shock",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Flushing",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Pruritus",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Dyspnoea",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "5TH INFUSION",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FW1349",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "620",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "620 MILLIGRAM IV EVERY 8 WEEKS (DURATION: 5 DOSES) X 7 VIALS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220214",
                        "drugenddateformat": "102",
                        "drugenddate": "20220719",
                        "drugtreatmentduration": "156",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220719"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21257556",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221027",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220826",
            "receiptdateformat": "102",
            "receiptdate": "20220826",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US011144",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US011144"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US011144"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "2"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Hypersensitivity",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Pruritus",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FT5303",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "802",
                        "drugdosagetext": "500 MILLIGRAM, MONTHLY",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Sarcoidosis",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202204",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FT5307",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "802",
                        "drugdosagetext": "500 MILLIGRAM, MONTHLY",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202204",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220708",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "80ML/HR",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "TYLENOL",
                        "drugbatchnumb": "Unknown",
                        "drugindication": "Premedication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ACETAMINOPHEN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "UNKNOWN",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10 MG AT HOME FOR 5 DAYS",
                        "drugadministrationroute": "048",
                        "drugtreatmentduration": "5",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220401"
                }
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "21261616",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220827",
            "receiptdateformat": "102",
            "receiptdate": "20221107",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US014101",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US014101"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US014101"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Crohn^s disease",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Immunoglobulin therapy",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Immune system disorder",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "3",
            "safetyreportid": "21268798",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220830",
            "receiptdateformat": "102",
            "receiptdate": "20221109",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US014118",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US014118"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US014118"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Rheumatoid arthritis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Colitis ulcerative",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug ineffective",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202109",
                        "drugenddateformat": "610",
                        "drugenddate": "202110",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20210901"
                }
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "21310618",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220909",
            "receiptdateformat": "102",
            "receiptdate": "20221102",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US014427",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US014427"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US014427"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Sarcoidosis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG, 0,2,6 THEN 8 WEEKS. QUANTITY 12 REFILLS 6",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Sarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "21335467",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220915",
            "receiptdateformat": "102",
            "receiptdate": "20221026",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US014708",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US014708"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US014708"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Juvenile idiopathic arthritis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Juvenile idiopathic arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21346162",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221026",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220917",
            "receiptdateformat": "102",
            "receiptdate": "20220917",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US014779",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US014779"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US014779"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "2"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Arthroscopic surgery",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Drug intolerance",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Rotator cuff repair",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Musculoskeletal stiffness",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Synovitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Wheezing",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Dizziness",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Fatigue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Flushing",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Hyperhidrosis",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Myalgia",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Muscular weakness",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Dyspnoea",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Chest pain",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Back pain",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Nausea",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Pruritus",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Cough",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Bronchitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Back pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Herpes zoster",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Drug ineffective",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Drug ineffective",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG, QD",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202203",
                        "drugtreatmentduration": "98",
                        "drugtreatmentdurationunit": "803",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "HUMIRA",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugadministrationroute": "058",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "602",
                        "drugstartdate": "2019",
                        "drugenddateformat": "602",
                        "drugenddate": "2019",
                        "actiondrug": "6",
                        "drugadditional": "4",
                        "activesubstance": {
                            "activesubstancename": "ADALIMUMAB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "ACTEMRA",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "TOCILIZUMAB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "ACTEMRA",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "INCREASED DOSE (8 MG/KG)",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "602",
                        "drugstartdate": "2017",
                        "drugenddateformat": "602",
                        "drugenddate": "2019",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "TOCILIZUMAB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "ACTEMRA",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "602",
                        "drugstartdate": "2017",
                        "drugenddateformat": "602",
                        "drugenddate": "2019",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "TOCILIZUMAB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "METHOTREXATE SODIUM",
                        "drugbatchnumb": "Unknown",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHOTREXATE SODIUM"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "HYDROXYCHLOROQUINE DIPHOSPHATE",
                        "drugbatchnumb": "Unknown",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "HYDROXYCHLOROQUINE DIPHOSPHATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "TYLENOL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "325",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "325 MILLIGRAM",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "drugindication": "Pain",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ACETAMINOPHEN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ZOSTRIX [CAPSAICIN]",
                        "drugbatchnumb": "unknown",
                        "drugdosagetext": "1 APP, PRN, 56.6 GM (3 IN 1 D)",
                        "drugdosageform": "Cream",
                        "drugadministrationroute": "061",
                        "drugindication": "Pain",
                        "actiondrug": "5",
                        "drugadditional": "3"
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "RESTASIS",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Eye drops, emulsion",
                        "drugadministrationroute": "047",
                        "drugindication": "Dry eye",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CYCLOSPORINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CYMBALTA",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "60",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "60 MG, 1 IN 1 D",
                        "drugdosageform": "Tablet, prolonged release",
                        "drugadministrationroute": "048",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DULOXETINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FUROSEMIDE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "20",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "20 MG, 1 IN 1 D",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FUROSEMIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "IBUPROFEN",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "4 EVERY 4-6 HOURS AS NEEDED",
                        "drugdosageform": "Capsule",
                        "drugadministrationroute": "048",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "IBUPROFEN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "IBUPROFEN",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK, 2 IN 1 D",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "IBUPROFEN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METHIMAZOLE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "1 IN 8 HOURS",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHIMAZOLE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METOPROLOL",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "1 IN 1 DAY",
                        "drugdosageform": "Capsule, prolonged release",
                        "drugadministrationroute": "048",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METOPROLOL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PANTOPRAZOLE",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "40",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "40 MG, DAILY",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PANTOPRAZOLE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISOLONE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "1 DROP, 1 IN 1 D",
                        "drugadministrationroute": "047",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISOLONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "3",
                        "drugstructuredosageunit": "032",
                        "drugdosagetext": "3 TABS DAILY X 3 DAYS",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "2",
                        "drugstructuredosageunit": "032",
                        "drugdosagetext": "2 TABS DAILY X 3 DAYS",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "1",
                        "drugstructuredosageunit": "032",
                        "drugdosagetext": "1 TAB DAILY X 3 DAYS",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "0.5",
                        "drugstructuredosageunit": "032",
                        "drugdosagetext": "1/2 TAB DAILY (1 IN 1 D)",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SERTRALINE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SERTRALINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ACETAMINOPHEN",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "1000",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1000 MILLIGRAM",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220714",
                        "drugenddateformat": "102",
                        "drugenddate": "20220714",
                        "drugtreatmentduration": "1",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ACETAMINOPHEN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ACETAMINOPHEN",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "1000",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1000 MILLIGRAM",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220519",
                        "drugenddateformat": "102",
                        "drugenddate": "20220519",
                        "drugtreatmentduration": "1",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ACETAMINOPHEN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "DEXILANT",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "60",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1 IN 1D",
                        "drugdosageform": "Capsule, prolonged release",
                        "drugadministrationroute": "048",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DEXLANSOPRAZOLE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "BENADRYL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "25",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "GIVE PRIOR TO THE START OF INFUSION",
                        "drugadministrationroute": "048",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220714",
                        "drugenddateformat": "102",
                        "drugenddate": "20220714",
                        "drugtreatmentduration": "1",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DIPHENHYDRAMINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "BENADRYL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "25",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "GIVE PRIOR TO THE START OF INFUSION",
                        "drugadministrationroute": "048",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220519",
                        "drugenddateformat": "102",
                        "drugenddate": "20220519",
                        "drugtreatmentduration": "1",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DIPHENHYDRAMINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "DIPHENHYDRAMINE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "50 MILLIGRAM PER MILLILITRE",
                        "drugdosageform": "Solution for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220714",
                        "drugenddateformat": "102",
                        "drugenddate": "20220714",
                        "drugtreatmentduration": "1",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DIPHENHYDRAMINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "GABAPENTIN",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "90 CAPSULES (3 IN 1D)",
                        "drugdosageform": "Capsule",
                        "drugadministrationroute": "048",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "GABAPENTIN"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20190101"
                }
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "21346207",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "1",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220917",
            "receiptdateformat": "102",
            "receiptdate": "20221104",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US014782",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US014782"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US014782"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Haemorrhage",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Condition aggravated",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Weight fluctuation",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Arthralgia",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Abdominal pain upper",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNSPECIFIED DOSE EVERY 2 MONTHS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202204",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220101"
                }
            }
        },
        {
            "safetyreportversion": "3",
            "safetyreportid": "21349681",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "1",
            "seriousnessdisabling": "1",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220919",
            "receiptdateformat": "102",
            "receiptdate": "20221115",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US014873",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US014873"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US014873"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Gait inability",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Spinal pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pain in extremity",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pain",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Diarrhoea",
                        "reactionoutcome": "3"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220722",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220720",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220905",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220803",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20221026"
                }
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "21357908",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "1",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20220921",
            "receiptdateformat": "102",
            "receiptdate": "20221110",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US014865",
            "duplicate": "1",
            "reportduplicate": {
                "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US014865"
            },
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hospitalisation",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "3",
            "safetyreportid": "21384620",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20220928",
            "receiptdateformat": "102",
            "receiptdate": "20221111",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US015387",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US015387"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US015387"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Crohn^s disease",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Condition aggravated",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, EIGHT WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "600 MG MAINTENANCE DOSE",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "IMURAN",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "AZATHIOPRINE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21398628",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20221026",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20220930",
            "receiptdateformat": "102",
            "receiptdate": "20220930",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US015537",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.0",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MILLIGRAM Q8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "21398979",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221001",
            "receiptdateformat": "102",
            "receiptdate": "20221011",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US015808",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Nausea",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "EVERY 7 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21400802",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "1",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221003",
            "receiptdateformat": "102",
            "receiptdate": "20221003",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2016US010458",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "PFIZERINC",
                    "duplicatenumb": "US-PFIZERINC-2016417755"
                },
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2016US010458"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2016US010458"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3",
                "literaturereference": "Mahadevan, U.. Infliximab levels in infants born to women with inflammatory bowel disease. Gastroenterology. 2007;132(Suppl 2):A144"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Maternal exposure during pregnancy",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Respiratory distress",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Adverse event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "064",
                        "drugindication": "Inflammatory bowel disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "21409871",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221005",
            "receiptdateformat": "102",
            "receiptdate": "20221121",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US011556",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US011556"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US011556"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Colitis ulcerative",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Condition aggravated",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapeutic product effect incomplete",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "General physical health deterioration",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapeutic response changed",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FJ9914",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG (VIALS: 3)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Colitis ulcerative",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220112",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FJ9913",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG (VIALS: 3)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220310",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FN1125",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG (VIALS: 3)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220511",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FM8814",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG (VIALS: 3)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220627",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FW3200",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10 MG/KG (VIALS: 3)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220822",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "40",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "40 MG",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202206",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "40",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "40 MG",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220729",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220101"
                }
            }
        },
        {
            "safetyreportversion": "3",
            "safetyreportid": "21409969",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221005",
            "receiptdateformat": "102",
            "receiptdate": "20221118",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US015960",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US015960"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US015960"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Dehydration",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Diarrhoea",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Nausea",
                        "reactionoutcome": "2"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Malaise",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Rash erythematous",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insomnia",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Diarrhoea",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Nausea",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Rash",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Illness",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Infusion site rash",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, CYCLIC (EVERY TWO MONTHS, IV INFUSION OVER 2 HOURS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Rheumatoid arthritis",
                        "drugtreatmentduration": "2",
                        "drugtreatmentdurationunit": "805",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "STARTING TO HAVE THINGS HAPPEN SINCE THE 07SEP2022 INFUSION",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220907",
                        "drugtreatmentduration": "2",
                        "drugtreatmentdurationunit": "805",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220907"
                }
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "21434282",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221010",
            "receiptdateformat": "102",
            "receiptdate": "20221121",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US016198",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US016198"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US016198"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Sarcoidosis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Sarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21444101",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221012",
            "receiptdateformat": "102",
            "receiptdate": "20221012",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2019US024797",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "600 MG ON 1,2,2,8 WK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "3",
            "safetyreportid": "21445069",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "1",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221012",
            "receiptdateformat": "102",
            "receiptdate": "20221221",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US015288",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Rheumatoid arthritis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "General physical health deterioration",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Impaired work ability",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "580",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "580 MG, FREQUENCY: EVERY 8 WEEKS, QUANTITY: 12",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "RUXIENCE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "SINGLE-DOSE VIAL: 6",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "RITUXIMAB-PVVR"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "21445565",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "1",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221012",
            "receiptdateformat": "102",
            "receiptdate": "20221124",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US014900",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "2"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Crohn^s disease",
                        "reactionoutcome": "4"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Abdominal pain",
                        "reactionoutcome": "2"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug ineffective",
                        "reactionoutcome": "4"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "100MG/VIAL X 4 VIALS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "EN5163",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "350",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "350 MG",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220309",
                        "drugenddateformat": "102",
                        "drugenddate": "20220902",
                        "drugtreatmentduration": "178",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "REMICADE",
                        "drugbatchnumb": "Unknown",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220101"
                }
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "21448266",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "1",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221012",
            "receiptdateformat": "102",
            "receiptdate": "20221203",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US014127",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Joint range of motion decreased",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Loss of personal independence in daily activities",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Ill-defined disorder",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Weight increased",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Musculoskeletal stiffness",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Joint stiffness",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Spinal pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Lip pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Stomatitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Joint swelling",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Swelling",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Swelling",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Peripheral swelling",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Arthralgia",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pain",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pain in extremity",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Gait disturbance",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Photosensitivity reaction",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug ineffective",
                        "reactionoutcome": "3"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNKNOWN DOSE (ON 04 AUG 2022, PATIENT HAD HER LAST INFUSION; THIS LAST INFUSION WAS HER 4TH ONE)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Arthritis",
                        "actiondrug": "1",
                        "drugadditional": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220805"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21448949",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221013",
            "receiptdateformat": "102",
            "receiptdate": "20221013",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2020US019086",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product preparation error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "AM4173",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500MG DOSE OF 5 VIALS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21449551",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221013",
            "receiptdateformat": "102",
            "receiptdate": "20221013",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US002884",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Rheumatoid arthritis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy change",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy cessation",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MG MAINTENANCE DOSAGE",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220401",
                        "drugenddateformat": "102",
                        "drugenddate": "20220815",
                        "drugtreatmentduration": "137",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21454475",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221013",
            "receiptdateformat": "102",
            "receiptdate": "20221013",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2020US020786",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "10 MG/KG, Q4WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "21457512",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "1",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221014",
            "receiptdateformat": "102",
            "receiptdate": "20221123",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US015673",
            "duplicate": "1",
            "reportduplicate": {
                "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US015673"
            },
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Subcorneal pustular dermatosis",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Bullous haemorrhagic dermatosis",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Eczema",
                        "reactionoutcome": "3"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "3 INFUSIONS OF INFLECTRA",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "1",
                        "drugadditional": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "3 INFUSIONS OF INFLECTRA",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "1",
                        "drugadditional": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "3 INFUSIONS OF INFLECTRA",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "1",
                        "drugadditional": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "40",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "40 MG FOR 10 DAYS",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220822",
                        "drugtreatmentduration": "10",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "30",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "30 MG FOR 10 DAYS",
                        "drugtreatmentduration": "10",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "20",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "20 MG FOR 10 DAYS",
                        "drugtreatmentduration": "10",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10 MG FOR 10 DAYS",
                        "drugenddateformat": "102",
                        "drugenddate": "20220930",
                        "drugtreatmentduration": "10",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CLOBETASOL PROPIONATE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "0.05",
                        "drugstructuredosageunit": "030",
                        "drugdosagetext": "0.05 PERCENT",
                        "drugdosageform": "Cream",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CLOBETASOL PROPIONATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CLOBETASOL PROPIONATE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "0.05",
                        "drugstructuredosageunit": "030",
                        "drugdosagetext": "TOPICAL",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CLOBETASOL PROPIONATE"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220816"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21462995",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221017",
            "receiptdateformat": "102",
            "receiptdate": "20221017",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2020US035173",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Night sweats",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MILLIGRAM EVERY 7 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MILLIGRAM EVERY 7 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202010",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21464302",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221017",
            "receiptdateformat": "102",
            "receiptdate": "20221017",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US016646",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US016646"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US016646"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Surgery",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "GA3756",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21468850",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US006663",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Fistula discharge",
                        "reactionoutcome": "2"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Feeling hot",
                        "reactionoutcome": "2"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Burning sensation",
                        "reactionoutcome": "2"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Flushing",
                        "reactionoutcome": "2"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pruritus",
                        "reactionoutcome": "2"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "DA6565",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "5 MG/KG 0, 2, 6 WKS THEN Q 8 WKS=600 MG",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20200812",
                        "drugenddateformat": "102",
                        "drugenddate": "20200915",
                        "drugtreatmentduration": "35",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "1",
                        "drugrecurreadministration": "2",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20200915"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21468851",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US006682",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pruritus",
                        "reactionoutcome": "2"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Erythema",
                        "reactionoutcome": "2"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "DW2376",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG Q8WKS = 300MG",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20201014",
                        "actiondrug": "1",
                        "drugrecurreadministration": "2",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20201014"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21469208",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US003672",
            "duplicate": "1",
            "reportduplicate": {
                "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2021US003672"
            },
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Musculoskeletal stiffness",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapeutic response shortened",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "REMICADE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNKNOWN DOSAGE, ADMINISTERED EVERY 6 WEEKS",
                        "drugdosageform": "Infusion",
                        "drugindication": "Rheumatoid arthritis",
                        "drugenddateformat": "102",
                        "drugenddate": "20201211",
                        "drugtreatmentduration": "5",
                        "drugtreatmentdurationunit": "801",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21469886",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US009904",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product container issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product leakage",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "7 VIALS IN 250 ML OF NORMAL SALINE",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "7 VIALS IN 250 ML OF NORMAL SALINE",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "7 VIALS IN 250 ML OF NORMAL SALINE",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "7 VIALS IN 250 ML OF NORMAL SALINE",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "7 VIALS IN 250 ML OF NORMAL SALINE",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "7 VIALS IN 250 ML OF NORMAL SALINE",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "7 VIALS IN 250 ML OF NORMAL SALINE",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "EN5165",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10 MG/KG Q6WKS",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "SODIUM CHLORIDE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "250",
                        "drugstructuredosageunit": "012",
                        "drugdosagetext": "250 ML",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SODIUM CHLORIDE"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20210713"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21470218",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US016694",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US014096"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US014096"
                },
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US016694"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US016694"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Surgery",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG (WEEK 0,2,6, THEN EVERY 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474560",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US013090",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Iridocyclitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Uveitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474561",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US013095",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474563",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US013100",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Adverse drug reaction",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy cessation",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product distribution issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10 MG/KG ON WEEKS 2,6 THEN EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "drugstartdateformat": "610",
                        "drugstartdate": "201806",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "635",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "FREQUENCY:WEEK 2, 6 LOAD DOSE THEN Q 8WKS MAINT",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474564",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US013102",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474565",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US013161",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Sarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474567",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US013172",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug specific antibody present",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "UNK, EVERY 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "drugstartdateformat": "610",
                        "drugstartdate": "201906",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474568",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US013192",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Condition aggravated",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNKNOWN DOSE ADMINISTERED AS INTRAVENOUS INFUSION PRESCRIBED TO BE ADMINISTERED EVERY 2 MONTHS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Psoriatic arthropathy",
                        "drugstartdateformat": "602",
                        "drugstartdate": "2018",
                        "drugenddateformat": "602",
                        "drugenddate": "2021",
                        "actiondrug": "1",
                        "drugadditional": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Arthralgia",
                        "actiondrug": "1",
                        "drugadditional": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20210101"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474569",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US013350",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "2"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Chills",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474570",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US013412",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Juvenile idiopathic arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Uveitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474571",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US013447",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug ineffective",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474603",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US013460",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Pulmonary sarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474604",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US013481",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "No adverse event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474613",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US013522",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK EVERY 7 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474614",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US013534",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474615",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2021US013567",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Malignant melanoma",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474616",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US013663",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Infection",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Intentional dose omission",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10 MG/KG, CYCLIC (EVERY 6 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20210101"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474619",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US013767",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Weight increased",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Alopecia",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "drugtreatmentduration": "6",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474620",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US013731",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "2"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pruritus",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210817",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LINZESS",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LINACLOTIDE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474623",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US013768",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474624",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US013809",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Hidradenitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474682",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US013811",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474687",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US013833",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis microscopic",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474688",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US013900",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Hidradenitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474690",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US013908",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202006",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474693",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US013996",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug ineffective",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy change",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "INFUSION OF INFLECTRA THAT PATIENT RECEIVED WAS ON AUGUST 6 OF THIS YEAR",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210806",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "REMICADE",
                        "drugbatchnumb": "Unknown",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474695",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US014069",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202004",
                        "drugenddateformat": "102",
                        "drugenddate": "20201214",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG, 0,2,6 THEN EVERY 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5MG/KG WEEK 0, 2 6 THEN IV Q 4-5 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "RELOAD INFLECTRA 5MG/KG, 0, 2, 6 THEN EVERY 4-5 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211011",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474699",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US014175",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Rash",
                        "reactionoutcome": "4"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy change",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "E45165",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "700",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10 MG/KG (700MG), Q 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Colitis ulcerative",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210619",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "E41089",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "700",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10 MG/KG (700MG), Q 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210731",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "APRISO",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "0.375 X4 TAKEN DAILY",
                        "drugindication": "Colitis ulcerative",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20140718",
                        "drugtreatmentduration": "7",
                        "drugtreatmentdurationunit": "801",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "MESALAMINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CARISOPRODOL",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK, PRN",
                        "drugindication": "Muscle spasms",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20200731",
                        "drugtreatmentduration": "1",
                        "drugtreatmentdurationunit": "801",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CARISOPRODOL"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20210710"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474700",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US014204",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Diarrhoea",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "INTRAVENOUS INFUSION; DOSE UNKNOWN",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474702",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US014213",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474703",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US014226",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy change",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474760",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US014252",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Behcet^s syndrome",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474763",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US014254",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Pulmonary sarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474764",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US014267",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Inappropriate schedule of product administration",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474765",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US014456",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Psoriatic arthropathy",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Immunosuppression",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474771",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US014531",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Hidradenitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474774",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US014532",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10 MG/KG, EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202008",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20200801"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474777",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US014533",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474778",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US014530",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Vulvovaginal rash",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Asthma",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Wheezing",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Rash",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pruritus",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Osteopetrosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Osteoporosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METFORMIN",
                        "drugbatchnumb": "UNKNOWN",
                        "drugstructuredosagenumb": "2000",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "2000 MG A DAY",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METFORMIN HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FISH OIL",
                        "drugbatchnumb": "UNKNOWN",
                        "drugstructuredosagenumb": "1000",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1000 MG, TWICE A DAY",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FISH OIL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LISINOPRIL",
                        "drugbatchnumb": "UNKNOWN",
                        "drugstructuredosagenumb": "40",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "40 MG",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LISINOPRIL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "GABAPENTIN",
                        "drugbatchnumb": "UNKNOWN",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG AT NIGHT",
                        "drugindication": "Pain",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "GABAPENTIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LIPITOR",
                        "drugbatchnumb": "UNKNOWN",
                        "drugstructuredosagenumb": "40",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "40 MG",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ATORVASTATIN CALCIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VITAMINS",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "VITAMINS"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ASPIRIN",
                        "drugbatchnumb": "UNKNOWN",
                        "drugstructuredosagenumb": "81",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "81 MG, EVERY NIGHT BUT AND IN MORNING",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ASPIRIN"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474781",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US014539",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "2"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product preparation issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474784",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US014543",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Dyspnoea",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Nausea",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK (RECEIVING HER SECOND DOSE OF INFLECTRA)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474859",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US014546",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "DOSE UNKNOWN, INFUSION",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20211011"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474877",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US014578",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Infusion related reaction",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FD1713",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "BENTYL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "20",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "20MG BY MOUTH EVERY 6 HOURS AS NEEDED",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DICYCLOMINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CALCIUM\\VITAMIN D",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500MG DAILY",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CALCIUM\\VITAMIN D"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "DICYCLOMINE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "20",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "20MG",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DICYCLOMINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FAMOTIDINE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "40",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "40MG TWICE DAILY",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FAMOTIDINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "MESALAMINE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "4GM/ 60ML 1 ENEMA PER RECTUM AT NIGHT",
                        "drugdosageform": "Enema",
                        "drugadministrationroute": "054",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "MESALAMINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "MESALAMINE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "1000",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1000MG, 1 SUPPOSITORY PER RECTOR AT NIGHT",
                        "drugdosageform": "Suppository",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "MESALAMINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METOPROLOL SUCCINATE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "25",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "25MG, 1 BY MOUTH TWICE A DAY",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METOPROLOL SUCCINATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VITAMINS",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "ONE BY MOUTH EVERY DAY",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "VITAMINS"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "OLMESARTAN",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "40",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "40 MG, DAILY",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "OLMESARTAN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SERTRALINE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "50",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "50MG DAILY",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SERTRALINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VANCOMYCIN",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "125",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "125 MG 4 TIMES DAILY FOR 14 DAYS",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "VANCOMYCIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "TYLENOL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "650",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "650 MG",
                        "drugindication": "Premedication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ACETAMINOPHEN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ZYRTEC",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10 MG",
                        "drugindication": "Premedication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CETIRIZINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SOLU-MEDROL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "40",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "40 MG",
                        "drugadministrationroute": "042",
                        "drugindication": "Premedication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHYLPREDNISOLONE SODIUM SUCCINATE"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20211021"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474881",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221018",
            "receiptdateformat": "102",
            "receiptdate": "20221018",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US014600",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Childhood",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "6",
                        "drugadditional": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474891",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US014787",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474897",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US014878",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Psoriatic arthropathy",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210322",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SULFASALAZINE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MG, 4 PER DAY",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202102",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SULFASALAZINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "HYDROXYCHLOROQUINE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "200 MG, 2 PER DAY",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202102",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "HYDROXYCHLOROQUINE"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20210101"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474900",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US014887",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474909",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US014918",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Hidradenitis",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211026",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474912",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US014919",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy cessation",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Maternal exposure before pregnancy",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "(PHARMACEUTICAL FORM: NOT PROVIDED)",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "drugenddateformat": "610",
                        "drugenddate": "202104",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugenddateformat": "610",
                        "drugenddate": "202107",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474913",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US014934",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hidradenitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "CYCLIC",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Hidradenitis",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211021",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21474918",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US014941",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475032",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US014977",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Pyoderma gangrenosum",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475038",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US015099",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hidradenitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Psoriasis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Hidradenitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475043",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US015100",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Body temperature increased",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Oral pruritus",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Haemoglobin decreased",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Blood pressure increased",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Swelling face",
                        "reactionoutcome": "2"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Urticaria",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Erythema",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug hypersensitivity",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "INFUSION, RECEIVED 5MG",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210601",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "5 MG (5TH DOSE)",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211103",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LEVOTHYROXINE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "50",
                        "drugstructuredosageunit": "004",
                        "drugdosagetext": "50MCG EVERY DAY",
                        "drugindication": "Thyroid disorder",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LEVOTHYROXINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "MESALAMINE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "2400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "2400 MG A DAY",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "MESALAMINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ASPIRIN",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ASPIRIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CLOPIDOGREL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "75",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "75MG ONCE A DAY",
                        "drugenddateformat": "102",
                        "drugenddate": "20211101",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CLOPIDOGREL BISULFATE"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20211103"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475046",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US015102",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475051",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US015103",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Sarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Iridocyclitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475055",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US015109",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Neurosarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475059",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US015112",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475065",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US015140",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Blood pressure increased",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hypotension",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "FIRST INFUSION",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "SECOND INFUSION",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475073",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000814",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FG4230",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400MG EVERY 6 WEEKS BY INFUSION, IV",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Ankylosing spondylitis",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202112",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220117"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475078",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000842",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "600 MG, EVERY 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "600 MG, EVERY 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "002",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "600 G, EVERY 4 WEEKS (6 VIALS 100MG/ 20ML; QUANTITY: 6 VIALS; REFILLS: 12)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475622",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US011590",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Poor venous access",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Limb injury",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475625",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US011934",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475626",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US011783",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475628",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US011761",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Burning sensation",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Decreased appetite",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Sensitive skin",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Condition aggravated",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Feeling abnormal",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Illness",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Abdominal pain upper",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Diarrhoea",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Weight decreased",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Joint swelling",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pruritus",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Arthralgia",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Infusion site pain",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pain in extremity",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Asthenia",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Infusion site discomfort",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Infusion related reaction",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Myalgia",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "IV INFUSION, UNKNOWN DOSAGE, EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Colitis ulcerative",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210716",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20210716"
                }
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "21475629",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221129",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2021US011766",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Sarcoidosis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Sarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475630",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US011765",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "802",
                        "drugdosagetext": "UNK UNK, MONTHLY",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475633",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US012021",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "EVERY 5 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475634",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US012154",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475635",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US012023",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475636",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US011937",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Psoriatic arthropathy",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Arthritis enteropathic",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475637",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2021US012120",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Mycobacterium tuberculosis complex test positive",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475638",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US012210",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "2"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Maternal exposure before pregnancy",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475639",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US012064",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Dyspnoea",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Chest pain",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "AVSOLA",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-AXXQ"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475640",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US012184",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "100",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "100 MG VIAL",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475643",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US012236",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475644",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US012566",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Drug therapy",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475645",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US012420",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Hepatic cancer metastatic",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475646",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US012544",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475647",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US012606",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Iridocyclitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475648",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US012238",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Gastrointestinal disorder",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Infusion site extravasation",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product substitution",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug ineffective",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475649",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US012475",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Eye pruritus",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Eye swelling",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hypersensitivity",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "HUMIRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugstructuredosagenumb": "40",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "2",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "40 MG,1 IN 2 WK",
                        "drugdosageform": "Solution for injection",
                        "drugadministrationroute": "058",
                        "drugindication": "Colitis ulcerative",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202105",
                        "drugenddateformat": "102",
                        "drugenddate": "20210831",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "ADALIMUMAB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "HUMIRA",
                        "drugdosageform": "Solution for injection",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "ADALIMUMAB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20210101"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475653",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2021US012864",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2021US012864"
                },
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2021US012864"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hypersensitivity",
                        "reactionoutcome": "2"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "HYDROXYCHLOROQUINE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "HYDROXYCHLOROQUINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "RELAFEN",
                        "drugbatchnumb": "Unknown",
                        "drugindication": "Pain",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "NABUMETONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "RELAFEN",
                        "drugindication": "Inflammation",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "NABUMETONE"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20210901"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475654",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US012645",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Cholangitis sclerosing",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475657",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US012697",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "2"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product preparation error",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Poor quality product administered",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475658",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US012610",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "700",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "700 MG EVERY 5 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Ankylosing spondylitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475659",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US012636",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Neurosarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Sarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475660",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US012888",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hidradenitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Hidradenitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475661",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US012805",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475665",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000865",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475666",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US013003",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475885",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US015425",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Infusion related reaction",
                        "reactionoutcome": "1"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "FIRST TREATMENT",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Psoriasis",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "SECOND TREATMENT",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475914",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US015432",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Psoriasis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475918",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US015435",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug ineffective",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21475937",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US015579",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "No adverse event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Sacroiliitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Juvenile idiopathic arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Enthesopathy",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476004",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US015586",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Weight increased",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476012",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US015588",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476032",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US015593",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug hypersensitivity",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476056",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US015595",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Hidradenitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476080",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US015696",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476091",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US015699",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Condition aggravated",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Poor venous access",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product supply issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug dose omission by device",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FD1719",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "100",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "100 MG",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Hidradenitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476101",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US015719",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476209",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US015721",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Anal fistula",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Anal fistula",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476225",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US015724",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476233",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US015861",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Adverse event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy change",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476289",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US016021",
            "duplicate": "1",
            "reportduplicate": {
                "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2021US016021"
            },
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment failure",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476309",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US016025",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Illness",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Feeling abnormal",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476318",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US016351",
            "duplicate": "1",
            "reportduplicate": {
                "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2021US016351"
            },
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Viral infection",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "5MG/KG, LOADING DOSE INFUSED",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Rheumatoid arthritis",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211018",
                        "drugenddateformat": "102",
                        "drugenddate": "20211101",
                        "drugtreatmentduration": "15",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "UNK (INJECT 400 MG OF INFLECTRA FREQUENCY: EVERY 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20211101"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476333",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US016389",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Weight increased",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Intentional dose omission",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Underdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MG, (EVERY 8 WEEKS BY INFUSION)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "610",
                        "drugstartdate": "201909",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "AZATHIOPRINE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "50",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "50MG TABLET, 1 TABLET TWICE DAILY",
                        "drugdosageform": "Tablet",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "AZATHIOPRINE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476375",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US016496",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "PATIENT WITH INSTRUCTIONS INFUSE 0,2,4 THEN Q8W",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476387",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US016497",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "200 MG Q 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Psoriatic arthropathy",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476404",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US016523",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "10 MG/KG, MONTHLY EVERY 4 WEEKS (LAST INFUSION: 08SEP2021)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210809",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476421",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US016524",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Inflammatory marker increased",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "PRIOR FREQUENCY CHANGE",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "530",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "530 MG EVERY 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476437",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US016526",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product storage error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476506",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US016537",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hidradenitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Hidradenitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476600",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US016650",
            "duplicate": "1",
            "reportduplicate": {
                "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2021US016650"
            },
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Fibromyalgia",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476608",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US016761",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product use issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476627",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US016815",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Arthralgia",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapeutic response shortened",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476662",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017090",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "TREATMENT WITH INFLECTRA, 10MG/LG UP TO EVERY 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Ankylosing spondylitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476666",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017181",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Exposure to allergen",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Diarrhoea",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Weight decreased",
                        "reactionoutcome": "1"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Psoriatic arthropathy",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211207",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20211207"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476667",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017088",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Dehydration",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Dehydration",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476671",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017189",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "1 WEEKLY",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476674",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017195",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "1000",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1000 MG (100MG/20ML, FREQUENCY IV ON DAY 1 Q28 DAYS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "1000",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1000 MG IV ON DAY 1, 18, AND 43",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476675",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017190",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Underdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "5 MILLIGRAM, INJECT, EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476679",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017198",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "600 MG/ INJECT 600 MG OF INFLECTRA; 100 MG/20 ML (FREQUENCY: 98 WEEKS, QUANTITY:6, REFILLS:12)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476680",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017194",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Adverse drug reaction",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476682",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017192",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Musculoskeletal stiffness",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Peripheral swelling",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Mouth ulceration",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Diarrhoea",
                        "reactionoutcome": "3"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "METHOTREXATE",
                        "drugbatchnumb": "UNKNOWN",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "032",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "10 TABLETS WEEKLY",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "065",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "METHOTREXATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FOLIC ACID",
                        "drugbatchnumb": "UNKNOWN",
                        "drugdosagetext": "UNK",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "FOLIC ACID"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FOLIC ACID",
                        "drugbatchnumb": "UNKNOWN",
                        "drugstructuredosagenumb": "3",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "3 MG, QDAY",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "FOLIC ACID"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476699",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017325",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "400 MG OF INFLECTRA ON DAY 1+15 THEN EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476701",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017355",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "7 VIALS EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476702",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017353",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "400 MG, Q4WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476703",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US016892",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Irritable bowel syndrome",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Irritable bowel syndrome",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476711",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017399",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "800",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "800 MG Q8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476712",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017409",
            "duplicate": "1",
            "reportduplicate": {
                "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2021US017409"
            },
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476713",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017364",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10 MG, EVERY 7 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476715",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017358",
            "duplicate": "1",
            "reportduplicate": {
                "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2021US017358"
            },
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211106",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211119",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211206",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476722",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017412",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Weight decreased",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476723",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017609",
            "duplicate": "1",
            "reportduplicate": {
                "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2021US017609"
            },
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Erythema nodosum",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Erythema nodosum",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476724",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017457",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "2"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Infection",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Intentional dose omission",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476731",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017631",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Impaired quality of life",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476732",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017623",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Dyspnoea",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hypersensitivity",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476733",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017625",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476735",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017626",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2021US017626"
                },
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2021US017626"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hepatitis B antibody abnormal",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476736",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US016953",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10 MG/KG EVERY 6 WEEKS VIA IV QUANTITY: 6 VIALS REFILLS: BLANK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "600MG Q 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476744",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017643",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "600 MG (WK0, WK2, THEN Q 4W)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476745",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017722",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hypersensitivity",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Urticaria",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FLOVENT",
                        "drugbatchnumb": "Unknown",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FLUTICASONE PROPIONATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SYNTHROID",
                        "drugbatchnumb": "Unknown",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LEVOTHYROXINE SODIUM"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476746",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017686",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Weight decreased",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "600 MG",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476747",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017741",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Discomfort",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Arthritis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Malaise",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Malaise",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Abdominal pain",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Chest pain",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pyrexia",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Intentional dose omission",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "802",
                        "drugdosagetext": "UNK (1 PER MONTH)",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Rheumatoid arthritis",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210518",
                        "drugenddateformat": "102",
                        "drugenddate": "20210714",
                        "drugtreatmentduration": "58",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "802",
                        "drugdosagetext": "UNK (1 PER MONTH)",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Arthritis",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210613",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "802",
                        "drugdosagetext": "UNK (1 PER MONTH)",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210714",
                        "drugenddateformat": "102",
                        "drugenddate": "20210714",
                        "drugtreatmentduration": "1",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20210613"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476752",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017774",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "100",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "100 MG, CYCLIC (Q 8 WK)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476753",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017776",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "523",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "523 MG 0,2,6 WEEKS FOLLOWED BY EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476754",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017812",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476758",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017773",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Peripheral swelling",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy change",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug ineffective for unapproved indication",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy cessation",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Peripheral swelling",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "TOOK IT FEW MONTHS IN 2018",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Rheumatoid arthritis",
                        "drugstartdateformat": "602",
                        "drugstartdate": "2018",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LOSARTAN",
                        "drugbatchnumb": "UNKNOWN",
                        "drugstructuredosagenumb": "50",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "50 MG, QD",
                        "drugdosageform": "Tablet",
                        "drugindication": "Hypertension",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LOSARTAN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "UNKNOWN",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "5 MG, PRN",
                        "drugindication": "Peripheral swelling",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ORENCIA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugstructuredosagenumb": "125",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "125 MG",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ABATACEPT"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "RINVOQ",
                        "drugbatchnumb": "UNKNOWN",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "UPADACITINIB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "KEVZARA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "200 MG",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SARILUMAB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20180101"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476763",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017891",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Psoriasis",
                        "reactionoutcome": "1"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "IV; AMOUNT OF DOSE: UNKNOWN",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Ankylosing spondylitis",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202001",
                        "drugenddateformat": "610",
                        "drugenddate": "202008",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20200501"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476764",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017890",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Trismus",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Arthralgia",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Adverse drug reaction",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug specific antibody present",
                        "reactionoutcome": "1"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "EVERY 8 WEEKS (STOP DATES: 15 OCT 2021 - 9 MONTHS AND 21 NOV 2021)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Colitis ulcerative",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210122",
                        "drugenddateformat": "102",
                        "drugenddate": "20211121",
                        "drugtreatmentduration": "10",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LIALDA",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "MESALAMINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "TRIAMTERENE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "TRIAMTERENE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "COVID-19 VACCINE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "3 SHOTS",
                        "actiondrug": "5",
                        "drugadditional": "3"
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20210305"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476765",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017896",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "2"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476768",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017991",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Intercepted medication error",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Prescribed overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476769",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017901",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Weight increased",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "100 MG/20 ML (4 VIALS) DIRECTIONS: EVERY 8 WEEKS QUANTITY: 4 VIALS REFILLS: BLANK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476770",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US017923",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "100MG/10MG",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476772",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2021US017990",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hypersensitivity",
                        "reactionoutcome": "1"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476777",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US018000",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476778",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US018246",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Diarrhoea",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Diarrhoea",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476779",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000023",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Medication error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "300 100MG/20ML",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476784",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US018941",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Inability to afford medication",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "(THERAPY DATE: STATES MAYBE 21 SEP 2021)",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202109",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10MG, DAILY",
                        "drugindication": "Pain",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202110",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20210901"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476801",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000027",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FH9868",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MG",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476802",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000026",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476808",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000029",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pain",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476820",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000100",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Inflammatory bowel disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220104",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476821",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000090",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476827",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000107",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product storage error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476834",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000117",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Adverse drug reaction",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNKNOWN DOSE",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476842",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000260",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Inability to afford medication",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapeutic product effect incomplete",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "802",
                        "drugdosagetext": "5 MG, MONTHLY",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "802",
                        "drugdosagetext": "10 MG, MONTHLY",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476846",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000128",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Urticaria",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug specific antibody present",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "drugenddateformat": "610",
                        "drugenddate": "202107",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476854",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000263",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dispensing error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG Q 8WKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476855",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000340",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476856",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000266",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product storage error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476858",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000335",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product availability issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21476866",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000864",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dispensing issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5MG/KG EVERY 6 WEEKS BY INFUSION",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202011",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5MG/KG EVERY 6 WEEKS BY INFUSION (LAST INFUSION)",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211216",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21478667",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000409",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "3"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "300 OR WHATEVER THE LOWEST DOSAGE IS,SHE DOESN^T",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20211231"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21478846",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000489",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "361",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "361 MG AT DAY 0,2,6 THEN Q 8 WK THEREAFTER (100MG/20ML) QUANTITY: 12 REFILLS: 11",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21478870",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000532",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "6",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "6 MG/KG EVERY 6 WEEKS, CYCLIC",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Psoriatic arthropathy",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21478958",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000411",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "760",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "760 MG EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481218",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001595",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211106",
                        "drugenddateformat": "102",
                        "drugenddate": "20211106",
                        "drugtreatmentduration": "1",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481219",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001599",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product temperature excursion issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481220",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001603",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481223",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001608",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "308",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "308 MG, WEEK 0,2,6 THEN EVERY 56 DAYS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481225",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001660",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481229",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001664",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pain",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481236",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001666",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Microscopic polyangiitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481240",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001670",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481242",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001678",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "600 MILLIGRAM",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481289",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001764",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "2"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FG4226",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481364",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001765",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "LOAD: 5 MG/KG - 0,2,6 WKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210803",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "MAINT: 5 MG/KG - EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210803",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "LAST INFUSION",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211124",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481368",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001766",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481377",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001775",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481380",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001782",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MILLIGRAM, AT 0, 2, + 6 WKS, THEN Q 8 WKS; QUANTITY: 3 (FOR INDUCTION)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481381",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001897",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MILLIGRAM EVERY 10 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481385",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001953",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481390",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001956",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481399",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001957",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Herpes zoster",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product substitution issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "REMICADE",
                        "drugbatchnumb": "Unknown",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481400",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001964",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "3"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Rheumatoid arthritis",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20191022",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220209"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481403",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001983",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Weight increased",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481443",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US009654",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Lung disorder",
                        "actiondrug": "6",
                        "drugadditional": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481475",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001994",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product distribution issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481477",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002024",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product distribution issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481481",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002025",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481485",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002028",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481489",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002068",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10MG/KG Q 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481492",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221019",
            "receiptdateformat": "102",
            "receiptdate": "20221019",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002069",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product use issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MILLIGRAM (INFUSE 300 MG WEEK 0,2,6 THEN EVERY 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481503",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002266",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METHOTREXATE",
                        "drugbatchnumb": "UNKNOWN",
                        "drugstructuredosagenumb": "2.5",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "2.5MG , SIX TABLETS ONE TIME A WEEK",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHOTREXATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FOLIC ACID",
                        "drugbatchnumb": "UNKNOWN",
                        "drugstructuredosagenumb": "1",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1 MG, DAILY",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FOLIC ACID"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481511",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002268",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "247",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "247MG (3MG/KG 82.1 K PT WT) FREQUENCY WEEK 0,2,6 THEN Q 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481518",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002280",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pain",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FD1721",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "189",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "189MG EVERY 8 WEEKS INTRAVENOUS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Rheumatoid arthritis",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210315",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220215"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481523",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002282",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481660",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002323",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product availability issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "SG4222",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20200305",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481671",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002440",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481675",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002442",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481678",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002443",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "600 MG, Q 12 WEEKS; INFUSE 600MG IV EVERY 12 WEEKS QUANTITY 6 REFILLS 3 (100 MG/20ML)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481683",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002445",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Circumstance or information capable of leading to medication error",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product distribution issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481686",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002465",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product delivery mechanism issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug dose omission by device",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FM6844",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481689",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002466",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy cessation",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "INFUSION, EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210701",
                        "drugenddateformat": "102",
                        "drugenddate": "20211230",
                        "drugtreatmentduration": "183",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481699",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002471",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481703",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002484",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "600MG (EVERY 4 WEEKS, INFUSION)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202103",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481706",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002485",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product distribution issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Underdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FJ9914",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "410",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "410 MG",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Psoriatic arthropathy",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211227",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481836",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000869",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Circumstance or information capable of leading to medication error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481844",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009404",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220419",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Ankylosing spondylitis",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220609",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481852",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002498",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy change",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Underdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10 MILLIGRAM, EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481853",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002507",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product availability issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481857",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002511",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MG EVERY 2 MONTHS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481865",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002541",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20200101",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481870",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002546",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "INJECT 400MG OF INFLECTRA FREQUENCY: 0,2,6 WEEKS, THEN EVERY 8 WEEKS THEREAFTER",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481871",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002544",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Arthritis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK (DOSAGE UNKNOWN, EVERY 6-7 WEEKS, IV INFUSION)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "100MG/20ML IV EVERY 8 WEEKS QUANTITY: 4 REFILLS: 12",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "100MG/20ML IV EVERY 4 WEEKS QUANTITY: 4 REFILLS: 12",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220223"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481877",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002547",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "397",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "397 MG, EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481879",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002550",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "INFUSION",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220228"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21481886",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002553",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482088",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "2",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002564",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapeutic product effect incomplete",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Loss of therapeutic response",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Underdose",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "5 MG, Q4W",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Colitis ulcerative",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20190826",
                        "drugenddateformat": "102",
                        "drugenddate": "20200515",
                        "drugtreatmentduration": "264",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "7.5",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "7.5 MG, Q4W",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20200515",
                        "drugenddateformat": "102",
                        "drugenddate": "20200807",
                        "drugtreatmentduration": "85",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20200515"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482089",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002601",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10 MG/KG EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Rectal haemorrhage",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482098",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002629",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product availability issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MILLIGRAM (INFLECTRA INDUCTION INFUSION)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5MG/ML (ONE TIME DOSE OF 10MG/KG)\\X INFLECTRA 6 100MG/20ML",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PEPCID",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "20",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "20MG",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FAMOTIDINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ZOFRAN",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "4",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "4MG",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ONDANSETRON HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SENOKOT",
                        "drugbatchnumb": "unknown",
                        "drugdosagetext": "5.6-50MG",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SENNOSIDES"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220301"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482102",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002631",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Irritable bowel syndrome",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Irritable bowel syndrome",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482110",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002635",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482117",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002649",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "INFUSION: 10MG PER KG EVERY 4 WEEKS, APPROXIMATELY 900-1000MG DEPENDING ON THE PATIENT^S WEIGHT",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Hidradenitis",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20200824",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220301"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482121",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002663",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482127",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010718",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG (300 MG) Q 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG, EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METHOTREXATE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHOTREXATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FOLIC ACID",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FOLIC ACID"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482132",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010719",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "800",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "800 MG (INJECT Q 4 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "700",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "700 MILLIGRAM, Q 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482136",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010796",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Sinus congestion",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Condition aggravated",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Anosmia",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Sinus headache",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug level below therapeutic",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapeutic product effect incomplete",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Paranasal sinus discomfort",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK (UNKNOWN DOSE INJECTED IN ARM EVERY 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Chronic disease",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202201",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ALEGRA",
                        "drugbatchnumb": "22A212C",
                        "drugstructuredosagenumb": "180",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "180 MG, ONE A DAY (30 TABLETS)",
                        "actiondrug": "5",
                        "drugadditional": "3"
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220301"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482231",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000874",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product availability issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MG, IV Q 8 WKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482263",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000944",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "200 MG (FREQUENCY: NOTHING LISTED); 2 100 MG/20 ML (QUANTITY: 2; REFILLS: 12)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482269",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000947",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482277",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001011",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482297",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001093",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482320",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001163",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNKNOWN",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482344",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001164",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Dry eye",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482366",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001178",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482400",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001188",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482417",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001195",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Underdose",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product distribution issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "400 MG (0,2,6 WK THEN Q 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400MG; INTRAVENOUS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482433",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001196",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Condition aggravated",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482699",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001197",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482706",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001262",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Condition aggravated",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Underdose",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FG4221",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211203",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FG4221",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MG",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FG4221",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MG, TID",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482771",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001266",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dispensing error",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482779",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001297",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482785",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001312",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MILLIGRAM (2 MORE LOADING DOSES AND THEN EV. 6 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482794",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001338",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug ineffective",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482797",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001340",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug ineffective",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482811",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001342",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Condition aggravated",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug effect less than expected",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482820",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001345",
            "duplicate": "1",
            "reportduplicate": {
                "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US001345"
            },
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "600 MG Q 4 WEEKS (QUANTITY: 6 REFILLS: 12)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "051",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "300 MG, CYCLIC (EVERY 4 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482833",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001347",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Condition aggravated",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482860",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001349",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Condition aggravated",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug ineffective",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482878",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001350",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Condition aggravated",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482898",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001381",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Sarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Cardiac sarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482913",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001382",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK (INFUSE10 MG/KG (800 MG) EVERY 4 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482934",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001383",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "2200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "2200 MG (EVERY 28 DAYS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482946",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001456",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482961",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001477",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MG EVERY 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21482981",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009426",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220113",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220210",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220412",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483006",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009428",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "3",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "3 MG/KG, WEEK 0,2,6 AND THEN EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Rheumatoid arthritis",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220517",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483014",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001548",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product storage error",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "900",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "900 MG, CYCLIC (INFUSE 900MG IV WEEKS 0,2,6 THEN 54 DAYS QUANTITY 9)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483018",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009434",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "600 MG, WEEK 0,2,6 THEN 42 DAY, QUANTITY; 18, FILLS: 11",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483038",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009436",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "GIVE 500 MG IV @ 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483043",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009439",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10 MG, CYCLIC (FREQUENCY Q6 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "1000",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1000 MG, CYCLIC (FREQUENCY: Q 6 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483045",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009458",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Illness",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Intentional dose omission",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MG INFUSED EVERY 6 WEEKS.",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220607"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483065",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009459",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Anaemia",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Anaemia",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Gastric disorder",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483076",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009597",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Symptom recurrence",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Intentional dose omission",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product availability issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483084",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009603",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483098",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009611",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, CYCLIC (EVERY 6WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10 MG/KG OVER 2 HOURS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483365",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US002685",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US002685"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US002685"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Seizure",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hypersensitivity",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483369",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "2",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002687",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Adverse drug reaction",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "100",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "100 MG/KG, EVERY 8 WEEKS (3 VIALS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "610",
                        "drugstartdate": "201902",
                        "drugenddateformat": "610",
                        "drugenddate": "201903",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20190201"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483377",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002722",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "4 100MG/20 ML DIRECTIONS: 400MG IV EVERY 8 WEEKS QUANTITY: 4 (100 MG) REFILLS: AS NEED FOR 1 YEAR",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483378",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002707",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "250",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "250MG EACH VISIT, EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483379",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002854",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Micturition urgency",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Dysuria",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Malaise",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "EY1084",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Rheumatoid arthritis",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202012",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483380",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002705",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Decreased appetite",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Weight decreased",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Underdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Ankylosing spondylitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "100",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "100 MG(OF 8 WEEKS, QUANTITY: 1, REFILLS: 6)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500MG (EVERY 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLIXIMAB",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Solution for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220516",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "5 MG, 4 TABLET ONCE A DAY X 3 DAYS, THEN 3 TABS/DAY X 3 DAYS/THEN 2 TABS/DAY X 3 DAYS, THEN 1 TAB/DA",
                        "drugdosageform": "Tablet",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220518",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483385",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002897",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483386",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002947",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483387",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002879",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hidradenitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "INJECT 400 MG OF INFLECTRA FREQUENCY: EVERY 4 WEEKS QUANTITY: 1 REFILLS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Hidradenitis",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "INFUSE 400 MG INFLECTRA IVPB EVERY 28 DAYS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483388",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002857",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Circumstance or information capable of leading to medication error",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product distribution issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483389",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002899",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483390",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002946",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483404",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003015",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "305",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "305 MG (300 + 5 MG) EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483405",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003010",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483406",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003009",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product availability issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "350",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "350 MG",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220211"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483407",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US002951",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Streptococcal infection",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Anaemia",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483408",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003013",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10 MG/KG ON WEEKS 0,2,6 THEN EVERY 8 WEEKS THEREAFTER",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483417",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003095",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product distribution issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product storage error",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Prescribed overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10 MG/KG AT WEEK 0, 2, 6 THEN EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "TYLENOL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "1000",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1000 MG",
                        "drugadministrationroute": "048",
                        "drugindication": "Premedication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ACETAMINOPHEN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "DIPHENHYDRAMINE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "25",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "25 MG",
                        "drugadministrationroute": "048",
                        "drugindication": "Premedication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DIPHENHYDRAMINE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483418",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003127",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "410",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "410 MG (5 100 MG/20 ML); FREQUENCY: IV DAY 1, DAY 15 FOLLOWED BY 6 WEEKS AND 12 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483419",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003060",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "INJECT: 500 MG OF INFLECTRA FREQUENCY: Q 8 WEEKS/500MG EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500MG Q6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483424",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003199",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product selection error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483425",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003225",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483426",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003228",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product availability issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483428",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003316",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "ON WEEKS 0,2,6 THEN EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "100 MG/20 ML ON WKS 0,2,6 THEN EVERY 8 WKS. QTY: 7 VIALS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483429",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003271",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product selection error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "350",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "350 MG, 1X/DAY, (100 MG/20 ML) (FREQUENCY: Q 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483430",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003335",
            "duplicate": "1",
            "reportduplicate": {
                "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US003335"
            },
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483431",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003336",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pyrexia",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Headache",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Nausea",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Palpitations",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "SECOND INFUSION",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483432",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003245",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hidradenitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Hidradenitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483434",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003423",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "550",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "INFUSE 550 MG IV Q 4 WKS QUANTITY: 6/100 REFILLS: 11",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483435",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003404",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "713",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "713 MG, EVERY 4 WEEKS QUANTITY: 7, REFILLS: 11",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483436",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003409",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "1000",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1000 MILLIGRAM FOR EVERY 3 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483437",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003415",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "291 100 MG/20 ML; (BLANK) MG OF INFLECTRA (FREQUENCY: AT WEEK 0,2,6 THEN EVERY 8 WKS, QUANTITY 3, RE",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, CYCLIC (INJECT (BLANK) MG OF INFLECTRA AT WEEK 0,2,6 THEN EVERY 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "RITUXIMAB",
                        "drugbatchnumb": "UNKNOWN",
                        "drugdosagetext": "SINGLE DOSE VIAL: 3",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "RITUXIMAB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483438",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003407",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MG Q 8 WEEKS QUANTITY 4 VIALS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Vogt-Koyanagi-Harada disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483448",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003428",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10 MG/KG (QUANTITY: 8 REFILLS: 11)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483449",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003424",
            "duplicate": "1",
            "reportduplicate": {
                "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US003424"
            },
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MG, (EVERY 6 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483450",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003426",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "280",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "280 MG (EVERY 56 DAYS QUANTITY: 3 REFILLS 6)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483451",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003427",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "350",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "350MG (FREQUENCY:0, 2WK , 6WK THEN EVERY 8 WKS.)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483452",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003425",
            "duplicate": "1",
            "reportduplicate": {
                "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US003425"
            },
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MG, CYCLIC (EVERY 56 DAYS, QUANTITY: 5 REFILLS: 11)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "760",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "760 MG, CYCLIC (EVERY 42 DAYS, QUANTITY: 8 REFILLS: 11)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483469",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003436",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "9",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "9 MG/KG",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483472",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003435",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "240",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "240 MG, EVERY 56 DAYS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400MG, EVERY 56 DAYS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483476",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003453",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Deprescribing error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG IV WEEKS 0,2,6 EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483477",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003449",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "900",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "900 MG CYCLIC, (INFUSE 900MG IV EVERY 28 DAYS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483481",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003440",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product distribution issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "INFUSE 10MG/KG EVERY 6 WEEKS QUANTITY OF 6 VIALS REFILLS-9",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220309"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483482",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003437",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "EVERY 56 DAYS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483483",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003452",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product availability issue",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "3"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "380",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "INFUSE 5MG/KG MG OF INFLECTRA FREQUENCY Q 8 WKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "380",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "380MG, 5MG/KG, BY INFUSION EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220316"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483487",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003491",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483488",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003465",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483490",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003455",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "No adverse event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "100 MG/2ML DIRECTIONS: INJECT 400MG OF INFLECTRA FREQUENCY 56 DAYS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483500",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003526",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "5 MG/KG (300 MG EVERY 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483501",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003541",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product distribution issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "5MG/KG INTRAVENOUS INFUSION:INDUCTION PROCESS:SUPPOSED TO DO WEEK 0, 2, 6, THEN EVERY 8 WEEKS AFTER",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "041",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220301",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220314"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483502",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003515",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Rash",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483503",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003511",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Respiration abnormal",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Throat tightness",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Dyspnoea",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Nausea",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Palpitations",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Flushing",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Underdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FG9317",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG (PERIPHERAL IV)",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Colitis ulcerative",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202106",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FM4731",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "200 MG",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220318",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FG9317",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220318",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220318"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483504",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003562",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "INJECT 400 MG OF INFLECTRA FREQUENCY: EVERY 8 WEEKS QUANTITY: 80 ML REFILLS: 6",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK (EVERY 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483510",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003584",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "100",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "100 MG",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483511",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003618",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483512",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003575",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG, EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483513",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003616",
            "duplicate": "1",
            "reportduplicate": {
                "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US003616"
            },
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483528",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003628",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10 MG/KG",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483529",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003699",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "10 MG/KG, MONTHLY Q 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Proctitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483530",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010824",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hidradenitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "650",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "650 MILLIGRAM (WEEK 0,2,4 THEN EVERY 28 DAYS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "HUMIRA",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "40",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "40 MG, EVERY 7 DAYS",
                        "drugadministrationroute": "058",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220313",
                        "drugenddateformat": "102",
                        "drugenddate": "20220804",
                        "drugtreatmentduration": "145",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ADALIMUMAB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "NORVASC",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10 MG, DAILY",
                        "drugadministrationroute": "048",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220702",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "AMLODIPINE BESYLATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CHLORHEXIDINE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "4% EXTERNAL LUQUID 120 ML",
                        "drugadministrationroute": "061",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210512",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CHLORHEXIDINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CLINDAGEL",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "1% GEL 60G",
                        "drugdosageform": "Gel",
                        "drugadministrationroute": "061",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20200117",
                        "drugenddateformat": "102",
                        "drugenddate": "20220504",
                        "drugtreatmentduration": "839",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CLINDAMYCIN PHOSPHATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "TEMOVATE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK, BID",
                        "drugdosageform": "Ointment",
                        "drugadministrationroute": "061",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20160725",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CLOBETASOL PROPIONATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "HYDRODIURIL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "25",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "25 MG, DAILY",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220722",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "HYDROCHLOROTHIAZIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "GLUCOPHAGE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MG, 2 TIMES A DAY WITH MEALS",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220629",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METFORMIN HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "DELTASONE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10 MG, TAKE 3 TABLETS (30 MG TOTAL), EVERY MONDAY AND THURSDAY",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220630",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483696",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009625",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hidradenitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Hidradenitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483738",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009650",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, (300MG/20ML) (EVERY 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483762",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009679",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "600 MILLIGRAM EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "DIPHENHYDRAMINE",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DIPHENHYDRAMINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ACETAMINOPHEN",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ACETAMINOPHEN"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483852",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009700",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG (100 MG/20ML, INJECT 300 MG FREQUENCY: 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483857",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009725",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MILLIGRAM, EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "21483880",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221221",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US009930",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US009930"
                },
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US009930"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Cardiac failure",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Oedema peripheral",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Joint swelling",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Peripheral swelling",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Palpitations",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product substitution issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Sarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483923",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010014",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "380",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "380 MG, EVERY 3 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21483941",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010104",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Incorrect drug administration rate",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNSPECIFIED MAINTENANCE DOSE EVERY 6 WEEKS (OVER 91 MIN RATE)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21484489",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010109",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "742",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "DIRECTIONS: 742MG (7.5MG/KG IV EVERY 7 WEEKS) QUANTITY: 800 REFILLS: 6 (PATIENT^S WEIGHT: 218 LBS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21484501",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010153",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21484508",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010154",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "0,2, + 6 THEN EVERY 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MG (REGIMEN #2)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21484529",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010213",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "250",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "250 MG (EVERY 6 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21484542",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010235",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product substitution issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product quality issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10 MILLIGRAM",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "RITUXIMAB",
                        "drugbatchnumb": "Unknown",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "RITUXIMAB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220622"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21484565",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010247",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "DIRECTIONS: 558 MG IV DAY 1, DAY 15, DAY 43 THEN Q 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "5MG/ML, CYCLIC (5MG/ML, CYCLIC (DAY 1, DAY 15, DAY 43 THEN Q 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21484591",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010255",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220310",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220407",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220505",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220531",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220628",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21484600",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010262",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dispensing error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "1100",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "DOSE = 1100MG ON 6/22/21 WT = 118.2KG DIRECTIONS INFLECTRA 10MG/KG Q 42 DAYS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210622",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "1200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "DOSE + 1200MG ON 8/3/21 WT 121.1 KG DIRECTIONS: INFLECTRA 10 MG/KG Q 42 DAYS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210803",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21484633",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010291",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220331",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220428",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220531",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220628",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21484657",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010301",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US005173"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US010301"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "0, 2, 6 AND EVERY (Q) 6 WEEKS THEREAFTER",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21484852",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010315",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "272",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "272 MG (Q8WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21484875",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010341",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Condition aggravated",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product selection error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FM8778",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "1000",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "INFUSION; ADMINSTIER 1000MG EVERY 6 WEEKS 10MG /KG INFUSRED ABOUT 1000MG , ONE INUDSION 1,000MG VIAL",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "drugenddateformat": "102",
                        "drugenddate": "20220414",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FM6845",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "1000",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1000 MG ADMINISTER 1000MG EVERY 6 WEEKS 10MG/KG INFUSED ABOUT 1000MG, ONE INFUSION 1,000MG VIAL",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "drugenddateformat": "102",
                        "drugenddate": "20220414",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "DIRECTIONS: (BLANK) FREQUENCY: Q 6 QUANTITY: 9 VIALS REFILLS:11",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ENTYVIO",
                        "drugbatchnumb": "unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "VEDOLIZUMAB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "REMICADE",
                        "drugbatchnumb": "unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CYMBALTA",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "60",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "60 MG",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DULOXETINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "DIPHENHYDRAMINE HYDROCHLORIDE",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "50",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "50 MG",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DIPHENHYDRAMINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METOPROLOL",
                        "drugbatchnumb": "UNKNOWN",
                        "drugstructuredosagenumb": "50",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "50 MG, ONE TIME A DAY, TABLET",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METOPROLOL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "BUSPAR",
                        "drugbatchnumb": "UNKNOWN",
                        "drugstructuredosagenumb": "15",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "15 MG, TWICE A DAY, TABLET",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "BUSPIRONE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ATORVASTATIN",
                        "drugbatchnumb": "UNKNOWN",
                        "drugdosagetext": "ONCE A DAY(LOW DOSE) TABLET",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ATORVASTATIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "INSULIN NOS",
                        "drugbatchnumb": "UNKNOWN",
                        "drugdosagetext": "AS NEEDED, INJECTABLE",
                        "drugdosageform": "Injection",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INSULIN NOS"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220414"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21484901",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010344",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "DIRECTIONS: INJECT 500 MG OF INFLECTRA FREQUENCY: EVERY 8 WKS QUANTITY: 100ML } 100MG REFILLS: 10",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21484949",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010357",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Alopecia",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21484970",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010382",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21485151",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010384",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "250",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "250MG EVERY 8 WEEKS QUANTITY: 1 VIAL REFILLS: 11",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21485163",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010388",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21485218",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010413",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hidradenitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug effective for unapproved indication",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Hidradenitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21485241",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010435",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "5 MG/KG, CYCLIC (INFUSE 5 MG/KG INFLECTRA Q 7 WKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METHOTREXATE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "8 TABS WKLY",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHOTREXATE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21485416",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013384",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21485495",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US012471",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MG Q8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "RUXIENCE",
                        "drugbatchnumb": "Unknown",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "RITUXIMAB-PVVR"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21485506",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221020",
            "receiptdateformat": "102",
            "receiptdate": "20221020",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013463",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "EVERY FIRST OF MONTH",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488373",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003702",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488374",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003706",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488379",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003710",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MG, EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488384",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003712",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US003712"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US003712"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "415",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "415 MG, CYCLIC (EVERY 6 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488392",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003807",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "800",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "800 MG, EVERY 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Ankylosing spondylitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488489",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005188",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488490",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005187",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug ineffective",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488491",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005172",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488493",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005170",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "5 MILLIGRAM, (FREQUENCY 0,2,6, 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488501",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005192",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488502",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005223",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG (WEEK 0,2,6 THEN EVERY 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488503",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005216",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "800",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "800 MG EVERY 5 WEEKS (INJECT 800 MG OF INFLECTRA FREQUENCY Q 5 WEEKS QUANITY 8 REFILL 7)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488504",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005215",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488505",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005190",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "200 MILLIGRAM, EVERY 8WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488506",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005222",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Impaired work ability",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Emotional disorder",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Infusion related reaction",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Malaise",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapeutic response changed",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Incorrect dose administered",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FT1656",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5MG PER KG EVERY 8 WEEKS, PERIPHERAL IV (DOSAGE FORM: 100MG IN 20ML VIAL AS A POWDER)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Psoriatic arthropathy",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220329",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220401",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220401"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488507",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005225",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Swelling",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "220",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "220 MILLIGRAM EVERY 0, 2, 6 THEN Q 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220520",
                        "drugenddateformat": "102",
                        "drugenddate": "20220701",
                        "drugtreatmentduration": "43",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488508",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005208",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "114",
                        "drugstructuredosageunit": "012",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "INFUSE 114ML EVERY 4 WEEKS QUANTITY: 11 VIALS REFILLS: 11",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488509",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005221",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Gastrointestinal bacterial infection",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Gastrointestinal bacterial infection",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488510",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005227",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488512",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005354",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "138",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "138 MG, CYCLIC (FREQUENCY: EVERY 2 WEEK X 2 DOSES THEN EVERY 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488514",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005356",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "200 MILLIGRAM, WEEK 0,2,6 AND EVERY 8 WEEKS THEREAFTER",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488515",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005362",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "5 MG, EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "800",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "800 MG, EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488524",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005686",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "600 MG (FREQUENCY: EVERY 8 WEEKS QUANTITY: 6 VIALS REFILLS: 5); 6 VIALS 100 MG/20 ML",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488529",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005452",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "5 MG, EVERY 7 WEEKS (QUANTITY: 4 REFILLS: 1 YEAR)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488531",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005451",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MG, EVERY 8 WEEKS (QUANTITY: 500 REFILLS: 5)",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488533",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005583",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "1000",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1000 MG EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488535",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005446",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Infection",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Intentional dose omission",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488536",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005911",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "CYCLIC (INJECT 5 MG/KG IV EVERY 6 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488538",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005692",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488539",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005747",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Condition aggravated",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488540",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005746",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product preparation error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "7 MG/KG CYCLIC (FREQUENCY: Q 6-8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488541",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005931",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488542",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005975",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "No adverse event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488543",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005974",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Intentional product use issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "5 MG, CYCLIC (FREQUENCY: WEEK 0, 2, 6 THEN EVERY 8 WEEKS THEREAFTER)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Psoriatic arthropathy",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488544",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005960",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "600 MG (MAINT Q8WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "100",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "100 MG (SINGLE POSE VIAL MAINT Q8 WEEK)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488547",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006016",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug eruption",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Drug eruption",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488548",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006011",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG 0,2,6, LOADING DOSES THEN EV. 8 WKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488549",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005998",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488550",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006094",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Gastrooesophageal reflux disease",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Gastrooesophageal reflux disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488551",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005996",
            "duplicate": "1",
            "reportduplicate": {
                "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US005996"
            },
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "260",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "260 MG EVERY 2 WEEKS X 28 DAYS, THEN EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488552",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006121",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488553",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005995",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "800",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "800 MG (FREQUENCY: 56 DAYS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488555",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006251",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300MG (VIALS 100MG/20ML)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488556",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006256",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG (400MG) EVERY 6 WEEKS QUANTITY: 2 REFILLS: 4",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Psoriatic arthropathy",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MG (EVERY 6 WEEKS (EXTRA VIAL WAS SENT LAST TIME) QUANTITY: 1 VIAL",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488557",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006254",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "3",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "3 MG/KG, IV Q (EVERY) 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG [FREQUENCY: 0,2,6 THEN Q (EVERY) 8 WKS QUANTITY: 3MG/KG REFILLS:12]",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488558",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006241",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Gastrointestinal inflammation",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Gastrointestinal inflammation",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488559",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006274",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "600 MG/KG 5MG/PER KG; FREQUENCY: 0,2,6 WEEKS THEN EVERY8WEEKS PER PROTOCOL",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488560",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006279",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488563",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003857",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488564",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006252",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MILLIGRAM, (INFUSE 5MG/KG) EVERY 8 WEEKS QUANTITY: 3 VIALS REFILLS: 6",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488565",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006260",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MG, LOADING 0,2,6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488569",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006486",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "2"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Contusion",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Adverse event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "STARTED ABOUT 8 MONTHS AGO",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488570",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006363",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG (ONCE AT 125ML/HR OVER 2 HOURS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Colitis ulcerative",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220429",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "2",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "300 MG, 2/WEEK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "300 MG, Q4WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG, THEN Q8WKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488571",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006385",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Abdominal discomfort",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Psoriasis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Adverse drug reaction",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Malaise",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Chills",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug ineffective",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Psoriasis",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202203",
                        "drugenddateformat": "610",
                        "drugenddate": "202203",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Psoriatic arthropathy",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "REMICADE",
                        "drugbatchnumb": "Unknown",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488572",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006413",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG, CYCLIC EVERY 2 WEEKS, 2 DOSES; EVERY 4 WEEKS, 1 DOSE; EVERY 8 WEEKS, 3 DOSES",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488573",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003861",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488574",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006352",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5MG/KG WEEK 0,2,6 THEN Q8WEEKS QUANTITY 5 VIALS REFILLS 1 YR",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488575",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006359",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "1200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "INJECT 1200 MG FREQUENCY: 8 QUANTITY",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488579",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006560",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product packaging issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product preparation issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488580",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US013723",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Anaphylactic reaction",
                        "reactionoutcome": "1"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Inflammatory bowel disease",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488581",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013728",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Articular disc disorder",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "C-reactive protein increased",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Joint stiffness",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Anxiety",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488582",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013736",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Posterior tibial tendon dysfunction",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Foot deformity",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Herpes simplex reactivation",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Oral herpes",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Psoriatic arthropathy",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Posterior tibial tendon dysfunction",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Foot deformity",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "METHOTREXATE",
                        "drugbatchnumb": "Unknown",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHOTREXATE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488585",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013732",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Dysstasia",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Musculoskeletal stiffness",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Dyspnoea",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Arthralgia",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Swelling",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Joint swelling",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Back pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Arthralgia",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Oedema peripheral",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Palpitations",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "(5MG/KG) 700MG EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "HYDROXYCHLOROQUINE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "200 MG, BID",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "HYDROXYCHLOROQUINE"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "REMICADE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "700",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "700 MG, CYCLIC EVERY 8 WEEKS",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220801"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488586",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003865",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "200MG WITH A LOADING DOSE PATTERN: EVERY 14 DAYS X 3 DOSES",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488587",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006488",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "200 MG, INJ",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488599",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003886",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hidradenitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Hidradenitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488601",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003868",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product selection error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MG, EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488609",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003871",
            "duplicate": "1",
            "reportduplicate": {
                "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US003871"
            },
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488616",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003874",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "340",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "DIRECTIONS: INFUSE 340MG IV EVERY 27 DAYS QUANTITY: 4 REFILLS 11",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488626",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003878",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488644",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003866",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488653",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003898",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "450.8",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "5MG/KG EVERY 4 WEEKS;450.8 MG (PATIENT WEIGHT: 90.16)",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488783",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003900",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "INFLECTRA 300 100MG/20ML;0, 2 WEEKS, 4 WEEKS, THEN EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488794",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003901",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Prescribed overdose",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "1000",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1000 MG CYCLIC (1,000 MG FREQUENCY EVERY 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488796",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003917",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product temperature excursion issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488797",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003927",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Rash",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488812",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003929",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488817",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003930",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK (EVERY 56 DAYS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488827",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US003942",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US003942"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US003942"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hepatitis B",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10 MG/KG",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488838",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003946",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, (19JAN2022, 15MAR2022, THEN EVERY 6 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488851",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003953",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product selection error",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "1100",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1100 MG, CYCLIC (EVERY 6 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10 MG/KG",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "100MG/20ML; (99.5 KGS)PT-WT, INFUSE 10MG/KG OVER 2 HOURS; QUANTITY: 11 VIALS; REFILLS: 6",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21488864",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003955",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "200 MG (FREQUENCY WEEK 1,2,6, THEN EVERY 6 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489106",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US003979",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "2",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "5 MILLIGRAM/KILOGRAM, Q2WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10 MG/KG EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ASCORBIC ACID",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ASCORBIC ACID"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "AZATHIOPRINE",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "AZATHIOPRINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "BUDESONIDE",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "BUDESONIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CARVEDILOL",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CARVEDILOL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CHOLECALCIFEROL",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CHOLECALCIFEROL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CYANOCOBALAMIN",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CYANOCOBALAMIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CYCLOBENZAPRINE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CYCLOBENZAPRINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FLONASE",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FLUTICASONE PROPIONATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "HYDRALAZINE",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "HYDRALAZINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LISINOPRIL",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LISINOPRIL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LORATADINE",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LORATADINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "MELATONIN",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "MELATONIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METRONIDAZOLE",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METRONIDAZOLE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "OMEPRAZOLE",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "OMEPRAZOLE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "OXYCODONE AND ACETAMINOPHEN",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ACETAMINOPHEN\\OXYCODONE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "POTASSIUM GLUCONATE",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "POTASSIUM GLUCONATE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489114",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004013",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product distribution issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "100",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "3 MG/KG, EVERY 5 WEEKS/DIRECTIONS: INFLECTRA 3MG/KG IV EVERY 5 WEEKS QUANTITY: (400MG) REFILLS: 3",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MG (EVERY 5 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METOPROLOL SUCCINATE",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "50",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "ER 50 MG TABLET, EXTENDED RELEASE 24 HR 1 TABLET BY ORAL ROUTE 2 TIMES EVERY DAY",
                        "drugdosageform": "Tablet, extended release",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METOPROLOL SUCCINATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "GABAPENTIN",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1 PO BID",
                        "drugdosageform": "Capsule",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "GABAPENTIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METFORMIN HYDROCHLORIDE",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "50MG ER TABLET, EXTENDED RELEASE, 24HR 1 PO QAM, 1 PO QHS",
                        "drugdosageform": "Tablet, extended release",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METFORMIN HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "OZEMPIC",
                        "drugbatchnumb": "unknown",
                        "drugdosagetext": "1MG/DOSE (2MG/1.5ML); INJECT (1MG) BY SUBCUTANEOUS ROUTE EVERY WEEK ON THE SAME DAY OF EACH WEEK, IN",
                        "drugadministrationroute": "058",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SEMAGLUTIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "OZEMPIC",
                        "drugbatchnumb": "unknown",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "2MG/1.5ML (2MG; INJECT (1MG) BY SUBCUTANEOUS ROUTE EVERY WEEK ON THE SAME DAY OF EACH WEEK, IN THE A",
                        "drugadministrationroute": "058",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SEMAGLUTIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ELIQUIS",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "TAKE 1 TABLET BY ORAL ROUTE 2 TIMES EVERY DAY",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "APIXABAN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PANTOPRAZOLE SODIUM",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "40",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "TAKE 1 TABLET BY ORAL ROUTE EVERY DAY",
                        "drugdosageform": "Tablet, delayed release",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PANTOPRAZOLE SODIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PRAVASTATIN SODIUM",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "40",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "40 MG",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PRAVASTATIN SODIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "AMLODIPINE",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1 PO DAILY",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "AMLODIPINE BESYLATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LISINOPRIL",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "40",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1 PO DAILY",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LISINOPRIL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LEFLUNOMIDE",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "20",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "TAKE 1 TABLET BY MOUTH EVERY DAY",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LEFLUNOMIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "BENADRYL",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "25",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "25 MG",
                        "drugdosageform": "Capsule",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DIPHENHYDRAMINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "HYDROXYCHLOROQUINE SULFATE",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "TAKE 1 TABLET BY MOUTH TWICE DAILY",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "HYDROXYCHLOROQUINE SULFATE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489116",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004020",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "INJECT 600 MG FREQUENCY: EVERY 6 WEEKS QUANTITY: 8 REFILLS: 1",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489120",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004025",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "INJECT 500 MG INTO THE VEIN EVERY 28 (TWENTY-EIGHT) DAYS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489133",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004090",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "OMEPRAZOLE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Capsule, delayed release",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211118",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "OMEPRAZOLE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "MOMETASONE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Cream",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210620",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "MOMETASONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "DIETARY SUPPLEMENT\\HERBALS",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DIETARY SUPPLEMENT\\HERBALS"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ASCORBIC ACID",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20171107",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ASCORBIC ACID"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LOSARTAN",
                        "drugbatchnumb": "Unknown",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LOSARTAN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ASPIRIN",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20200727",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ASPIRIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FOLIC ACID",
                        "drugbatchnumb": "Unknown",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FOLIC ACID"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "THIAMINE MONONITRATE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "THIAMINE MONONITRATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FISH OIL",
                        "drugbatchnumb": "Unknown",
                        "drugdosageform": "Capsule",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FISH OIL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CHOLECALCIFEROL",
                        "drugbatchnumb": "Unknown",
                        "drugdosageform": "Capsule",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CHOLECALCIFEROL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FLUOXETINE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FLUOXETINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "RETINOL",
                        "drugbatchnumb": "Unknown",
                        "drugdosageform": "Capsule",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "RETINOL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "AMLODIPINE",
                        "drugbatchnumb": "Unknown",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "AMLODIPINE BESYLATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VITAMIN C",
                        "drugbatchnumb": "Unknown",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ASCORBIC ACID"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "IBUPROFEN",
                        "drugbatchnumb": "Unknown",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "IBUPROFEN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METHOTREXATE SODIUM",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Solution (Except Syrup)",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211118",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHOTREXATE SODIUM"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489140",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004091",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, CYCLIC (EVERY 4 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489142",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004135",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, ((7) 100 MG/20 ML)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489143",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004150",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "7010",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "7010 MG, EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489144",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004169",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "1000",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1000 MG (100 MG/20 ML) (FREQUENCY: Q 6 WEEKS QUANTITY: 10 VIALS REFILLS: 1 YEAR)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489149",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004170",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "DIRECTIONS: 400 MG IV EVERY 8 WKS QUANTITY: 4 REFILLS: 11",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489317",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004173",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489336",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004175",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Weight increased",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "LAST INFUSION 11/2021",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202111",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20211101"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489370",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004177",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10 MG/KG (1100MG), EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ALBUTEROL SULFATE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ALBUTEROL SULFATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "AMOXICILLIAN-CLAVULONATE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3"
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "AZITHROMYCIN",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "AZITHROMYCIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "BUPROPION HYDROCHLORIDE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "BUPROPION HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CARBIDOPA\\LEVODOPA",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CARBIDOPA\\LEVODOPA"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CEFDINIR",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CEFDINIR"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CHOLECALCIFEROL",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CHOLECALCIFEROL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CYANOCOBALAMIN",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CYANOCOBALAMIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "DOCUSATE SODIUM",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DOCUSATE SODIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "DULOXETINE HYDROCHLORIDE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DULOXETINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ERYTHROMYCIN",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ERYTHROMYCIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FLUTICASONE PROPIONATE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FLUTICASONE PROPIONATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "GLIMEPIRIDE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "GLIMEPIRIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "KETAMINE HYDROCHLORIDE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "KETAMINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SODIUM CHLORIDE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SODIUM CHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LISINOPRIL",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LISINOPRIL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "MAGNESIUM OXIDE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "MAGNESIUM OXIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "MELATONIN",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "MELATONIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METFORMIN HYDROCHLORIDE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METFORMIN HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METHYLPREDNISOLONE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHYLPREDNISOLONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METOPROLOL SUCCINATE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METOPROLOL SUCCINATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "MORPHINE SULFATE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "MORPHINE SULFATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "MUPIROCIN",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "MUPIROCIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "NALOXONE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "NALOXONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "NYSTATIN",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "NYSTATIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ONDANSETRON",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ONDANSETRON"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PANTOPRAZOLE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PANTOPRAZOLE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "POLYETHYLENE GLYCOL",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "POLYETHYLENE GLYCOL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PROMETHAZINE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PROMETHAZINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ROPINIROLE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ROPINIROLE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ROSUVASTATIN CALCIUM",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ROSUVASTATIN CALCIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SUCRALFATE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SUCRALFATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SUMATRIPTAN SUCCINATE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SUMATRIPTAN SUCCINATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "TESTOSTERONE CYPIONATE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "TESTOSTERONE CYPIONATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ZOLPIDEM TARTRATE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ZOLPIDEM TARTRATE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489373",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004184",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG WK 0,2,6 THEN Q 8 WKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489377",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004185",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product use issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG INFUSED EVERY 6 WEEKS (100MG/20ML)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489394",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004187",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "100 MG/20 ML",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489400",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004231",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "223",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "223 MG (FREQUENCY: WEEK 0,2,6, AND EVERY 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "220",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "220 MG, WEEK 2,6 (REMAINING LOAD) THEN EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489401",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000613",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "10 MG/KG, EVERY 4 WEEKS FOR APPROPRIATE BLOOD LEVELS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Inflammatory bowel disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489406",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004233",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Gastroenteritis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "650",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "650 MG, EVERY 56 DAYS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Gastroenteritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Colitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489410",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004237",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "((LD) DIRECTIONS: INJECT 500 MG OF INFLECTRA FREQUENCY: DAY 0, 14, 42 QUANTITY: 15 REFILLS 0; (M) DI",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "DIRECTIONS: UNKNOWN UNKNOWN; INJECTION; REGIMEN #2 INJECT 500 MG FREQUENCY: UNKNOWN EVERY (BLANK) QU",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "DIRECTIONS: 500 MG IV DAY 42 THEN EVERY 6 WEEKS QUANTITY: 5 REFILLS: 6",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489425",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004265",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product preparation error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG (383.5 MG) AT WEEKS 0, 2, 6 AND THEN EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489441",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000666",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400MG, Q 6-7 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489446",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000667",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, CYCLIC (WILL RECEIVE INFLECTRA ON DAYS 1 AND 15 THEN WEEK 6 AND WEEK 12)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489454",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000668",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product availability issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "800",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "800 MG, EVERY 7 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220118"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489469",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000693",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489474",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000714",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Circumstance or information capable of leading to medication error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489489",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000758",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Abnormal loss of weight",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Abnormal loss of weight",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489495",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000788",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "INJECT 400MG OF INFLECTRA FREQUENCY EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489521",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004345",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "736",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "736 MG, EVERY 4 WEEKS (DIRECTIONS: INJECT 736 MG OF INFLECTRA, FREQUENCY EVERY 4 WEEKS QUANTITY 7 RE",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "74",
                        "drugstructuredosageunit": "012",
                        "drugdosagetext": "74 MLS IN THE VEIN EVERY 28 DAYS",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "10MG/KG Q 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489525",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004347",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489528",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004350",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Adverse drug reaction",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product substitution issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489536",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004358",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "7.5",
                        "drugstructuredosageunit": "007",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "7.5 MG/KG, EVERY 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489538",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004362",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Arthritis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy cessation",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489559",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US012571",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Flushing",
                        "reactionoutcome": "2"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "4TH INFUSION",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489563",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US012667",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "305.1",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "INJECT 305.1 MG OF INFLECTRA FREQUENCY WK0 WK2 WK6 THEN EVERY 8 WKS QUANITIY 6 REFILLS 6",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489611",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005111",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MILLIGRAM FREQUENCY: Q 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489612",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005119",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment failure",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489618",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005157",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Iron deficiency anaemia",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "1,3 +7X 1 CYCLE THEN EVERY 8 WEEKS X 5 CYCLES",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Iron deficiency anaemia",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489622",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005160",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Blood pressure diastolic decreased",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FM6841",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "900",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "2",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "5 MG/KG, Q2WEEKS X 1 MONTH (WEIGHT: 167 KG)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220209",
                        "drugenddateformat": "102",
                        "drugenddate": "20220209",
                        "drugtreatmentduration": "122",
                        "drugtreatmentdurationunit": "806",
                        "actiondrug": "4",
                        "drugrecurreadministration": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FM6844",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "900",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "2",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "5 MG/KG, Q2WEEKS X 1 MONTH (WEIGHT: 167 KG)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Fistula",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220209",
                        "drugenddateformat": "102",
                        "drugenddate": "20220209",
                        "drugtreatmentduration": "122",
                        "drugtreatmentdurationunit": "806",
                        "actiondrug": "4",
                        "drugrecurreadministration": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FM6841",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "900",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "802",
                        "drugdosagetext": "5 MG/KG, Q4WEEKS X 1 MONTH (WEIGHT: 169 KG)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220309",
                        "drugenddateformat": "102",
                        "drugenddate": "20220309",
                        "drugtreatmentduration": "115",
                        "drugtreatmentdurationunit": "806",
                        "actiondrug": "4",
                        "drugrecurreadministration": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FM6844",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "900",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "802",
                        "drugdosagetext": "5 MG/KG, Q4WEEKS X 1 MONTH (WEIGHT: 169 KG)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220309",
                        "drugenddateformat": "102",
                        "drugenddate": "20220309",
                        "drugtreatmentduration": "115",
                        "drugtreatmentdurationunit": "806",
                        "actiondrug": "4",
                        "drugrecurreadministration": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG, Q8WEEKS X 1 YEAR",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "4",
                        "drugrecurreadministration": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SODIUM CHLORIDE",
                        "drugbatchnumb": "Y384131",
                        "drugdosagetext": "UNK",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SODIUM CHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SODIUM CHLORIDE",
                        "drugbatchnumb": "Y384360",
                        "drugdosagetext": "UNK",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SODIUM CHLORIDE"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220310"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489655",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US014098",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product temperature excursion issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "800",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "800MG EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220822",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489682",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US014103",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "1100",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "802",
                        "drugdosagetext": "X INFLECTRA DIRECTIONS: 1100 MG INFUSED IV EVERY MONTH QUANTITY: 11 REFILLS: 11",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "AMITRIPTYLINE HYDROCHLORIDE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "AMITRIPTYLINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "AMITRIPTYLINE HYDROCHLORIDE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "AMITRIPTYLINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LAMOTRIGINE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LAMOTRIGINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FLUTICASONE PROPIONATE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FLUTICASONE PROPIONATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CYPROHEPTADINE HYDROCHLORIDE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CYPROHEPTADINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LEVOTHYROXINE SODIUM",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LEVOTHYROXINE SODIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "GLUTAMINE [LEVOGLUTAMIDE]",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3"
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ACETYLCYSTEINE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ACETYLCYSTEINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CETIRIZINE HCL",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CETIRIZINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CEVIMELINE HYDROCHLORIDE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CEVIMELINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ZOFRAN",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ONDANSETRON HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "DEXLANSOPRAZOLE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DEXLANSOPRAZOLE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "GABAPENTIN",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "GABAPENTIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ZOLPIDEM TARTRATE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ZOLPIDEM TARTRATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VERAPAMIL HCL",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "VERAPAMIL HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VITAMIN D3",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CHOLECALCIFEROL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CARDURA",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DOXAZOSIN MESYLATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ACYCLOVIR",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ACYCLOVIR"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ASPIRIN",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ASPIRIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CARNITINE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CARNITINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CREATINE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CREATINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FOLIC ACID",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FOLIC ACID"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SUPER B COMPLEX [VITAMIN B COMPLEX]",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3"
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VITAMINS",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "VITAMINS"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CALCIUM 600+D [CALCIUM;COLECALCIFEROL]",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3"
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "NIMODIPINE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "NIMODIPINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METHOTREXATE SODIUM",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHOTREXATE SODIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CYMBALTA",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DULOXETINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LIOTHYRONINE SODIUM",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LIOTHYRONINE SODIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "AMBIEN",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ZOLPIDEM TARTRATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "NORCO",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ACETAMINOPHEN\\HYDROCODONE BITARTRATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FUROSEMIDE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FUROSEMIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "EPIPEN",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "EPINEPHRINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "COENZYME Q10",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DIETARY SUPPLEMENT\\UBIDECARENONE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489755",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013743",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Eosinophilic oesophagitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Eosinophilic oesophagitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489971",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US014079",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG Q6WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Hidradenitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "5 MG, Q6WEEKS, QUANTITY (BLANK), REFILLS: 5",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489986",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US000793",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10 MG/KG",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202106",
                        "drugenddateformat": "102",
                        "drugenddate": "20211208",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220106"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21489997",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010491",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "700",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "700 MG (7VIALS) IV INFUSION Q 8 WKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490008",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010549",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490026",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010551",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10 MG/KG (EVERY 6 WEEKS QUANTITY: 90)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490027",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US012848",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "4 VIALS (400MG); 400MG IV EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ACETAMINOPHEN",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "650",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "650 MG BY MOUTH",
                        "drugadministrationroute": "048",
                        "drugindication": "Premedication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ACETAMINOPHEN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ZYRTEC",
                        "drugbatchnumb": "UNKNOWN",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CETIRIZINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "EPINEPHRINE",
                        "drugbatchnumb": "UNKNOWN",
                        "drugadministrationroute": "030",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "EPINEPHRINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "BENADRYL",
                        "drugbatchnumb": "UNKNOWN",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DIPHENHYDRAMINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SODIUM CHLORIDE",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SODIUM CHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ANA-KIT",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3"
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490042",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US012858",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220223",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220505",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220630",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220825",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490044",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US014080",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Orofacial granulomatosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490048",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US012863",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "7.5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "7.5 MG/KG IVPB Q 8 WEEKS QUANTITY: 5 VIALS REFILLS: 6",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490066",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US012866",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "440",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "440 MG OF INFLECTRA FREQUENCY: 8 WEEKS QUANTITY: 9 REFILLS: (BLANK)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490093",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US012871",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MG, FREQUENCY: AT 0,2,6 WEEKS AND THEN EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "AZATHIOPRINE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "3 TABLETS BY MOUTH DAILY",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "AZATHIOPRINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "REMICADE",
                        "drugbatchnumb": "unknown",
                        "drugdosageform": "Infusion",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FLUOCINOLONE ACETONIDE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "TWICE DAILY FOR 3 WEEKS THEN DAILY FOR 1-2 WEEKS THEN AS NEEDED",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FLUOCINOLONE ACETONIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ONDANSETRON",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "1 TABLET BY MOUTH 3 TIMES DAILY AS NEEDED",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ONDANSETRON"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ONDANSETRON",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK UNK, TID",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ONDANSETRON"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "MELATONIN",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "BY MOUTH AT BEDTIME AS NEEDED",
                        "drugdosageform": "Capsule",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "MELATONIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "MUPIROCIN",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "APPLY TO AFFECTED AREA TWICE DAILY",
                        "drugdosageform": "Ointment",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "MUPIROCIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "TRIAMCINOLONE ACETONIDE",
                        "drugbatchnumb": "Unknown",
                        "drugdosageform": "Cream",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "TRIAMCINOLONE ACETONIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CLOBETASOL",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK, BID",
                        "drugdosageform": "Cream",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CLOBETASOL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FINASTERIDE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "1 TAB BY MOUTH",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FINASTERIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CELEXA",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "1 TABLET BY MOUTH EVERY DAY",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CITALOPRAM HYDROBROMIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "TAMSULOSIN HYDROCHLORIDE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "1 CAPSULE BY MOUTH EVERY DAY",
                        "drugdosageform": "Capsule",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "TAMSULOSIN HYDROCHLORIDE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490096",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010576",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Urticaria",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490110",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010579",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Fatigue",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "802",
                        "drugdosagetext": "ONCE A MONTH",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "drugtreatmentduration": "8",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490113",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US012872",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "2"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490124",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010580",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "2",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "400MG Q 2WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490127",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US012946",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product substitution",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug ineffective",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "ENBREL",
                        "drugbatchnumb": "Unknown",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ETANERCEPT"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490129",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010585",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Malaise",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Fatigue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490152",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010587",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "700",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "700 MG (FREQUENCY 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490156",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013000",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "DIRECTIONS: INJECT 300 MG FREQUENCY: Q 7 WEEKS QUANTITY: 3 REFILLS: 7",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PLAQUENIL",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "HYDROXYCHLOROQUINE SULFATE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490165",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010641",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490169",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010643",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "AZATHIOPRINE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "50",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "50 MILLIGRAM",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "AZATHIOPRINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CHOLECALCIFEROL",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "50000 UNK",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CHOLECALCIFEROL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FERROUS SULFATE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "324",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "324 MILLIGRAM",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FERROUS SULFATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PANTOPRAZOLE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "40",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "40 MILLIGRAM",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PANTOPRAZOLE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490170",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013012",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "EVERY 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490186",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013034",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "800",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "800 MG (EVERY 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "AZATHIOPRINE",
                        "drugbatchnumb": "Unknown",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "AZATHIOPRINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ENBREL",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "40",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ETANERCEPT"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VIT E [TOCOPHEROL]",
                        "drugbatchnumb": "Unknown",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3"
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VITAMIN D3",
                        "drugbatchnumb": "Unknown",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CHOLECALCIFEROL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "Unknown",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METHOTREXATE SODIUM",
                        "drugbatchnumb": "Unknown",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHOTREXATE SODIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "WARFARIN",
                        "drugbatchnumb": "Unknown",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "WARFARIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METOPROLOL",
                        "drugbatchnumb": "Unknown",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METOPROLOL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FOLIC ACID",
                        "drugbatchnumb": "Unknown",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FOLIC ACID"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "GABAPENTIN",
                        "drugbatchnumb": "Unknown",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "GABAPENTIN"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490191",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013037",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "INFUSION",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490192",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010648",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Haemoglobin decreased",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Blood iron decreased",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490210",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013057",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "420",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "420 MG, FREQUENCY: WEEK 0, 2 + 6 QUANTITY: 3 REFILLS: 6",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490220",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010649",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "EVERY 7 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490227",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013081",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Diarrhoea",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapeutic response shortened",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Intentional product use issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "800",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "800 MG AT 0, 2, 6 WEEKS, THEN EVERY 8 WEEKS (1ST LOADING DOSE). INFUSED 800 MG IN 1HR30MIN.",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211222",
                        "drugenddateformat": "102",
                        "drugenddate": "20211222",
                        "drugtreatmentduration": "1",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "800",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "800 MG AT 0, 2, 6 WEEKS, THEN EVERY 8 WEEKS (2ND LOADING DOSE). INFUSED 800 MG IN 1HR42MIN.",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220106",
                        "drugenddateformat": "102",
                        "drugenddate": "20220106",
                        "drugtreatmentduration": "1",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "800",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "800 MG AT 0, 2, 6 WEEKS, THEN EVERY 8 WEEKS (3RD LOADING DOSE). INFUSED 800 MG IN 1HR35MIN.",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220203",
                        "drugenddateformat": "102",
                        "drugenddate": "20220203",
                        "drugtreatmentduration": "1",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "800",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "800 MG, EVERY 8 WEEKS, INFUSED 800 MG IN 1HR25MIN.",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220331",
                        "drugenddateformat": "102",
                        "drugenddate": "20220331",
                        "drugtreatmentduration": "1",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "800",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "800 MG, EVERY 8 WEEKS, WEEKS SINCE LAST INFUSIION: 8.9, INFUSED 800 MG IN 1HR35MIN.",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220601",
                        "drugenddateformat": "102",
                        "drugenddate": "20220601",
                        "drugtreatmentduration": "1",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "800",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "800 MG, EVERY 8 WEEKS, INFUSED 800 MG IN 1HR35MIN.",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220727",
                        "drugenddateformat": "102",
                        "drugenddate": "20220727",
                        "drugtreatmentduration": "1",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20211222"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490240",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010650",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MG",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "600 MG (6 100 MG/20 ML/EVERY 8 WKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "IBUPROFEN",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "600 MG",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "IBUPROFEN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "RAMIPRIL",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10 MG",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "RAMIPRIL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "MELOXICAM",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "15",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "15 MG",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "MELOXICAM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "MEDROL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "4",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "4 MG",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHYLPREDNISOLONE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490276",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010662",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "900",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "900 MG, CYCLIC (Q 5 WEEKS QUANTITY: 9 REFILLS: 12)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product use in unapproved indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490277",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013113",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "100 MG/20ML, FREQUENCY: W 0, 2, 6 END OF 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490278",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US014084",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "DIRECTIONS: INJECT 5 MG OF INFLECTRA MAINT, FREQUENCY: Q8 WEEKS, QUANTITY: 56 REFILLS: 11",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490294",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010664",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Urticaria",
                        "reactionoutcome": "2"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "THIRD INFUSION",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490304",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010665",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "7.5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "7.5 MG, EVERY 8 WEEKS QUANTITY: 3 VIAL REFILLS: 12",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490310",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013117",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "655",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "655 MG, CYCLIC (0,2,6 AND EVERY 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ARAVA",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LEFLUNOMIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CYMBALTA",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DULOXETINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "GABAPENTIN",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "GABAPENTIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ACETAMINOPHEN\\ASPIRIN\\CAFFEINE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ACETAMINOPHEN\\ASPIRIN\\CAFFEINE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490338",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010673",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10 MILLIGRAM/KILOGRAM EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490343",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010684",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "5 MG (INJECT, FREQUENCY: Q 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490345",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013118",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "380",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "INFUSE 380MG STAT, AT 2 WKS, 6WKS, + EVERY 8 WKS THEREAFTER",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METHYLPREDNISOLONE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHYLPREDNISOLONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FAMOTIDINE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FAMOTIDINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "BENADRYL",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DIPHENHYDRAMINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "TYLENOL",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ACETAMINOPHEN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "OMEPRAZOLE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "OMEPRAZOLE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "DICYCLOMINE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DICYCLOMINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "MESALAMINE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "MESALAMINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "NYSTATIN",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "NYSTATIN"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490347",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010685",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490366",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010696",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Intentional product use issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "100",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "DIRECTIONS: INJECT 100 MG OF INFLECTRA FREQUENCY: EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490371",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US014085",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "DIRECTIONS: INJECT 5 MG/KG OF INFLECTRA FREQUENCY: Q 8 WEEKS QUANTITY: Q S REFILLS: 12",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490394",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US014092",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Anxiety",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Heart rate increased",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "7.5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "7.5MG/KG, CYCLIC (EVERY 6 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Hidradenitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490397",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013137",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490400",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US014105",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Dermatitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "415",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "415 MG, (Q14 DAYS QUANTITY: 5 REFILLS: 12)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Dermatitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "DECADRON",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DEXAMETHASONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "BENADRYL",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DIPHENHYDRAMINE HYDROCHLORIDE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490405",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US013145",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US013145"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US013145"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "COVID-19",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220808"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490450",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013164",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490451",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US014120",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Generalised oedema",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Musculoskeletal stiffness",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Stomatitis",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Nasal congestion",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pain",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Gait disturbance",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Loss of personal independence in daily activities",
                        "reactionoutcome": "3"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "4TH DOSE",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220804",
                        "actiondrug": "1",
                        "drugadditional": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220808"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490458",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013181",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "905",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "802",
                        "drugdosagetext": "905 MG, MONTHLY (INTO THE VEIN EVERY 30 DAYS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METHOTREXATE",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHOTREXATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490474",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013183",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "772",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "772 MILLIGRAM, Q8WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490482",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013185",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product availability issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490496",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013188",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG (EVERY 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490506",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013206",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "800",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "800 MG (5MG/KG) EVERY 4 WEEKS (QUANTITY: 6 REFILLS: 1)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490526",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013214",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "X INFLECTRA X 100MG/20ML DIRECTIONS: 5MG/KG, CYCLIC (5MG/KG IV FREQUENCY: 0,2,6,8 WEEKS QUANTITY: (B",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490527",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013222",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "INJECT 5 MG/KG, EVERY 8 WEEKS QUANTITY: (BLANK) REFILLS: 11",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "INFUSION EVERY 6 WEEKS QUANTITY: (10KG/MG) REFILLS: 11",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490533",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013224",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490554",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013225",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "DIRECTIONS: INJECT 600 MG FREQUENCY EVERY 4 WEEKS QUANTITY: 1 YEAR VIALS REFILLS: 13",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Psoriatic arthropathy",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "700",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "700 MG CYCLIC (700 MG, CYCLIC (EVERY 4 WEEKS IN SODIUM CHLORIDE 0.9% INFUSION 250 MILLILITER(S), FOR",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugtreatmentduration": "120",
                        "drugtreatmentdurationunit": "806",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490589",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013237",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490602",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013350",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "7.5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "7.5 MG, EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490739",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010832",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "DIRECTIONS: INJECT 400 MG OF INFLECTRA FREQUENCY: 0 WEEK, 2 WEEK, 4 WEEK THEN EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490747",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010833",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "NEW RX FOR DOSE INCREASE 500 MG EVERY 6 WEEKS QUANTITY: 5 REFILLS: 11/QUANTITY: 5 REFILLS 12",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "GABAPENTIN",
                        "drugbatchnumb": "unknown",
                        "drugdosagetext": "UNK",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "GABAPENTIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LEFLUNOMIDE",
                        "drugbatchnumb": "UNKNOWN",
                        "drugdosagetext": "UNK",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LEFLUNOMIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ALBUTEROL SULFATE",
                        "drugbatchnumb": "UNKNOWN",
                        "drugdosagetext": "UNK",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ALBUTEROL SULFATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "AMLODIPINE",
                        "drugbatchnumb": "unknown",
                        "drugdosagetext": "UNK",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "AMLODIPINE BESYLATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VENLAFAXINE",
                        "drugbatchnumb": "UNKNOWN",
                        "drugdosagetext": "UNK",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "VENLAFAXINE HYDROCHLORIDE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490769",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010863",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "700",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "700 MG, Q4WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490796",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010865",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "SIX(6) 100 MG/20ML (FREQUENCY: WKS 0,2,6, THEN Q8 WKS QUANTITY: 36 REFILLS: 12)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Furuncle",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490801",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010976",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "DIRECTIONS: INJECT 300 MG OF INFLECTRA, FREQUENCY: Q 8 WEEKS, QUANTITY: 60ML, REFILLS: 5",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490817",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010986",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Onychoclasis",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Alopecia",
                        "reactionoutcome": "3"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "INFUSIONS EVERY 2 MONTHS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202203",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220301"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490831",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010997",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "10 MG, WEEKLY",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490890",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010998",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "3",
                        "drugintervaldosagedefinition": "802",
                        "drugdosagetext": "400MG, CYCLIC EVERY 12 WEEKS VIA INFUSION",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METHOTREXATE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "2.5MG TABLETS, TAKES 4 OF THEM, TOTAL OF 10MG, ONCE A WEEK",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHOTREXATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ASPIRIN",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "81",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "81 MILLIGRAM, QD",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ASPIRIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CRESTOR",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "20",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "20MG TABLET ONCE A DAY",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ROSUVASTATIN CALCIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LISINOPRIL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10MG TABLETS ONCE A DAY",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LISINOPRIL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ZOLOFT",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "50",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "50MG TABLETS ONCE A DAY",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SERTRALINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SINGULAIR",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10MG TABLET ONCE A DAY",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "MONTELUKAST SODIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LEVOCETIRIZINE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "5MG TABLET ONCE A DAY",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LEVOCETIRIZINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VITAMIN D2",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ERGOCALCIFEROL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FLONASE SENSIMIST ALLERGY RELIEF",
                        "drugbatchnumb": "Unknown",
                        "drugdosageform": "Nasal spray",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FLUTICASONE FUROATE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21490897",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US010999",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Underdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "3",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "3 MG/KG BODY WEIGHT AT 0,2,6 WEEKS AND THEN EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Psoriatic arthropathy",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491035",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011019",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "DIRECTIONS: INJECT 5 MG OF INFLECTRA FREQUENCY: EVERY 8 WEEKS QUANTITY: 7 REFILLS: (BLANK)",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "DIRECTIONS: INFUSE 500 MG EVERY 8 WEEKS QUANTITY: 7 REFILLS: 7",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "DIRECTIONS: INJECT 5 MG/KG INFUSED EVERY 8 WEEKS QUANTITY:1 VIAL REFILLS:6",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "5 MG/ML, EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "HYDROCORTISONE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "HYDROCORTISONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LORAZEPAM AHN",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3"
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SITAGLIPTIN",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SITAGLIPTIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CLOPIDOGREL",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CLOPIDOGREL BISULFATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "OMEPRAZOLE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "OMEPRAZOLE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FUROSEMIDE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FUROSEMIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PRAVASTATIN",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PRAVASTATIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LOSARTAN",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LOSARTAN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "AMOXICILLIN",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "AMOXICILLIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "HYDROXYZINE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "HYDROXYZINE HYDROCHLORIDE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491049",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011076",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MG, DAILY EVERY 30 DAYS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "RITUXIMAB",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "RITUXIMAB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491058",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011135",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "530",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "530 MILLIGRAM",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "AMLODIPINE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "AMLODIPINE BESYLATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ASPIRIN",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ASPIRIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ATORVASTATIN",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ATORVASTATIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "AZATHIOPRINE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "AZATHIOPRINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CARVEDILOL",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CARVEDILOL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LISINOPRIL",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LISINOPRIL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VITAMINS NOS",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "VITAMINS"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ZINC",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ZINC"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VITAMIN B12",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CYANOCOBALAMIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VITAMIN D3",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CHOLECALCIFEROL"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491081",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011156",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hidradenitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Hidradenitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491095",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011167",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3",
                "literaturereference": "Valdes L, Cox J, Yang J, Susarla G, Han S, Papaliodis G, et al.. Anti-infliximab antibodies and clinical response in noninfectious uveitis and scleritis patients treated with infliximab: A retrospective review. AMERICAN JOURNAL OF OPHTHALMOLOGY CASE REPORTS. 2022;25;27:101634"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy responder",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug effective for unapproved indication",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "STARTING DOSE OF 5 MG/KG",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Chorioretinitis",
                        "drugtreatmentduration": "63",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "AFTER TWO LOADING DOSES TWO WEEKS APART, MAINTENANCE DOSES WERE GIVEN EVERY 4 WEEKS INITIALLY",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Eye inflammation",
                        "drugtreatmentduration": "63",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "7.5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "7.5 MG/KG MAX TOLERATE DOSE",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Uveitis",
                        "drugtreatmentduration": "63",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "REMICADE",
                        "drugbatchnumb": "UNKNOWN",
                        "drugdosagetext": "STARTING DOSE OF 5 MG/KG",
                        "drugindication": "Chorioretinitis",
                        "drugtreatmentduration": "63",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "REMICADE",
                        "drugbatchnumb": "UNKNOWN",
                        "drugdosagetext": "AFTER TWO LOADING DOSES TWO WEEKS APART, MAINTENANCE DOSES WERE GIVEN EVERY 4 WEEKS INITIALLY",
                        "drugindication": "Eye inflammation",
                        "drugtreatmentduration": "63",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "REMICADE",
                        "drugbatchnumb": "UNKNOWN",
                        "drugdosagetext": "7.5 MG/KG MAX TOLERATE DOSE",
                        "drugindication": "Uveitis",
                        "drugtreatmentduration": "63",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491123",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011169",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3",
                "literaturereference": "Valdes L, Cox J, Yang J, Susarla G, Han S, Papaliodis G et.al. Anti-infliximab antibodies and clinical response in noninfectious uveitis and scleritis patients treated with infliximab: A retrospective review. American Journal of Ophthalmology Case reports. 2022;101634:1-8"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy partial responder",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG STARTING DOSE",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Uveitis",
                        "drugtreatmentduration": "81",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "12",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "12 MG/KG CURRENT DOSE",
                        "drugdosageform": "Powder for injection",
                        "drugtreatmentduration": "81",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "MYCOPHENOLATE MOFETIL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "1440",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1440 MG, DAILY",
                        "drugindication": "Uveitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "MYCOPHENOLATE MOFETIL"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491165",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011170",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3",
                "literaturereference": "Valdes L., Cox J.T., Yang J., Susarla G., Han S., Papaliodis G.N., et al.. Anti-infliximab antibodies and clinical response in noninfectious uveitisand scleritis patients treated with infliximab: A retrospective review. American Journal of Ophthalmology Case Reports. 2022;27:2-8"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy partial responder",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "2",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "5 MG/KG; AFTER TWO LOADING DOSES TWO WEEKS APART",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Chorioretinitis",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "MAINTENANCE DOSES WERE GIVEN EVERY 4 WEEKS INITIALLY",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Eye inflammation",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10.5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10.5 MG/KG, MAXIMUM TOLERATE DOSE",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "REMICADE",
                        "drugbatchnumb": "UNKNOWN",
                        "drugdosagetext": "UNK",
                        "drugindication": "Uveitis",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "REMICADE",
                        "drugindication": "Scleritis",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491236",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011171",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3",
                "literaturereference": "Valdes L, Cox J, Yang J, Susarla G, Han S, Papaliodis G et.al. Anti-infliximab antibodies and clinical response in noninfectious uveitis and scleritis patients treated with infliximab: A retrospective review. American Journal of Ophthalmology Case reports. 2022;101634"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy responder",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug effective for unapproved indication",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG, STARTING DOSE",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Chorioretinitis",
                        "drugtreatmentduration": "12",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "AFTER TWO LOADING DOSES TWO WEEKS APART, MAINTENANCE DOSES WERE GIVEN EVERY 4 WEEKS INITIALLY",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Eye inflammation",
                        "drugtreatmentduration": "12",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "8.5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "8.5MG/KG CLINICAL RESPONSE FINAL AT MAX TOLERATE DOSE",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Uveitis",
                        "drugtreatmentduration": "12",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "REMICADE",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG, STARTING DOSE",
                        "drugindication": "Chorioretinitis",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "REMICADE",
                        "drugbatchnumb": "unknown",
                        "drugdosagetext": "AFTER TWO LOADING DOSES TWO WEEKS APART, MAINTENANCE DOSES WERE GIVEN EVERY 4 WEEKS INITIALLY",
                        "drugindication": "Eye inflammation",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "REMICADE",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "8.5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "8.5MG/KG CLINICAL RESPONSE FINAL AT MAX TOLERATE DOSE",
                        "drugindication": "Uveitis",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491245",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011172",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3",
                "literaturereference": "Valdes L, Cox JT, Yang J, Susarla G, Han Samuel, Papaliodis GN, et al. Anti-infliximab antibodies and clinical response in noninfectious uveitis and scleritis patients treated with infliximab: A retrospective review. American Journal of Ophthalmology Case Reports. 2022;27"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment failure",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG, LOADING DOSE TWO WEEKS APART",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Chorioretinitis",
                        "drugtreatmentduration": "33",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "7.5",
                        "drugstructuredosageunit": "007",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "7.5 MG/KG",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Eye inflammation",
                        "drugtreatmentduration": "33",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "REMICADE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG, TWO LOADING DOSES TWO WEEKS APART",
                        "drugindication": "Chorioretinitis",
                        "drugtreatmentduration": "33",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "REMICADE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "7.5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "7.5 MG/KG",
                        "drugindication": "Eye inflammation",
                        "drugtreatmentduration": "33",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491250",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011173",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3",
                "literaturereference": "Valdes L, Cox JT, Yang J, Susarla G, Han S, Papaliodis GN, et al.. Anti-infliximab antibodies and clinical response in noninfectious uveitis and scleritis patients treated with infliximab: A retrospective review. American Journal of Ophthalmology Case Reports. 2022;27:101634"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy partial responder",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG, AFTER TWO LOADING DOSES TWO WEEKS APART, MAINTENANCE DOSES WERE GIVEN EVERY 4 WEEKS INITIAL",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Uveitis",
                        "drugtreatmentduration": "29",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "9",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "9 MG/KG, MAXIMUM TOLERATE DOSE",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Eye inflammation",
                        "drugtreatmentduration": "29",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "REMICADE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG, AFTER TWO LOADING DOSES TWO WEEKS APART, MAINTENANCE DOSES WERE GIVEN EVERY 4 WEEKS INITIAL",
                        "drugindication": "Uveitis",
                        "drugtreatmentduration": "29",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "REMICADE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "9",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "9 MG/KG, MAXIMUM TOLERATE DOSE",
                        "drugindication": "Eye inflammation",
                        "drugtreatmentduration": "29",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491270",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US010383",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US010383"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US010383"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Cutaneous vasculitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Weight decreased",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug ineffective",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491444",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011174",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3",
                "literaturereference": "Sobrin L, Valdes L, Cox JT, Yang J, Susarla G, Han S, et al. Anti-infliximab antibodies and clinical response in noninfectious uveitis and scleritis patients treated with infliximab: A retrospective review. American Journal of Ophthalmology Case Reports. 2022;27"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy responder",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug effective for unapproved indication",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG (STARTING DOSE)",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Scleritis",
                        "drugtreatmentduration": "34",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "MAINTENANCE DOSE GIVEN EVERY 4 WEEKS INITIALLY",
                        "drugdosageform": "Powder for injection",
                        "drugtreatmentduration": "34",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "REMICADE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG (STARTING DOSE)",
                        "drugindication": "Scleritis",
                        "drugtreatmentduration": "34",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "REMICADE",
                        "drugbatchnumb": "Unknown",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "UNK UNK, Q4WEEKS",
                        "drugtreatmentduration": "34",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491459",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011176",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3",
                "literaturereference": "Sobrin L, Valdes L, Cox JT, Yang J, Susarla G, Han S, et al. Anti-infliximab antibodies and clinical response in noninfectious uveitis and scleritis patients treated with infliximab: A retrospective review. American Journal of Ophthalmology Case Reports. 2022;27"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy responder",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug effective for unapproved indication",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "STARTING DOSE OF 5 MG/KG",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Uveitis",
                        "drugtreatmentduration": "5",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "AFTER TWO LOADING DOSES TWO WEEKS APART, MAINTENANCE DOSES WERE GIVEN EVERY 4 WEEKS INITIALLY",
                        "drugdosageform": "Powder for injection",
                        "drugtreatmentduration": "5",
                        "drugtreatmentdurationunit": "802",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491474",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011179",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "487",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "487 MG, EVERY 8 WEEKS, INJECT 487 MG OF INFLECTRA FREQUENCY: EVERY 8 WEEKS QUANTITY: 48.7ML REFILLS:",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "RITUXIMAB",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "SINGLE-DOSE VIAL: X 100MG/10ML AND 500MG/50ML",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "RITUXIMAB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491479",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011181",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "320",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "320 MG EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "RITUXIMAB",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "SINGLE-DOSE VIAL: 4 100 MG/20 ML",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "RITUXIMAB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491498",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011213",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "430",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "430 MG WEEK 0,2,6 QUANTITY: 15 REFILLS: 0",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491505",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011376",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK MG",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491534",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011377",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG, EVERY 9 WEEKS (MAINTENANCE)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491647",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011390",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Illness",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Incorrect product administration duration",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy change",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "390",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "390 MG EVERY 5 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202104",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20210401"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491715",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011392",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "3 MG/KG",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "5 MG/KG",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SODIUM CHLORIDE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SODIUM CHLORIDE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491729",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011437",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "INJECT 5 MGKG INFUSED EVERY 8 WEEKS, QUANTITY: 1 VIAL, REFILLS: 5",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491777",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011558",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "600 MG Q8 WEEKS QUANTITY: 5 REFILLS: 6",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491841",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011586",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Vomiting",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Back pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hyperhidrosis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pruritus",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Nausea",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Flushing",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Dyspnoea",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Chest pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Dizziness",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product quality issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FT5307",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491860",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011616",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "7.5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "7.5MG IV Q 8-10 WEEKS QUANTITY: (8) REFILLS: (6)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491866",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011623",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "250",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "250MG Q 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491914",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011671",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "390",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "390 MG 100MG/20ML (Q8WEEKS QUNANITY: 1 REFILLS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400MG EVEY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220718",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ATORVASTATIN",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "80",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "80 MILLIGRAM, 1 TABLET BY MOUTH ONCE A DAY (QTY: 90)",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220718",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ATORVASTATIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "DENTA 5000 PLUS",
                        "drugbatchnumb": "UNKNOWN",
                        "drugstructuredosagenumb": "1.1",
                        "drugstructuredosageunit": "030",
                        "drugdosagetext": "1.1 PERCENT (QTY: 153)",
                        "drugdosageform": "Cream",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SODIUM FLUORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "GABAPENTIN",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "100",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1000 MILLIGRAM, 3 CAPSULES BY MOUTH AT BEDTIME (QTY: 270)",
                        "drugdosageform": "Capsule",
                        "drugadministrationroute": "048",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220718",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "GABAPENTIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LOPERAMIDE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "2",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "2 MILLIGRAM, 1 CAPSULE BY MOUTH FOUR TIMES A DAY AS NEEDED (QTY: 240)",
                        "drugdosageform": "Capsule",
                        "drugadministrationroute": "048",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220718",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LOPERAMIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "NYSTATIN",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "100000 UNIT/GRAM (QTY: 60)",
                        "drugdosageform": "Powder (Except [DPO])",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "NYSTATIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "OFLOXACIN",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "0.3",
                        "drugstructuredosageunit": "030",
                        "drugdosagetext": "0.3 PERCENT",
                        "drugdosageform": "Drop",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "OFLOXACIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "OMEPRAZOLE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "40",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "40 MILLIGRAM, 1 CAPSULE BY MOUTH ONCE A DAY (QTY: 90)",
                        "drugdosageform": "Capsule, delayed release",
                        "drugadministrationroute": "048",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220718",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "OMEPRAZOLE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "OXYCODONE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "5 MILLIGRAM, 1-2 TABLET BY MOUTH EVERY THREE TO FOUR HOURS AS NEEDED FOR PAIN",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "drugindication": "Pain",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220718",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "OXYCODONE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21491923",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011769",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "350",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "350 MG, CYCLIC (EVERY 4 WEEKS (QUANTITY: 4 VIALS REFILLS: 11)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494667",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011819",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "802",
                        "drugdosagetext": "UNK, MONTHLY",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220804"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494669",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011820",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MG (Q 12 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494672",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011849",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Cough",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494674",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011871",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product storage error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494675",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011960",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "700",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "700 MG EVERY 21 DAYS (QUANTITY: 8 CYCLES REFILLS: 8)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "RITUXIMAB",
                        "drugbatchnumb": "UNKNOWN",
                        "drugdosagetext": "RUXIENCE (2 100MG/10ML 1 500MG/50ML)",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "RITUXIMAB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494676",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US011962",
            "duplicate": "1",
            "reportduplicate": {
                "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US004878"
            },
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "100MG/20ML DIRECTIONS: 361.36 MG AT WEEK 0,2, WEEK 6. EVERY 8 WEEKS THEREAFTER QUANTITY: 8 REFILLS:",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "361.36",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "361.36 MG AT WEEK 0, 2, WEEK 6. EVERY 8 WEEKS THEREAFTER",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "368.63",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "368.63 MG AT WEEK 2, WEEK 6, REPEAT EVERY 8 WEEKS QUANTITY: 4 REFILLS:6",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494678",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US012069",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220701",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220801",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494679",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US012082",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "7",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "X INFLECTRA DIRECTIONS: INJECT 7 MG OF INFLECTRA FREQUENCY: EVERY 8 WEEKS QUANTITY: 3 REFILLS: 11",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494680",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US012095",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "2",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "400 MG, EVERY 14 DAYS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494683",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US012103",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5MG/KG@ WEEK 0,2,6 THEN Q6WKS, THEREAFTER (400MG IN",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Rheumatoid arthritis",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220610",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "SODIUM CHLORIDE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "250",
                        "drugstructuredosageunit": "012",
                        "drugdosagetext": "250 ML IVPB",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SODIUM CHLORIDE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494688",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008051",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220128",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494694",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008098",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "335",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "100 MG/20ML (DIRECTIONS: IV INFUSION 5 MG/KG= 335 MG) QUANTITY: 5 REFILLS: BLANK.",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494695",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008083",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "FREQUENCY: Q 8 WEEKS QUANTITY ^BLANK^ REFILLS: 6",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494696",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008059",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product supply issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10 MG/KG EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494697",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008144",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product selection error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG = 400MG FREQUENCY: EVERY 8 WKS QUANTITY 4 REFILLS: 5",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "RITUXIMAB",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG = 400MG FREQUENCY: EVERY 8 WKS QUANTITY 4 REFILLS: 5",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "RITUXIMAB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494698",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008124",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220502",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220531",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494699",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008076",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pruritus",
                        "reactionoutcome": "3"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNKNOWN, FIRST INFUSION OF INFLECTRA",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220521",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METFORMIN",
                        "drugbatchnumb": "Unknown",
                        "drugindication": "Type 2 diabetes mellitus",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METFORMIN HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "GLIPIZIDE",
                        "drugbatchnumb": "Unknown",
                        "drugindication": "Type 2 diabetes mellitus",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "GLIPIZIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LISINOPRIL",
                        "drugbatchnumb": "Unknown",
                        "drugindication": "Hypertension",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LISINOPRIL"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494700",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008148",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "200 MILLIGRAM, EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494701",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008145",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product temperature excursion issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "ADMINISTER 10MG/KG IV EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494702",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008147",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG ON WEEKS: ZERO, TWO, AND WEEK6. FOLLOW BY 5MG/KG EVERY 8 WEEK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5MG PER KG (MISSING FREQUENCY)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494713",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008237",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "800",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "(800MG) 100 MG/20 ML= (160 ML)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494714",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008192",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "7",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "7 MG/KG INFUSION EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494715",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008240",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Ankylosing spondylitis",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220131",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220317",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220511",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220317"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494716",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008299",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG (310MG) EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494717",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008305",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MG, IVPB Q8WKS/QTY 5 100MG/20ML, INFUSE INFLEXTRA 500 MG IV EVERY 8 WEEKS QUANTITY: 1 REFILLS:7",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LISINOPRIL",
                        "drugbatchnumb": "UNKNOWN",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10 MG, DAILY",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LISINOPRIL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "MERCAPTOPURINE",
                        "drugbatchnumb": "UNKNOWN",
                        "drugstructuredosagenumb": "50",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "50 MG, DAILY",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "MERCAPTOPURINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ATORVASTATIN",
                        "drugbatchnumb": "UNKNOWN",
                        "drugstructuredosagenumb": "20",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "20 MG, DAILY",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ATORVASTATIN"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494718",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008278",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494719",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008295",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Circumstance or information capable of leading to medication error",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product packaging quantity issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Underdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "449",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "449 MG EVERY 8 WEEKS; INTRAVENOUSLY",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Colitis ulcerative",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211020",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494721",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008311",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "FIRST ONE, PT WILL RECEIVE EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220311",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494722",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008320",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MILLIGRAM, CYCLIC WEEK 0,2,4 6, THEN EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494723",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008368",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Adverse drug reaction",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494751",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008377",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "470",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "470MG (5 MG/KG EVERY 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494753",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008382",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "No adverse event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "DIRECTIONS: 500 MG IV ONCE @160 ML/HR. OVER 120 MINUTES QUANTITY: 5 REFILLS: 9",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494754",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008385",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Antibody test positive",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Headache",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Nausea",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Malaise",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494755",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008452",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hidradenitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Hidradenitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494756",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008581",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494757",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008576",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400MG OF INFLECTRA IV FREQUENCY: 0,2,6 WEEKS QUANTITY: 4 REFILLS: EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494758",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008406",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "10 MG/KG, Q4WEEKS QUANTITY: 8 VIALS REFILLS: 11",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220525",
                        "drugenddateformat": "102",
                        "drugenddate": "20220525",
                        "drugtreatmentduration": "1",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220525"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494759",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008533",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Exposure via skin contact",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Accidental exposure to product",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product preparation error",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product contamination",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494760",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008415",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "2"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product temperature excursion issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494761",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008608",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "155",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "DIRECTIONS: INJECT 155 MG OF INFLECTRA FREQUENCY: EVERY 6 WKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494776",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US012106",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "900",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "900 MG, CYCLIC IV Q6WEEKS (EVERY 6 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Psoriatic arthropathy",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ERGOCALCIFEROL",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Capsule",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ERGOCALCIFEROL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "MISOPROSTOL",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "MISOPROSTOL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "MELOXICAM",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "MELOXICAM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ATORVASTATIN CALCIUM",
                        "drugbatchnumb": "Unknown",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ATORVASTATIN CALCIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FOLIC ACID",
                        "drugbatchnumb": "Unknown",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FOLIC ACID"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "HYDROCHLOROTHIAZIDE",
                        "drugbatchnumb": "Unknown",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "HYDROCHLOROTHIAZIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LISINOPRIL",
                        "drugbatchnumb": "Unknown",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LISINOPRIL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METFORMIN HYDROCHLORIDE",
                        "drugbatchnumb": "Unknown",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METFORMIN HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METOPROLOL SUCCINATE",
                        "drugbatchnumb": "Unknown",
                        "drugdosageform": "Capsule",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METOPROLOL SUCCINATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FISH OIL\\TOCOPHEROL",
                        "drugbatchnumb": "Unknown",
                        "drugdosageform": "Capsule",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FISH OIL\\TOCOPHEROL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VITAMIN E",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": ".ALPHA.-TOCOPHEROL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ZINC",
                        "drugbatchnumb": "Unknown",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ZINC"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494801",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008704",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494803",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008762",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "INFUSE 5MG/KG OF BODY WEIGHT",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494804",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008612",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "1"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "DATE STARTED: FEW YEARS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494805",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008695",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494806",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008683",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Rash",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Adverse drug reaction",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494808",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008710",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10MG FOR EACH DATE OF SERVICE",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220105",
                        "drugenddateformat": "102",
                        "drugenddate": "20220105",
                        "drugtreatmentduration": "1",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10MG FOR EACH DATE OF SERVICE",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220119",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10MG FOR EACH DATE OF SERVICE",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220216",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10MG FOR EACH DATE OF SERVICE",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220225",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10MG FOR EACH DATE OF SERVICE",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220408",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220105"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494809",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008782",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "600 MG QUANTITY: 6 REFILLS: 10",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494810",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008817",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Intentional product use issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "600 MG, CYCLIC, EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494811",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008798",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "SINGLE DOSE VIAL: 4 100MG/10 ML; DIRECTIONS: INJECT BLANK OF INFLECTRA FREQUENCY: 8 WEEKS QUANTITY:",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494812",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008797",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG (_3_3 100 MG/20ML 5M/KG (67.9 KG); FREQUENCY: EVERY 6 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494840",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008819",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MG, FREQUENCY: WK 0, 2, 6, THEN Q 8 WK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494852",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008936",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "5MG FREQUENCY: 0,2,6, EVERY 8",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494853",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009079",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Ankylosing spondylitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494854",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008825",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "600 MG EVERY 8 WEEKS QUANTITY: ONCE REFILLS: 6",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494855",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008871",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494856",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008982",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220603"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494857",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009022",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "800",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "800MG (FREQUENCY: 6 WEEKS QUANTITY: BLANK REFILLS: 8)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494858",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008889",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220407",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494859",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009069",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "EVERY 6-8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Enteritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494860",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221021",
            "receiptdateformat": "102",
            "receiptdate": "20221021",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009064",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US009064"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US009064"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "2"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Rash",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FL1260",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "600MG INTRAVENOUSLY INFUSED EVERY 8 WEEKS/ 600 MG (INFUSED EVERY 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Arthritis",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211105",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220607"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494907",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004394",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MILLIGRAM",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Colitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494908",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004401",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "7.5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "7.5 MG EVERY 6 WEEKS QUANTITY: 7 6 WEEKS QUANTITY: 7 REFILLS: 9",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494911",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004390",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220105",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220217",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220331",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494917",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009207",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "282",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "282 MG, ON WEEK 0,2,6 THEN Q 8 WEEKS AFTER",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494918",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009112",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494919",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009110",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Feeling abnormal",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Influenza",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Fatigue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "ONE LOADING DOSE",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Sarcoidosis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "MYCOPHENOLIC ACID",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500MG;TOTAL DOSE 2000 MG A DAY",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "MYCOPHENOLIC ACID"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "AZATHIOPRINE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "75",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "75MG 3 TIMES A DAY",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "AZATHIOPRINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREGABALIN",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "50",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "50MG 3 TIMES A DAY",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREGABALIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "DULOXETINE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "50",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "50MG TWICE A DAY",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DULOXETINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FAMOTIDINE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "20",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "20MG TWICE A DAY",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FAMOTIDINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METOPROLOL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "50",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "50MG ONCE A DAY",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METOPROLOL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "40",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "40 MG A DAY",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494920",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009151",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Circumstance or information capable of leading to medication error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494921",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009397",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Administration related reaction",
                        "reactionoutcome": "1"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494922",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009116",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "630",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "630 MG, EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494924",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009867",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, EVERY 13 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210108",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, EVERY 13 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210610",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, EVERY 13 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210909",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, EVERY 13 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211207",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, EVERY 13 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220301",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, EVERY 13 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220526",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494925",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US015791",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "165",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "DIRECTIONS: INJECT: 165 MG OF INFLECTRA FREQUENCY: 0,2,4, Q 8 WEEKS QUANTITY: 2 VIALS REFILLS: 10",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494926",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US014126",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hidradenitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Hidradenitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494927",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004402",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "5 MG, EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494929",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004442",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "40",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "40 MG (0, 2, 6 THEN 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494930",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004425",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494931",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004440",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "5MG/KG (600MG) IV EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494932",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004434",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Prescribed overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10 MG/KG",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494936",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004445",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "3",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "IV INFUSION 3 MG/KG EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494937",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004446",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Lacrimation increased",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Rhinorrhoea",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "INFUSE 400 MG EVERY 8 WEEKS QUANTITY:3 REFILLS: 5",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Rash",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MG (INFUSE 400MG WEEK 0,2,6 AND EVERY 8 WEEKS AFTER)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Rhinorrhoea",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211109",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MG (INFUSE 400MG WEEK 0,2,6 AND EVERY 8 WEEKS AFTER)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Eye discharge",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211204",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MG (INFUSE 400MG WEEK 0,2,6 AND EVERY 8 WEEKS AFTER)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220103",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494944",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004459",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Intentional product use issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494945",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004461",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "3",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "3 MG, CYCLIC (0,2,6, EVERY 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494946",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004470",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494950",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004480",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494951",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004472",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Anxiety",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hyperhidrosis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Erythema",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Diarrhoea",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Chest discomfort",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "FIRST INFUSION: INFUSION AT A RATE OF 125ML/HR",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "7",
                        "drugstructuredosageunit": "012",
                        "drugdosagetext": "SECOND INFUSION: 7 ML (INFUSION AT A RATE OF 125ML/HR)",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494952",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004474",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "708",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "708 MG, MONTHLY",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "712",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "712 MG, EVERY 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494953",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004475",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "2",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "400 MG, EVERY 2 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494954",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004482",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494957",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004487",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494959",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004485",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "300 MG, Q4WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494960",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004486",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product use issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "2",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "INJECT 400 MG OF INFLCTRA FREQUENCY EVERY 2 WEEKS QUANTITY 4-100MG REFILLS 8",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494961",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004501",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product preparation issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "521",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "521 MILLIGRAM (FREQUENCY: EVERY 8 WEEKS)/EVERY 8 WEEKS/100 MG/20 ML",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494963",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004604",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "200 MG WEEK 0, 2, 6, Q 6-8 W QUANTITY: 2 VIALS REFILLS: 9",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494964",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004511",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "5 MG (0, 2, 6, 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494965",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004619",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "666",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "666 MG OF INFLECTRA FREQUENCY: EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "660",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "660 MG IV EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "TYLENOL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "650",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "650 MG Q 8WKS",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ACETAMINOPHEN"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494966",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004621",
            "duplicate": "1",
            "reportduplicate": {
                "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US004621"
            },
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "325",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "325 MG, WEEK 0,2,6, THEN EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494967",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "2",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004578",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug hypersensitivity",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Psoriasis",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug ineffective",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug ineffective",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "HUMIRA",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "1 IN 14 D",
                        "drugadministrationroute": "058",
                        "drugindication": "Rheumatoid arthritis",
                        "drugstartdateformat": "602",
                        "drugstartdate": "2014",
                        "drugenddateformat": "602",
                        "drugenddate": "2014",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "ADALIMUMAB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "STELARA",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugadministrationroute": "065",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "USTEKINUMAB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "MODERNA COVID-19 VACCINE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "1 IN 1 ONCE",
                        "drugadministrationroute": "030",
                        "drugindication": "COVID-19 immunisation",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210423",
                        "drugenddateformat": "102",
                        "drugenddate": "20210525",
                        "drugtreatmentduration": "33",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ELASOMERAN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ELASOMERAN",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "1 IN 1 ONCE",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210525",
                        "drugenddateformat": "102",
                        "drugenddate": "20210525",
                        "drugtreatmentduration": "1",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ELASOMERAN"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220301"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494969",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004765",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494970",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004752",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "800",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "800 MILLIGRAM, IV Q 4 WKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "017",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494971",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004663",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "2",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "INFLECTRA IV INFUSION X 2 SPACED TWO WEEKS APART",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494973",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004751",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, EVERY 56 DAYS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494974",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004789",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product availability issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "No adverse event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "5 MG, WEEK 0, 2, 6 AND EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494975",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004796",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494976",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004792",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product use issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MG 0,2,6 (3 LOAD DOSES) EVERY 8 WEEKS QUANTITY: 12 VIALS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494978",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004809",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "360",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "360 MG EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MG EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494979",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004798",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Inflammation",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug ineffective",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494980",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004790",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494983",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004857",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MG Q 6 WEEKS QUANTITY: 1 REFILLS: 12",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494984",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004846",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "361",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "361 MG (FREQUENCY: WEEK 0,2,6 THENQ 42 DAYS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494985",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004898",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400MG, EVERY 8 WEEKS (QUANTITY: 4 REFILLS:6)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494986",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004899",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494987",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004893",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494988",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004895",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Arthritis enteropathic",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "100 MG/20 ML, 10 MG/KG/Q 8 WK (LAST 800 MG)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Arthritis enteropathic",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494989",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004891",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Colitis ulcerative",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210211",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210310",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210406",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210505",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210601",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210701",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210803",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210831",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210928",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211026",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211130",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210103",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210308",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, CYCLIC",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494992",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004911",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product container issue",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product leakage",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "No adverse event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FP8964",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "700",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "700 MG, EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "6",
                        "drugrecurreadministration": "2",
                        "drugadditional": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220330"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494993",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004900",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MG EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494998",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004962",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Feeling abnormal",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product substitution issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21494999",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US004928",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNKNOWN TO CALLER WHEN PROBED",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Pyoderma gangrenosum",
                        "drugenddateformat": "610",
                        "drugenddate": "202112",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20211201"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21495000",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005045",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21495001",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005067",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "8",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "8 MG/KG Q 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21495005",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005105",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "320",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "DIRECTIONS 320MG, FREQUENCY: WKS 0,2,6, Q6 WEEKS, QUANTITY 12, REFILLS 1",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "320",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "DIRECTIONS: INJECT 320MG OF INFLECTRA FREQUENCY: LOADING DOSE WKS 0,2,6 QUANTITY: 12 VIALS REFILLS:",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "320",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "DIRECTIONS: INJECT 320MG FREQUENCY: 0,2,6 EVERY 6 WEEKS QUANTITY: 12 REFILLS: NONE",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21495008",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005053",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product selection error",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "9- 100 MG/20 ML, (INFUSE OVER 2 HOURS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "900",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "900 MILLIGRAM, 0, 2, 6 WKS, THEN Q8 THEREAFTER",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SOLU-MEDROL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "125",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "125 MILLIGRAM, 15 MINUTES PRIOR",
                        "drugadministrationroute": "042",
                        "drugindication": "Premedication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHYLPREDNISOLONE SODIUM SUCCINATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "BENADRYL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "25",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "25 MILLIGRAM, 30 MINUTES PRIOR",
                        "drugadministrationroute": "048",
                        "drugindication": "Premedication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DIPHENHYDRAMINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "BENADRYL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "25",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "25 MILLIGRAM",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DIPHENHYDRAMINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "TYLENOL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "650",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "650 MILLIGRAM, 30 PRIOR",
                        "drugadministrationroute": "048",
                        "drugindication": "Premedication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ACETAMINOPHEN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CLARITIN",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10 MILLIGRAM, Q4HR PRN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LORATADINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ENBREL",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ETANERCEPT"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CYMBALTA",
                        "drugbatchnumb": "unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DULOXETINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "AMLODIPINE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "5 MILLIGRAM, DAILY",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "AMLODIPINE BESYLATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CLONAZEPAM",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "1",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1 MILLIGRAM, TID",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CLONAZEPAM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LYSINE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MILLIGRAM, DAILY",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LYSINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "WIXELA INHUB",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "250-50 MCG/DOSE",
                        "drugdosageform": "Inhalation powder",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FLUTICASONE PROPIONATE\\SALMETEROL XINAFOATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "20",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "20 MILLIGRAM, DAILY",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10 MILLIGRAM, BID FOR 30 DAYS",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "TIZANIDINE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "4",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "4 MILLIGRAM, DAILY",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "TIZANIDINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PROVENTIL HFA [SALBUTAMOL]",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "90 MCG/ACTUATION AEROSOL INHALER: 2 PUFFS 4-6 HOURS",
                        "actiondrug": "5",
                        "drugadditional": "3"
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "MORPHINE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "15",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "15 MILLIGRAM, 1 TAB Q8HR FOR PAIN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "MORPHINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SELENIUM",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "50",
                        "drugstructuredosageunit": "004",
                        "drugdosagetext": "50 MICROGRAM, 1 TABLET DAILY",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SELENIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METHOTREXATE SODIUM",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "10 TABLET ONCE A WEEK FOR 30 DAYS",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHOTREXATE SODIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FOLIC ACID",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "1",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1 MILLIGRAM, 1 TABLET DAILY FOR 30 DAYS",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FOLIC ACID"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "HYDROXYCHLOROQUINE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "200 MILLIGRAM, 1 TABLET BID FOR 90 DAYS",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "HYDROXYCHLOROQUINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SULFASALAZINE",
                        "drugbatchnumb": "UNKNOWN",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MILLIGRAM, QID FOR 30 DAYS",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SULFASALAZINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ALLOPURINOL",
                        "drugbatchnumb": "Unknown",
                        "drugindication": "Gout",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ALLOPURINOL"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21495011",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2021US019366",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product temperature excursion issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "DIRECTIONS: INJECTION 534 MG OF INFLECTRA FREQUENCY: WEEK 0,2,6 THEN Q 8 WKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "21495952",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221228",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US016971",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US016971"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US016971"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Throat tightness",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pruritus",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Urticaria",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Rash",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Malaise",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FX5000",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Hidradenitis",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220815",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "GA7126",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "800",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "800MG INFUSION EVERY 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20221010",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "BENADRYL",
                        "drugbatchnumb": "042044",
                        "drugdosagetext": "25 OF BENADRYL 30 MINUTES PRIOR TO THE PATIENTS^S INFUSION",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220815",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DIPHENHYDRAMINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SOLU-CORTEF",
                        "drugbatchnumb": "FN6860",
                        "drugdosagetext": "50 OF SOLU CORTEF 30 MINUTES PRIOR TO THE PATIENTS^S INFUSION",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220815",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "HYDROCORTISONE SODIUM SUCCINATE"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220815"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496358",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006587",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "290",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "5 MG/KG, EVERY 2 MONTHS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FP8959",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "450",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "450MG INFUSED ONCE EVERY TWO MONTHS (THREE VIALS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FG4223",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "450",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "450 MG (TWO VIALS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220701"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496364",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006636",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496365",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006642",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Underdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "100",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "100MG, EVERY 4 WEEKS (MONTHLY) BY INFUSION, CALLER SAID THAT SHE IS MAXED OUT IN THE DOSAGE",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Ankylosing spondylitis",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220510"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496366",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006706",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "5MG EVERY 4 WEEKS QUANTITY: 5 REFILLS: 11",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496367",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006708",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "INJECT 500 MG OF INFLECTRA FREQUENCY: 8 WEEKS QUANTITY: 5 REFILLS: 6",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496368",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006683",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Prescribed overdose",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product selection error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10 MG/KG EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496369",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006707",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hidradenitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Hidradenitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496371",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006770",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "100",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "100 MG, WEEKLY, DIRECTIONS: INJECT 100 MG AT WEEK 0,2,6 Q 8 WEEKS, IV AT WEEK 0,2,6 QUANTITY:6 REFIL",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496372",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006726",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Decreased appetite",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Symptom recurrence",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Diarrhoea",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy non-responder",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapeutic response decreased",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "(600 OR 800 INTRAVENOUSLY EVERY 8 WEEKS); ONLY HAD 2-3 IV^S STARTED IN AUG 2021 OR SEP 2021",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "600 OR 800 EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "602",
                        "drugstartdate": "2021",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496373",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006725",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG, WEEKS 0,2,6Q6-8 W",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496374",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006713",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "1100",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "1100 MG OF INFLECTRA FREQUENCY: EVERY 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "RITUXIMAB",
                        "drugbatchnumb": "UNKNOWN",
                        "drugdosageform": "Solution for infusion",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "RITUXIMAB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496375",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006763",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK (FREQUENCY: 0,2,6 Q8 WKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MG EVERY 2 WEEKS X 2 DOSES THEN 400 MG EVERY 8 WEEKS (STARTING WEEKS AFTER THE 2ND LOADING DOSE)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "AMITRIPTYLINE HYDROCHLORIDE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "EVERY 0,2,6, AND 8 WEEKS",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "AMITRIPTYLINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "AMITRIPTYLINE HYDROCHLORIDE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "0.5% KETAMINE AND 1% AMITRIPTYLINE COMPOUNDED INTO CREAM OR GEL INTO 60 GRAM TUBE",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "AMITRIPTYLINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ARAVA",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "1",
                        "drugstructuredosageunit": "032",
                        "drugdosagetext": "TAKE 1 TABLET BY MOUTH DAILY",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LEFLUNOMIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ASPIRIN",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "1",
                        "drugstructuredosageunit": "032",
                        "drugdosagetext": "TAKE 1 TABLE BY MOUTH DAILY",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ASPIRIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CYANOCOBALAMIN",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "1",
                        "drugstructuredosageunit": "032",
                        "drugdosagetext": "(STRENGTH: 1000 MICROGRAM) TAKE 1 TABLET BY MOUTH DAILY",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CYANOCOBALAMIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CYMBALTA",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "3",
                        "drugstructuredosageunit": "032",
                        "drugdosagetext": "TAKE 3 CAPSULES BY MOUTH DAILY",
                        "drugdosageform": "Capsule",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DULOXETINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISOLONE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "2",
                        "drugstructuredosageunit": "032",
                        "drugdosagetext": "2 TABS DAILY",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISOLONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "DRISDOL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "1",
                        "drugstructuredosageunit": "032",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "(STRENGTH: 1,250 MCG (50,000 UNIT)) TAKE 1 CAPSULE BY MOUTH ONE TIME PER WEEK",
                        "drugdosageform": "Capsule",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ERGOCALCIFEROL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "DRISDOL",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ERGOCALCIFEROL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ELAVIL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "1",
                        "drugstructuredosageunit": "032",
                        "drugdosagetext": "TAKE 1 TABLET BY MOUTH EVERY DAY AT NIGHT",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "AMITRIPTYLINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "EPIPEN",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "0.3",
                        "drugstructuredosageunit": "012",
                        "drugdosagetext": "INJECT 0.3 ML INTO THE MUSCLE AS NEEDED",
                        "drugadministrationroute": "030",
                        "drugindication": "Anaphylactic reaction",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "EPINEPHRINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FERROUS SULFATE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "1",
                        "drugstructuredosageunit": "032",
                        "drugdosagetext": "(STRENGTH: 325 MG (65 MG IRON)), TAKE 1 TABLET BY MOUTH 2 TIMES DAILY",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FERROUS SULFATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "HYDRODIURIL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "1",
                        "drugstructuredosageunit": "032",
                        "drugdosagetext": "TAKE 1 TABLET BY MOUTH DAILY",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "HYDROCHLOROTHIAZIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "JANUMET XR",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "2",
                        "drugstructuredosageunit": "032",
                        "drugdosagetext": "(STRENGTH: 50 - 1000 MG) TAKE 2 TABLETS BY MOUTH DAILY",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METFORMIN HYDROCHLORIDE\\SITAGLIPTIN PHOSPHATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "KETAMINE HYDROCHLORIDE",
                        "drugbatchnumb": "unknown",
                        "drugdosagetext": "0.5% KETAMINE AND 1% AMITRIPTYLINE COMPOUNDED INTO CREAM OR GEL INTO 60 GRAM TUBE",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "KETAMINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LAMICTAL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "1",
                        "drugstructuredosageunit": "032",
                        "drugdosagetext": "TAKE 1 TABLET BY MOUTH 2 TIMES DAILY",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LAMOTRIGINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "MAGNESIUM SULFATE;POTASSIUM;SODIUM CHLORIDE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "(STREGNTH: 17.5 ~3.13 - 1.6 GRAM) TAKE 6 OZ BY MOUTH 2 TIMES DAILY. SUPREP; THE FIRST 6-OUNCE BOTTLE",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3"
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "NALTREXONE HYDROCHLORIDE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "4.5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "TAKE 4.5 MG PO NIGHTLY",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "NALTREXONE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "NEURONTIN",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "1",
                        "drugstructuredosageunit": "032",
                        "drugdosagetext": "TAKE 1 TABLET IN THE MORNING AND 2 TABLETS IN THE EVENING",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "GABAPENTIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PRILOSEC",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "1",
                        "drugstructuredosageunit": "032",
                        "drugdosagetext": "TAKE 1 CAPSULE BY MOUTH EVERY DAY",
                        "drugdosageform": "Capsule",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "OMEPRAZOLE MAGNESIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PRINIVIL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "1",
                        "drugstructuredosageunit": "032",
                        "drugdosagetext": "TAKE 1 TABLET BY MOUTH DAILY",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LISINOPRIL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SYNTHROID",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "1",
                        "drugstructuredosageunit": "032",
                        "drugdosagetext": "(STRENGTH: 112 MCG) TAKE 1 TABLET BY MOUTH DAILY",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LEVOTHYROXINE SODIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "TRENTAL",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "1",
                        "drugstructuredosageunit": "032",
                        "drugdosagetext": "TAKE 1 TABLET BY MOUTH 3 TIMES DAILY",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PENTOXIFYLLINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VALIUM",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "1",
                        "drugstructuredosageunit": "032",
                        "drugdosagetext": "TAKE 1 TAB BY MOUTH 2-3 TIMES DAILY AS NEEDED",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "drugindication": "Anxiety",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DIAZEPAM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VALIUM",
                        "drugdosageform": "Tablet",
                        "drugindication": "Panic attack",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DIAZEPAM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ZESTRIL",
                        "drugbatchnumb": "Unknown",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LISINOPRIL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ZOCOR",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "1",
                        "drugstructuredosageunit": "032",
                        "drugdosagetext": "TAKE 1 TABLET BY MOUTH NIGHTLY",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SIMVASTATIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ZOFRAN",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "1",
                        "drugstructuredosageunit": "032",
                        "drugdosagetext": "TAKE 1 TABLET BY MOUTH EVERY 8 HOURS AS NEEDED",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "drugindication": "Nausea",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ONDANSETRON HYDROCHLORIDE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496376",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006836",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG AT WEEK 0,2,6 WEEKS THEN 5 MG EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496379",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007073",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "400 MG, EVERY 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496380",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007108",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": ": IV 200MG @WEEKS 0,2,6 THEN Q6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496381",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007099",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496382",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007110",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG EVERY 7 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496383",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006976",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "EVERY 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496386",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007327",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496387",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007193",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496388",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007329",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "700",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "700 MG EVERY 42 DAYS QUANTITY: 7 VIALS REFILLS: 12",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Psoriatic arthropathy",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496389",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007322",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "INFUSE 5MG/20ML",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496391",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007177",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Circumstance or information capable of leading to medication error",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496392",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007416",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, INFUSE 10MG/KG IV AFTER LOADING DOSES @ 0,2,6 AND THEN EVERY 8 WEEKS, QUANTITY-10 VIALS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496393",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007412",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "500MG FREQUENCY WEEKLY",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "600",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "2",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "600MG IV EVERY 2 WEEKS QUANTITY: #6 VIALS REFILLS: 11",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496394",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007370",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "5 MG (100MG/20ML/ DIRECTIONS: 5MG 1 KG) EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496395",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007332",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product prescribing error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "5 MILLIGRAM PER MILLILITRE",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496396",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007342",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10 MG/KG Q8WK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Hidradenitis",
                        "actiondrug": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496397",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007354",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Condition aggravated",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hypertension",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug ineffective",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG (300MG) WEEKS 0,2,6 THEN EVERY 8 WEEKS/300 MG, CYCLIC (WEEKS 0,2,6 THEN EVERY 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Rheumatoid arthritis",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202201",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "NORVASC",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "1 TABLET BY MOUTH EVERY 12 HOURS",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "AMLODIPINE BESYLATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LAC-HYDRIN",
                        "drugbatchnumb": "Unknown",
                        "drugdosageform": "Lotion (Except Lotion For Eye)",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "AMMONIUM LACTATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LIPITOR",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10 MILLIGRAM (1 TABLET), EVERYDAY AT BEDTIME BY MOUTH",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ATORVASTATIN CALCIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VITAMIN D3",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "50",
                        "drugstructuredosageunit": "004",
                        "drugdosagetext": "50 MICROGRAM 50 MCG (2000 UT) TABLET, TAKE 2,000 UNITS BY MOUTH",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CHOLECALCIFEROL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "TIAZAC",
                        "drugbatchnumb": "Unknown",
                        "drugdosageform": "Capsule, extended release",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DILTIAZEM HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PLAQUENIL",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "1 AND 1/2 TABLETS BY MOUTH DAILY",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "HYDROXYCHLOROQUINE SULFATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FEMARA",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "1 TABLET (2.5 MG TOTAL) BY MOUTH IN THE MORNING",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LETROZOLE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SYNTHROID",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "25 MCG BY MOUTH BEFORE BREAKFAST.",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LEVOTHYROXINE SODIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "RAYOS",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "3 TAB AT BEDTIME",
                        "drugdosageform": "Tablet, prolonged release",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PROLENSA",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "1 DROP IN LEFT EYE ONCE A DAY FOR 4 WEEKS (START 3 DAYS BEFORE SURGERY)",
                        "drugdosageform": "Solution (Except Syrup)",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "BROMFENAC SODIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ACTONEL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "150",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1 TABLET (150 MG) BY MOUTH EVERY 30 (THIRTY) DAYS",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "RISEDRONATE SODIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LISINOPRIL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "TAKE 1 TABLET DAILY",
                        "drugdosageform": "Tablet",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20120606",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LISINOPRIL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ZOCOR",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "1 TABLET DAILY",
                        "drugdosageform": "Tablet",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20120606",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SIMVASTATIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CALCIUM CARBONATE",
                        "drugbatchnumb": "Unknown",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CALCIUM CARBONATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LEVOXYL",
                        "drugbatchnumb": "Unknown",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LEVOTHYROXINE SODIUM"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220225"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496399",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007566",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496400",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007417",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MG, EVERY 8 WEEKS/(100MG/20ML; FREQUENCY: Q 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496401",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007418",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496404",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007562",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product distribution issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "2",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "UNKNOWN DOSE, EVERY 2 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Psoriatic arthropathy",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220504",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Ankylosing spondylitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496405",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007556",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MG ON DAY 1, 15 AND 43; THEN EVERY 8 WEEKS QUANTITY: 10 VIALS X1; THEN 5 VIALS REFILLS: 10",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496406",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007561",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Mesenteric panniculitis",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Mesenteric panniculitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496409",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007589",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MILLIGRAM/KILOGRAM, EVERY 7 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496411",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007636",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MG EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496412",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007585",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220101",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220317",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220520",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496413",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007627",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Injection site swelling",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Inability to afford medication",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNKNOWN DOSAGE INJECTION EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220509"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496414",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007578",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MG FREQUENCY: 0,2,6 WEEKS LOAD QUANTITY: 5 REFILLS: EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496415",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007666",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, WKS 0,2+6 THEN Q4WKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496417",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007802",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "1127",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "4",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "1127 MG, Q4WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496419",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007845",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Nausea",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Vomiting",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pruritus",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "C-reactive protein increased",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Red blood cell sedimentation rate increased",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496420",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007850",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "WILL START MEDICATION ON 7JUN2022",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Juvenile idiopathic arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496421",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007816",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug ineffective",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496422",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007820",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Intentional product use issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, CYCLIC (FROM Q8W (EVERY 8 WEEKS) TO Q6W (EVERY 6 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496423",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007872",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "200 MG, 0,2 + 6, THEN EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496425",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007738",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Skin lesion",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Papule",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Rash",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FM6845",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG, (INFUSE 5MG/KG IV Q 7 W)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210714",
                        "actiondrug": "4",
                        "drugrecurreadministration": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG, (INFUSE 5MG/KG IV Q 8 W)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "4",
                        "drugrecurreadministration": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG Q7W",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210825",
                        "drugenddateformat": "102",
                        "drugenddate": "20210825",
                        "drugtreatmentduration": "1",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "4",
                        "drugrecurreadministration": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20210906",
                        "drugenddateformat": "102",
                        "drugenddate": "20210906",
                        "drugtreatmentduration": "1",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "4",
                        "drugrecurreadministration": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG Q7W",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211022",
                        "drugenddateformat": "102",
                        "drugenddate": "20211022",
                        "drugtreatmentduration": "1",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "4",
                        "drugrecurreadministration": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG Q7W",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211215",
                        "drugenddateformat": "102",
                        "drugenddate": "20211215",
                        "drugtreatmentduration": "1",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "4",
                        "drugrecurreadministration": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG Q7W",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220209",
                        "drugenddateformat": "102",
                        "drugenddate": "20220209",
                        "drugtreatmentduration": "1",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "4",
                        "drugrecurreadministration": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG Q7W",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220330",
                        "drugenddateformat": "102",
                        "drugenddate": "20220330",
                        "drugtreatmentduration": "1",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "4",
                        "drugrecurreadministration": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "NEXIUM",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ESOMEPRAZOLE MAGNESIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "NEXION",
                        "drugbatchnumb": "UNKNOWN",
                        "actiondrug": "5",
                        "drugadditional": "3"
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496428",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007878",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Treatment delayed",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496429",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007906",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG, EVERY 56 DAYSQUANTITY: 6 VIALS REFILLS: BLANK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG, Q 56 DAYS QUANTITY: 6 VIALS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496430",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007877",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "490",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "490 MG ON WEEK 0,2,6 THEN EVERY 8 WEEKS THEREAFTER",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496433",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008017",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "200 MG (FREQUENCY: 02, +6, THEN EVERY 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496434",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007887",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, EVERY 5 WEEKS (FIRST DOSE)",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, EVERY 5 WEEKS (SECOND DOSE)",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK, EVERY 5 WEEKS (THIRD DOSE)",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METHOTREXATE",
                        "drugbatchnumb": "UNKNOWN",
                        "drugdosagetext": "2.5MG ONCE A WEEK, TAKES 6 PILLS (MORE THAN A YEAR AGO)",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHOTREXATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METHOTREXATE",
                        "drugindication": "Arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHOTREXATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VITAMIN D NOS",
                        "drugbatchnumb": "UNKNOWN",
                        "drugdosagetext": "DAILY DOSE (BEEN ON IT FOR ABOUT SIX YEARS)",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "VITAMIN D NOS"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VITAMIN D NOS",
                        "drugindication": "Arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "VITAMIN D NOS"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FLUOXETINE",
                        "drugbatchnumb": "UNKNOWN",
                        "drugdosagetext": "40MG DAILY (IMPACTING HER MENTAL HEALTH/ STARTED TAKING IT PROBABLY ABOUT TWO YEARS AGO)",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FLUOXETINE HYDROCHLORIDE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496435",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008047",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "UNK (5MG/KG FREQUENCY AT 0,2,6 Q8 WEEKS QUANTITY)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496436",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008007",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "430",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "430 MILLIGRAM EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496437",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US008015",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Malaise",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220111",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220222",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220405",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220520",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496438",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US012715",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "275",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "DIRECTIONS: INJECT 275MG OF INFLECTRA IV FREQUENCY: EVERY 6 WEEKS QUANTITY: 3-100 MG VIALS REFILLS:1",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496439",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US013989",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "10 MG/KG, EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21496440",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221022",
            "receiptdateformat": "102",
            "receiptdate": "20221022",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US014066",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "900",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "X INFLECTRA 10MG/20ML DIRECTIONS: INJECT 900 MG OF INFLECTRA FREQUENCY: ONCE EVERY 6 WEEKS QUANTITY:",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "900",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "900 MILLIGRAM, CYCLIC  (ONCE EVERY 6 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21497051",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221023",
            "receiptdateformat": "102",
            "receiptdate": "20221023",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US012113",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US012113"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US012113"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Autoimmune hepatitis",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21497052",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221023",
            "receiptdateformat": "102",
            "receiptdate": "20221023",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US012135",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MILLIGRAM, CYCLIC (INJECT 500 MG OF INFLECTRA EVERY 2 WEEKS; QTY 3 REFILLS 2)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21497053",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221023",
            "receiptdateformat": "102",
            "receiptdate": "20221023",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US012177",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "400 MG, EVERY 5 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21497057",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221023",
            "receiptdateformat": "102",
            "receiptdate": "20221023",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US012247",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "IV EVERY 8 WEEKS QUANTITY: 3 REFILLS: 3",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21497058",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221023",
            "receiptdateformat": "102",
            "receiptdate": "20221023",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US012376",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product storage error",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product dose omission issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG FREQUENCY: 0,2,6 THEN Q 8 WEEKS QUANTITY: 4 REFILLS: 12",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21497060",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221023",
            "receiptdateformat": "102",
            "receiptdate": "20221023",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US012284",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "500",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "500 MG EVERY 7 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "9",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "500 MG IN SODIUM CHLORIDE 0.9% (NS) 250 ML INFUSION AT 9MG/KG AT UNSPECIFIED FREQUENCY",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugenddateformat": "102",
                        "drugenddate": "20220726",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FOSAMAX",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "70",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "70 MG, 1/WEEK",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211104",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ALENDRONATE SODIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ARAVA",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10 MG, DAILY",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211104",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LEFLUNOMIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "DELTASONE",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "5 MG AS NEEDED",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211104",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "DELTASONE",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "5 MG AS NEEDED",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220519",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "BACTROBAN",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "APPLY TWICE DAILY TO CRACKS AND FISSURES ON THE HANDS UNTIL WELL HEALED",
                        "drugdosageform": "Ointment",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220519",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "MUPIROCIN\\MUPIROCIN CALCIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PRILOSEC",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "20",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "20 MG, DAILY",
                        "drugdosageform": "Capsule, delayed release",
                        "drugadministrationroute": "048",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220510",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "OMEPRAZOLE MAGNESIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "KENALOG",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "APPLY TWICE DAILY TO ITCHY RASH ON THE ARMS AND HANDS FOR UP TO 2 WEEKS/MONTH AS NEEDED FOR FLARES",
                        "drugdosageform": "Ointment",
                        "drugindication": "Condition aggravated",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220519",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "TRIAMCINOLONE ACETONIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SODIUM CHLORIDE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "250",
                        "drugstructuredosageunit": "012",
                        "drugdosagetext": "250 MILLILITER, ONCE",
                        "drugadministrationroute": "042",
                        "drugenddateformat": "102",
                        "drugenddate": "20220726",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SODIUM CHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SOLU-MEDROL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "40",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "40 MG, ONCE",
                        "drugadministrationroute": "042",
                        "drugenddateformat": "102",
                        "drugenddate": "20220726",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHYLPREDNISOLONE SODIUM SUCCINATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "TYLENOL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "650",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "650 MG, ONCE",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "drugenddateformat": "102",
                        "drugenddate": "20220726",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ACETAMINOPHEN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "REMICADE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VITAMIN D NOS",
                        "drugbatchnumb": "Unknown",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "VITAMIN D NOS"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "OMEGA-3 FATTY ACIDS",
                        "drugbatchnumb": "Unknown",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "OMEGA-3 FATTY ACIDS"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21497061",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221023",
            "receiptdateformat": "102",
            "receiptdate": "20221023",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US012426",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product temperature excursion issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product packaging issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "ST1659",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "800",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "800 MG EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Axial spondyloarthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FX4998",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Peripheral spondyloarthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21497062",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221023",
            "receiptdateformat": "102",
            "receiptdate": "20221023",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US012434",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Back pain",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hyperhidrosis",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pruritus",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Flushing",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Dyspnoea",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Chest pain",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Nausea",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Dizziness",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product quality issue",
                        "reactionoutcome": "1"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FT5307",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG Q8WKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "1",
                        "drugrecurreadministration": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "TYLENOL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "325",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "325 MG, T=2 TABS QID AS NEEDED FOR PAIN",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ACETAMINOPHEN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ZOSTRIX [CAPSAICIN]",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "1 APP, TOPICAL, TID, PRN AS NEEDED FOR PAIN PRN",
                        "drugadministrationroute": "061",
                        "actiondrug": "5",
                        "drugadditional": "3"
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "RESTASIS",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK, PRN DRY EYES",
                        "drugdosageform": "Emulsion",
                        "drugadministrationroute": "047",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CYCLOSPORINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CYMBALTA",
                        "drugstructuredosagenumb": "60",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1 DAILY (60 MG)",
                        "drugdosageform": "Capsule, delayed release",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DULOXETINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FUROSEMIDE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "20",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "DAILY (20 MG)",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FUROSEMIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "IBUPROFEN",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "4 EVERY 4-6 HOURS AS NEEDED (200 MG)",
                        "drugdosageform": "Capsule",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "IBUPROFEN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "IBUPROFEN",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "800",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1 TAB(S), PO, BID, AS NEEDED",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "IBUPROFEN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METHIMAZOLE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1 TAB(S), PO, Q8H",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHIMAZOLE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METOPROLOL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "100",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1 CAP(S), PO, DAILY",
                        "drugdosageform": "Capsule",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METOPROLOL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PANTOPRAZOLE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "40",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "40 MG, DAILY",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PANTOPRAZOLE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISOLONE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "1 DROP(S), EYES, BOTH, DAILY",
                        "drugdosageform": "Solution (Except Syrup)",
                        "drugadministrationroute": "047",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISOLONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREDNISONE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "3 TAB(S), PO, 3 TABS DAILY X 3 DAYS; 2 TABS DAILY X 3 DAYS, 1 TAB DAILY X 3 DAYS, 1/2 TAB DAILY",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREDNISONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SERTRALINE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "50",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1 TAB DAILY (50 MG)",
                        "drugdosageform": "Tablet",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SERTRALINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SERTRALINE",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SERTRALINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ACETAMINOPHEN",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "1000",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1000 MG, PO, ONCE",
                        "drugadministrationroute": "048",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220717",
                        "drugenddateformat": "102",
                        "drugenddate": "20220717",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ACETAMINOPHEN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "DEXILANT",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "60",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1 CAP(S), PO, DAILY",
                        "drugdosageform": "Capsule, delayed release",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DEXLANSOPRAZOLE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "BENADRYL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "25",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "25 MG, PO, ONCE",
                        "drugadministrationroute": "048",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220714",
                        "drugenddateformat": "102",
                        "drugenddate": "20220714",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DIPHENHYDRAMINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "BENADRYL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "25",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "25 MG, PO, ONCE",
                        "drugadministrationroute": "048",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220519",
                        "drugenddateformat": "102",
                        "drugenddate": "20220519",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DIPHENHYDRAMINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "DIPHENHYDRAMINE",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "25",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "25 MG, IV, ONCE",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220714",
                        "drugenddateformat": "102",
                        "drugenddate": "20220714",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DIPHENHYDRAMINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "GABAPENTIN",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "400",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1 CAP(S), PO, TID",
                        "drugdosageform": "Capsule",
                        "drugadministrationroute": "048",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "GABAPENTIN"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220714"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21498428",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221024",
            "receiptdateformat": "102",
            "receiptdate": "20221024",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US007334",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "200 MG FREQUENCY: 56 QUANTITY: 2 VIALS REFILLS: 5",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "200MG EVERY 2 MONTHS QUANTITY: 2 VIAL REFILLS: 2",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "200MG EVERY 2 MONTHS QUANTITY: 2 VIAL REFILLS: 2",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ASPIRIN",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ASPIRIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VOLTAREN",
                        "drugbatchnumb": "unknown",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Gel",
                        "drugadministrationroute": "061",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DICLOFENAC SODIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METHOTREXATE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHOTREXATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "OMEGA-3 FATTY ACIDS",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Capsule",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "OMEGA-3 FATTY ACIDS"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LIDOCAINE HYDROCHLORIDE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Patch",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LIDOCAINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FOLATE SODIUM",
                        "drugbatchnumb": "Unknown",
                        "drugdosageform": "Tablet",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FOLATE SODIUM"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21498435",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221024",
            "receiptdateformat": "102",
            "receiptdate": "20221024",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US009326",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Impaired work ability",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product substitution issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug ineffective",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Underdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "10",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "10MG AT 70 10MG UNITS INFUSION NORMAL SALINE SOLUTION 250CC OVER 1 HOUR DURATION",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Ankylosing spondylitis",
                        "drugtreatmentduration": "1",
                        "drugtreatmentdurationunit": "805",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "REMICADE",
                        "drugbatchnumb": "UNKNOWN",
                        "drugdosagetext": "UNK",
                        "drugindication": "Inflammation",
                        "drugstartdateformat": "602",
                        "drugstartdate": "2008",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "21498448",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221024",
            "receiptdateformat": "102",
            "receiptdate": "20221109",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US011364",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Infusion related reaction",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "220",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "5MG/KG 220.0 MG- INFLECTA DIRECTIONS INJECT 5MG/KG 220.0 MG OF INFLECTRA FREQUENCY 2WKS FOR 2 WKS, 4",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "1",
                        "drugrecurreadministration": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5MG/KG (Q 2 WEEKS FOR 2 WEEKS; Q 4 WEEKS FOR 4 WEEKS, Q 6 WEEKS FOR 12 MONTHS) (REFILLS: 11)",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "1",
                        "drugrecurreadministration": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "507194696380",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220901",
                        "drugenddateformat": "102",
                        "drugenddate": "20220922",
                        "drugtreatmentduration": "22",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "1",
                        "drugrecurreadministration": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "718907731373",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220901",
                        "drugenddateformat": "102",
                        "drugenddate": "20220922",
                        "drugtreatmentduration": "22",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "1",
                        "drugrecurreadministration": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "906229099286",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "5 MG/KG",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220901",
                        "drugenddateformat": "102",
                        "drugenddate": "20220922",
                        "drugtreatmentduration": "22",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "1",
                        "drugrecurreadministration": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "BUDESONIDE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "BUDESONIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FAMOTIDINE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FAMOTIDINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CITALOPRAM",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CITALOPRAM HYDROBROMIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FERROUS SULFATE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FERROUS SULFATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "HYDROXYZINE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "HYDROXYZINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PEPCID [ALUMINIUM HYDROXIDE;MAGNESIUM TRISILICATE;SODIUM ALGINATE]",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3"
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "TYLENOL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "650",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "650 MG",
                        "drugadministrationroute": "048",
                        "drugindication": "Premedication",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220922",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ACETAMINOPHEN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "BENADRYL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "50",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "50 MG",
                        "drugadministrationroute": "042",
                        "drugindication": "Premedication",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220922",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DIPHENHYDRAMINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SOLU-MEDROL",
                        "drugbatchnumb": "Unknown",
                        "drugstructuredosagenumb": "125",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "125 MG",
                        "drugadministrationroute": "042",
                        "drugindication": "Premedication",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220922",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHYLPREDNISOLONE SODIUM SUCCINATE"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220922"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21498594",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221024",
            "receiptdateformat": "102",
            "receiptdate": "20221024",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US006768",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "8",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "8 MG/KG EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Psoriatic arthropathy",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "1200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "1200MG EVERY 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugenddateformat": "102",
                        "drugenddate": "20220710",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21513105",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221027",
            "receiptdateformat": "102",
            "receiptdate": "20221027",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US001530",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "200",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "200 MG, EVERY 12 WEEKS (QUANTITY: 2 REFILLS: 5)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "2",
                        "drugstructuredosageunit": "007",
                        "drugdosagetext": "2MG/KG EVERY 12 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CHOLECALCIFEROL",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CHOLECALCIFEROL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "DEPAKOTE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DIVALPROEX SODIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "LEVOFLOXACIN",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "LEVOFLOXACIN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FOLVITE [FOLIC ACID]",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3"
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "MOBIC",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "MELOXICAM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "RHEUMATREX",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHOTREXATE SODIUM"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ZOFRAN",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ONDANSETRON HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ROXICODONE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "OXYCODONE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "OMEPRAZOLE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "OMEPRAZOLE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SENOKOT",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SENNOSIDES"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21513107",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221027",
            "receiptdateformat": "102",
            "receiptdate": "20221027",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US012891",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product storage error",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21513108",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221027",
            "receiptdateformat": "102",
            "receiptdate": "20221027",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US012952",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapy interrupted",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Overdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "900",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "INJECT 900 MG OF INFLECTRA FREQUENCY: EVER 6 WEEKS, QUANTITY: 1 REFILLS: 11",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "900",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "900MG EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20170609",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "900",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "900MG EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220609",
                        "actiondrug": "4",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220805"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21547300",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221103",
            "receiptdateformat": "102",
            "receiptdate": "20221103",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US017969",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US017969"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US017969"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Systemic lupus erythematosus",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug intolerance",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "DOSE AND FREQUENCY NOT AVAILABLE",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21558419",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "2",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221107",
            "receiptdateformat": "102",
            "receiptdate": "20221107",
            "fulfillexpeditecriteria": "2",
            "companynumb": "US-CELLTRION INC.-2022US005461",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "250",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "250 MG, : Q 8 AFTER INDUCTION OF 0,2,6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "3",
            "safetyreportid": "21621210",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221121",
            "receiptdateformat": "102",
            "receiptdate": "20221229",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US019165",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US019165"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US019165"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pyoderma gangrenosum",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Condition aggravated",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapeutic response increased",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Drug effective for unapproved indication",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "5",
                        "drugstructuredosageunit": "007",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "1",
                        "drugintervaldosagedefinition": "802",
                        "drugdosagetext": "5 MG/KG, MONTHLY (LAST DOSE REPORTED WAS ON 25 AUG 2022)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Pyoderma gangrenosum",
                        "drugstartdateformat": "602",
                        "drugstartdate": "2021",
                        "drugenddateformat": "102",
                        "drugenddate": "20220825",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21630294",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221122",
            "receiptdateformat": "102",
            "receiptdate": "20221122",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US011781",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US011781"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US011781"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "COVID-19",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Product storage error",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Underdose",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Intentional dose omission",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG EVERY 0,2,6 THEN Q 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Psoriatic arthropathy",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FT1659",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG (300 MG INTRAVENOUSLY WEEK 0 WEEK 2 ANS WEEK 4 THEN EVERY 8 WEEKS), Q12H",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MG CYCLIC (300MG INTRAVENOUSLY WEEK 0, WEEK 2 AND WEEK 4. THEN EVERY 8 WEEKS)",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "IBUPROFEN",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "IBUPROFEN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "VITAMIN D3",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "CHOLECALCIFEROL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "FOLIC ACID",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FOLIC ACID"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METHOTREXATE",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METHOTREXATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "BREO ELLIPTA",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "FLUTICASONE FUROATE\\VILANTEROL TRIFENATATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "CARDIZEM",
                        "drugbatchnumb": "Unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DILTIAZEM HYDROCHLORIDE"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21659922",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "1",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221130",
            "receiptdateformat": "102",
            "receiptdate": "20221130",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US020008",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Death",
                        "reactionoutcome": "5"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220301"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21665533",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221201",
            "receiptdateformat": "102",
            "receiptdate": "20221201",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US017987",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US017987"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US017987"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "2"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Face oedema",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Rash",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FW0363",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "700",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "700 MILLIGRAM",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20211216",
                        "actiondrug": "1",
                        "drugadditional": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FW0363",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "700",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "700 MILLIGRAM",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220217",
                        "actiondrug": "1",
                        "drugadditional": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FW0363",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "700",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "700 MILLIGRAM",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220516",
                        "actiondrug": "1",
                        "drugadditional": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FW0363",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "700",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "700 MILLIGRAM",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220705",
                        "actiondrug": "1",
                        "drugadditional": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FW0363",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "800",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "800 MILLIGRAM",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220404",
                        "actiondrug": "1",
                        "drugadditional": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "FW0363",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "800",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "800 MILLIGRAM, (10 MG/KG) EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220825",
                        "actiondrug": "1",
                        "drugadditional": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PRAZOSIN HYDROCHLORIDE",
                        "drugbatchnumb": "unknown",
                        "drugdosagetext": "UNK",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PRAZOSIN HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "TIZANIDINE",
                        "drugbatchnumb": "unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "TIZANIDINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "TRIAMCINOLONE",
                        "drugbatchnumb": "unknown",
                        "drugdosageform": "Cream",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "TRIAMCINOLONE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "METRONIDAZOLE",
                        "drugbatchnumb": "unknown",
                        "drugdosageform": "Cream",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "METRONIDAZOLE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "SUMATRIPTAN",
                        "drugbatchnumb": "unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "SUMATRIPTAN"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "DICLOFENAC",
                        "drugbatchnumb": "unknown",
                        "drugdosageform": "Patch",
                        "drugadministrationroute": "061",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "DICLOFENAC"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ONDANSETRON",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "4",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "4 MILLIGRAM, TID",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ONDANSETRON"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PROMETHAZINE HYDROCHLORIDE",
                        "drugbatchnumb": "unknown",
                        "drugstructuredosagenumb": "25",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "25 MILLIGRAM, Q4WEEKS PRN",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PROMETHAZINE HYDROCHLORIDE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "OLANZAPINE",
                        "drugbatchnumb": "unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "OLANZAPINE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "NALOXEGOL",
                        "drugbatchnumb": "unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "NALOXEGOL"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "ZOLPIDEM",
                        "drugbatchnumb": "unknown",
                        "drugdosagetext": "UNK",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "ZOLPIDEM TARTRATE"
                        }
                    },
                    {
                        "drugcharacterization": "2",
                        "medicinalproduct": "PREGABALIN",
                        "drugbatchnumb": "unknown",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "PREGABALIN"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220828"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21680428",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221205",
            "receiptdateformat": "102",
            "receiptdate": "20221205",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US010099",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Fall",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Upper limb fracture",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Lymphoedema",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Influenza like illness",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Balance disorder",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Weight increased",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Fatigue",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Swelling",
                        "reactionoutcome": "3"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNKNOWN",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Colitis ulcerative",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202109",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20210101"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21708526",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221210",
            "receiptdateformat": "102",
            "receiptdate": "20221210",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US017581",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US017581"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US017581"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pyoderma gangrenosum",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Skin ulcer",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "065",
                        "drugindication": "Skin ulcer",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Pyoderma gangrenosum",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "21718609",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221212",
            "receiptdateformat": "102",
            "receiptdate": "20221216",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US018295",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US018295"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US018295"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Colitis ulcerative",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Insurance issue",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Colitis ulcerative",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21718680",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "1",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221213",
            "receiptdateformat": "102",
            "receiptdate": "20221213",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US020801",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US020801"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US020801"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Cerebrovascular accident",
                        "reactionoutcome": "5"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNKNOWN",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21719578",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "1",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221213",
            "receiptdateformat": "102",
            "receiptdate": "20221213",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US020789",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Respiratory failure",
                        "reactionoutcome": "5"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Breast cancer",
                        "reactionoutcome": "5"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNKNOWN",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220908"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21725452",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "1",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221214",
            "receiptdateformat": "102",
            "receiptdate": "20221214",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US020800",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US020800"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US020800"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pericarditis infective",
                        "reactionoutcome": "5"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "DOSE/FORMULATION: UNKNOWN",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Rheumatoid arthritis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21725465",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "1",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221214",
            "receiptdateformat": "102",
            "receiptdate": "20221214",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US020804",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US020804"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US020804"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Death",
                        "reactionoutcome": "5"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21727494",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "1",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221214",
            "receiptdateformat": "102",
            "receiptdate": "20221214",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US020912",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US020912"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US020912"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Diabetic ketoacidotic hyperglycaemic coma",
                        "reactionoutcome": "5"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220806"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21730851",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "1",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221215",
            "receiptdateformat": "102",
            "receiptdate": "20221215",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US020836",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Death",
                        "reactionoutcome": "5"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21736223",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221215",
            "receiptdateformat": "102",
            "receiptdate": "20221215",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US020859",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US020859"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US020859"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Surgery",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "UNKNOWN",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21736278",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "1",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221215",
            "receiptdateformat": "102",
            "receiptdate": "20221215",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US020887",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Death",
                        "reactionoutcome": "5"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNK",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20220901"
                }
            }
        },
        {
            "safetyreportversion": "2",
            "safetyreportid": "21736499",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221215",
            "receiptdateformat": "102",
            "receiptdate": "20221223",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US021038",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US021038"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US021038"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Gastric ulcer",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Gastric ulcer",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21745264",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "1",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221219",
            "receiptdateformat": "102",
            "receiptdate": "20221219",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US021292",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US021292"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US021292"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Death",
                        "reactionoutcome": "5"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20221125"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21745285",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "1",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221219",
            "receiptdateformat": "102",
            "receiptdate": "20221219",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US021266",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US021266"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US021266"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Death",
                        "reactionoutcome": "5"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Cardiac disorder",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20211224"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21758006",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221221",
            "receiptdateformat": "102",
            "receiptdate": "20221221",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US021176",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Throat irritation",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Urticaria",
                        "reactionoutcome": "1"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "GH1784",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "207",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "207MG IV ON WEEK 0, 2, 4 THEN Q 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Felty^s syndrome",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20221129",
                        "drugenddateformat": "102",
                        "drugenddate": "20221213",
                        "drugtreatmentduration": "15",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20221213"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21769799",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "1",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221223",
            "receiptdateformat": "102",
            "receiptdate": "20221223",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US021363",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US021363"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US021363"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "1"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Eating disorder",
                        "reactionoutcome": "3"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Abdominal pain",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Underdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "2",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "300 MG, Q2WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Colitis ulcerative",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220726",
                        "actiondrug": "1",
                        "drugadditional": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugseparatedosagenumb": "1",
                        "drugintervaldosageunitnumb": "2",
                        "drugintervaldosagedefinition": "803",
                        "drugdosagetext": "300MG, INTRAVENOUS INFUSION, 2 WEEKS APART",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20220809",
                        "actiondrug": "1",
                        "drugadditional": "2",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21770462",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221223",
            "receiptdateformat": "102",
            "receiptdate": "20221223",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US016094",
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Rash",
                        "reactionoutcome": "2"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Pruritus",
                        "reactionoutcome": "2"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Underdose",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugstructuredosagenumb": "300",
                        "drugstructuredosageunit": "003",
                        "drugdosagetext": "300 MILLIGRAM AT WEEKS 0,2,6, THEN AT 8 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Colitis ulcerative",
                        "drugstartdateformat": "102",
                        "drugstartdate": "20221006",
                        "drugenddateformat": "102",
                        "drugenddate": "20221018",
                        "drugtreatmentduration": "13",
                        "drugtreatmentdurationunit": "804",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Colitis",
                        "actiondrug": "1",
                        "drugadditional": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20221010"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21774113",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "1",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221223",
            "receiptdateformat": "102",
            "receiptdate": "20221223",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US021364",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US021364"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US021364"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Basal cell carcinoma",
                        "reactionoutcome": "5"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Crohn^s disease",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Therapeutic response changed",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "EVERY 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202108",
                        "drugenddateformat": "610",
                        "drugenddate": "202108",
                        "actiondrug": "1",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "REMICADE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "WAS ON REMICADE FOR 20 YEARS",
                        "drugindication": "Crohn^s disease",
                        "drugenddateformat": "610",
                        "drugenddate": "202207",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21780766",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "1",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "1",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221227",
            "receiptdateformat": "102",
            "receiptdate": "20221227",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US021534",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US021534"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US021534"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Ovarian cancer",
                        "reactionoutcome": "5"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21787100",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221228",
            "receiptdateformat": "102",
            "receiptdate": "20221228",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US019389",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US019389"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US019389"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "3"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Breakthrough COVID-19",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "COVID-19",
                        "reactionoutcome": "1"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Diarrhoea",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Unevaluable event",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "Q 6 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "drugindication": "Product used for unknown indication",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "Q 4 WEEKS",
                        "drugdosageform": "Powder for injection",
                        "drugadministrationroute": "042",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "PFIZER-BIONTECH COVID-19 VACCINE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugadministrationroute": "030",
                        "drugindication": "COVID-19 immunisation",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202012",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "TOZINAMERAN"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "PFIZER-BIONTECH COVID-19 VACCINE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugadministrationroute": "030",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202101",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "TOZINAMERAN"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "PFIZER-BIONTECH COVID-19 VACCINE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugadministrationroute": "030",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202110",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "TOZINAMERAN"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "PFIZER-BIONTECH COVID-19 VACCINE",
                        "drugbatchnumb": "Unknown",
                        "drugdosagetext": "UNK",
                        "drugadministrationroute": "030",
                        "drugstartdateformat": "610",
                        "drugstartdate": "202205",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "TOZINAMERAN"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20221014"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21793913",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230113",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "1",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "2",
            "receivedateformat": "102",
            "receivedate": "20221229",
            "receiptdateformat": "102",
            "receiptdate": "20221229",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US021697",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US021697"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT- 2022US021697"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Completed suicide",
                        "reactionoutcome": "5"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Hanging",
                        "reactionoutcome": "5"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosagetext": "UNKNOWN",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Crohn^s disease",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    },
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Colitis",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ],
                "summary": {
                    "narrativeincludeclinical": "CASE EVENT DATE: 20221013"
                }
            }
        },
        {
            "safetyreportversion": "1",
            "safetyreportid": "21797460",
            "primarysourcecountry": "US",
            "occurcountry": "US",
            "transmissiondateformat": "102",
            "transmissiondate": "20230112",
            "reporttype": "1",
            "serious": "1",
            "seriousnessdeath": "2",
            "seriousnesslifethreatening": "2",
            "seriousnesshospitalization": "2",
            "seriousnessdisabling": "2",
            "seriousnesscongenitalanomali": "2",
            "seriousnessother": "1",
            "receivedateformat": "102",
            "receivedate": "20221230",
            "receiptdateformat": "102",
            "receiptdate": "20221230",
            "fulfillexpeditecriteria": "1",
            "companynumb": "US-CELLTRION INC.-2022US021736",
            "duplicate": "1",
            "reportduplicate": [
                {
                    "duplicatesource": "CELLTRION INC.",
                    "duplicatenumb": "US-CELLTRION INC.-2022US021736"
                },
                {
                    "duplicatesource": "CELLTRION HEALTHCARE HUNGARY KFT",
                    "duplicatenumb": "US-CELLTRION HEALTHCARE HUNGARY KFT-2022US021736"
                }
            ],
            "primarysource": {
                "reportercountry": "US",
                "qualification": "5"
            },
            "sender": {
                "sendertype": "2",
                "senderorganization": "FDA-Public Use"
            },
            "receiver": {
                "receivertype": "6",
                "receiverorganization": "FDA"
            },
            "patient": {
                "reaction": [
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Colectomy",
                        "reactionoutcome": "6"
                    },
                    {
                        "reactionmeddraversionpt": "25.1",
                        "reactionmeddrapt": "Off label use",
                        "reactionoutcome": "6"
                    }
                ],
                "drug": [
                    {
                        "drugcharacterization": "1",
                        "medicinalproduct": "INFLECTRA",
                        "drugbatchnumb": "Unknown",
                        "drugauthorizationnumb": "125544",
                        "drugdosageform": "Powder for injection",
                        "drugindication": "Colectomy",
                        "actiondrug": "5",
                        "drugadditional": "3",
                        "activesubstance": {
                            "activesubstancename": "INFLIXIMAB-DYYB"
                        }
                    }
                ]
            }
        }
    ]
}